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 Abstract 
Formulating multiple nutrient supplements and better dosage forms for paediatric patients 
are still current needs and challenges. This study aims to develop a cost-effective novel 
delivery system capable of delivering water-soluble and oil-soluble nutrients or drugs to 
address paediatric compliance. Two ranges of micron and submicron scale carriers for 
nutrients and drugs were developed and characterized thoroughly. First, fast-dissolving 
orodispersible film was produced using an emerging electrospinning technique to deliver 
iodine, an essential micronutrient. PEO and KIO3 were used in a formulation that ensures the 
safety and cost-effectiveness of the final product. Second, a novel structured oil system (SOS), 
capable of holding a large amount of oil, was designed as a carrier for fat-soluble vitamins and 
drugs. This SOS was produced using a freeze dryer that is suitable for heat sensitive vitamins 
and drugs. Gelatine/Xanthangum were used as emulsifiers due to the affinity of protein-
polysaccharide complexes to form emulsions stable to environmental stresses such as 
freezing. In addition, a range of SOSs were formulated using Hypromellose/Xanthangum, 
Methylcellulose/Xanthangum, Tween 20/Xanthangum, and Gelatine/Carboxymethylcellulose 
in order to understand the formation of SOS, to prove the concept that any surface active and 
non-surface active polymers that can form electrostatic complexes can form SOS, and to find 
an alternative to Gelatine/Xanthangum emulsifiers. A thorough physicochemical 
characterisation of both the fast-dissolving orodispersible film and structured oil systems was 
conducted using a range of analytical techniques including imaging techniques (various 
optical and electron microscopes, and XμCT), ATR-FTIR, PXRD, DSC, TGA, a texture analyser, 
LD, and in vitro dissolution testing. 
This study demonstrated that electrospinning technology has great potential to be used in 
formulating a dosage form for children, that liquid vegetable oil and fish oil can be 
encapsulated within fibres using emulsion electrospinning and introduced a novel solid 
structured oil system capable of holding large amounts of oil. 
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1 Chapter 1. Introduction 
1.1 Introduction 
In the human body, multiple micronutrient deficiency is more common than single nutrient 
deficiency because nutrients act synergistically or antagonistically relative to each other, with 
the lack or excess of one micronutrient affecting the absorption and metabolism of another. 
In infants and children, nutrition is one of the most important environmental factors 
influencing individual brain development. In addition, it is known that the brain grows rapidly 
within the first two years of a baby’s life during which time it reaches 80 % of its adult weight 
[1]. It is therefore very important that in their early life children have sufficient nutritional 
intake. Prenatal, pregnant and lactating women are also susceptible to multiple micronutrient 
deficiency due to the extensive loss of vital vitamins and minerals during pregnancy. Multiple 
strategies for micronutrient supplementation and fortification of foods have been 
implemented by international organizations in partnership with government and public 
health officials, and the food and pharmaceutical industries, in order to prevent nutrient 
deficiency. Such examples include salt iodization and supplementation with iodized oil 
capsules, triple salt fortification, flour fortification with iron, iron-folic acid supplementation, 
periodic vitamin A supplementation and micronutrient powders to sprinkle on the foods 
being prepared at home. The United Nations Children's Fund (UNICEF) has been working with 
partners to develop and test a multiple micronutrient formulation to reduce anaemia, and is 
now working with partners to develop global guidance on intervention for the delivery of 
multiple micronutrient supplements [1-3]. In addition to salt, UNICEF supports national 
governments to develop food fortification programmes for vitamin A, iron and folic acid and 
they are advocating for legislation to make food fortification mandatory. Despite all these 
efforts, according to UNICEF and the World Health Organization (WHO) estimations, millions 
of children still suffer from stunted growth, cognitive delays, weakened immunity, and 
disease and even lose their life as a result of micronutrient deficiency. Often micronutrient 
deficiencies are also referred to as “hidden hunger”, because they progress gradually over 
time without any evident symptoms until irreversible harm to health has been done. A child 
may go to sleep each night with a full belly; however, an imbalanced diet could mean that his 
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or her body is suffering from micronutrient deficiency. WHO prioritise four forms of hidden 
malnutrition and these are vitamin A, iodine, iron and zinc deficiencies [4]. Every year 
between 250,000 to 500,000 children become blind just because of vitamin A deficiency. In 
2011, it was estimated that about 800 million children and women worldwide were affected 
with anaemia [5]. Over 740 million people have iodine deficiency disorders and 50 million 
people have some degree of mental retardation due to iodine deficiency disorders [6]. About 
17.3% of the world’s population is at risk of inadequate zinc intake [7]. 
1.2 Nutritional Supplements 
Nutritional supplementation was first implemented as a main strategy to correct or prevent 
nutritional deficiencies in populations between the First and Second World Wars (1924–
1945). During that period, salt iodization, margarine and milk fortification with vitamins A and 
D, and flours and bread fortification with vitamins B1, B2, niacin, and iron were introduced 
[8]. These micronutrients play a key role in the mental and physical development of the 
human body. For example, vitamin A is vital for the visual system, for growth and 
development [9]. Iodine is responsible for normal formation and function of the brain and 
thyroid gland, and for normal pregnancy and birth [10]. Zinc is a builder of the immune 
system, while iron deficiency causes anaemia [11]. 
The definition for dietary supplements slightly differs in different countries. In the UK it is 
defined as “foods in unit dosage form, e.g. tablets, capsules and elixirs, taken to supplement 
the diet. Most are products containing nutrients normally present in foods which are used by 
the body to develop cells, bone, muscle, etc., to replace co-enzymes depleted by infection and 
illness, and generally to maintain good health” [12]. 
In Europe, the definition is that “food supplements are preparations including tablets, 
capsules, powders and liquids which are composed of, or contain, nutrients, micronutrients 
and/or other eligible substances consumed in unit quantities in addition to the normal food 
intake. Food supplements can be composed of vitamins, minerals and trace elements; 
peptides, amino acids and similar nitrogen-containing compounds; oils and fatty acids and 
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their esters; fibres and other materials of plant or animal microbial origin as well as 
fermentation products, including those in dehydrated, concentrated or extracted form” [12]. 
In the United States, the Food and Drug Administration (FDA) includes herbs and other 
botanicals together with the items defined above. 
The majority of dietary supplements existing in the UK are classified as foods and are not 
controlled as strictly as medicines. They are regulated by the Food Labelling Regulations 
(1996). Only the Medical and Healthcare Regulatory Agency, which includes the former 
Medicine Control Agency can determine whether a product is a medicine or not [12]. The 
majority of nutritional supplements are sold without prescription. Nevertheless, some 
nutritional products prescribed for specific conditions will be classified as medicines rather 
than food. Those prescriptions are offered to patients who have a chronic disease and may 
need special nutrients over a long period [13]. 
Vitamins and minerals. Vitamins and minerals play an essential role in the body’s metabolic 
processes. They perform a function in enzymatic reactions and structure tissues such as bone 
and blood. Although the amount needed by the human body is very small, ranging from 
micrograms to milligrams, the effect of these nutrients is great. Most vitamins and minerals 
cannot be synthesized by the body, and therefore must be acquired from the outside, e.g. 
from the diet or from dietary supplements [14]. 
Vitamins are organic compounds, categorised as water or oil (fat) soluble. The fat-soluble 
vitamins are vitamins A, D, E and K. They are stored in the fatty tissue and sometimes can be 
secreted through bile. The water-soluble vitamins are thiamine (B1), riboflavin (B2), niacin (B3), 
vitamin B6, vitamin B12, folate, vitamin C, pantothenic acid, biotin, and choline. The water-
soluble characteristic limits their storage in the body for a long time [15]. 
Minerals are inorganic elements and fall into two categories: macrominerals and trace 
minerals. The macrominerals (calcium, phosphorus, magnesium, sodium, chloride, potassium 
and sulphur) exist in the body in larger amounts. The Dietary Reference Intake level for an 
adult is more than 100 milligrams per day. The Dietary Reference Intake level of trace minerals 
(iron, copper, iodine, manganese, fluoride, chromium, molybdenum, selenium, zinc and 
cobalt) is mostly less than 100 milligrams per day [16]. 
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Essential fatty acids (EFAs) are unsaturated fatty acids that are essential to human health but 
are not metabolized by the body and must be acquired through the diet [17]. 
The doses for nutritional supplements depend on the individual needs and territory. For 
minerals and vitamins there is a recommended guideline developed by WHO that can be 
found on their official websites [18]. Some nutritional supplements may have some side 
effects, depending on personal hypersensitivity or intolerance to certain substances, or health 
conditions and dietary patterns. They may cause allergic reaction, nausea, headaches, 
sweating, or stomach upset [19]. 
1.2.1 Iodine 
Iodine status in the world 
Iodine deficiency is one of the key factors responsible for mental impairment worldwide and 
is easily preventable by supplementing the population using iodized salt [20-22]. 
Unfortunately, complete elimination of iodine deficiency in the world has not been achieved 
[23, 24]. It is still a major health problem in many developing countries, and it can easily re-
emerge anywhere because of the socioeconomic situation and/or the circulation of iodine in 
nature. Iodine deficiency has occurred in some iodine-sufficient countries, including the UK 
(Figure 1.1) [25-31]. In an attempt to address this, the WHO and UNICEF urged all countries 
to control and monitor their iodine status every 3 years [32] and recommended oral iodine 
medicaments/supplements for the most vulnerable groups in the population, such as 
children, pregnant, and lactating women, in order to ensure they meet their required daily 
dose [9]. 
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Figure 1.1. The top 10 iodine-deficient countries with the greatest numbers of school-age 
children with insufficient iodine intake in 2011. Adapted from [33]. 
Iodine prevention and control  
Universal salt iodization (USI) is the main strategy to regulate and prevent iodine deficiency 
[33]. It was adopted in 1922 by the World Health Assembly as a highly effective and cheap 
method. However, a conflict between the two main goals of the health community, to reduce 
the average salt intake among the population due to the increase in hypertension and 
cardiovascular diseases and preventing iodine deficiency through salt iodization, suggests 
other means need to be developed to increase iodine intake. Thus, many other methods have 
been advanced and one of them is iodized oil. WHO recommends supplementation with 
iodized oil for women of reproductive age, children less than 2 years, pregnant women and 
people living in the areas with inadequate access to iodized salt [26]. The iodized oil can be 
prepared by esterification of the unsaturated fatty acids and adding iodine to the double 
bound [10]. The most popular iodized oils are Lipiodol® and poppy seed oil (where iodine 
content is 40 % per weight) or vegetable oils [26]. However, problems arising from the need 
for a distribution programme to deliver the supplement direct to the target population, and 
the potential for an unstable level of iodine in the body, makes iodized oil less attractive [34]. 
Other existing iodine medicaments and supplements are mostly in tablet form, which often 
cause serious difficulties in swallowing for paediatric and elderly patients. Although liquid 
iodine supplement formulations are available, such as Lugol’s iodine (iodine and potassium 
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iodide dissolved in water, where the ratio of iodine to potassium iodide is 1:2) [19], there 
have been a number of drawbacks related with their reduced physical storage stability, 
increased manufacturing cost, and increased contamination risk for multiple dose 
formulations [26]. 
Bread fortification with iodine was successfully implemented in Australia, the Russian 
Federation and in some European countries. However, iodine intake remained insufficient; 
therefore, iodized salt has been introduced in bread making. Iodized water has been 
implemented in Thailand and Mali but it is costly. Iodized tea has been utilized in China. 
Indirect iodization methods in preventing iodine deficiency have also been developed. In 
Xinjiang, China, potassium iodate was successfully added into irrigation water; it has been 
reported that the infant mortality rate has fallen by 50 %. Finland, as a consequence of using 
iodized table salt to fortify animal fodder, is increasing the iodine intake through animal 
sources [26]. 
Functions of iodine in our body 
Although iodine is accumulated in the ovary and other tissues [35], at present, the only 
physiological role known for iodine in the human body is in the synthesis of thyroid hormones 
by the thyroid gland [9]. The function of iodine is in the formation of the thyroid hormones 
thyroxine (T4) and triiodothyronine (T3), which are the main drivers for normal growth and 
development of brain tissues, the central nervous system, the body, as well as for energy 
production and oxygen consumption in cells [35]. Figure 1.2 provides an illustration 
summarising the thyroid hormone production and regulation in the body. Figure 1.3 provides 
an illustration of synthesis thyroid hormone. 
When thyroid hormone secretion is insufficient, in the condition called hypothyroidism, the 
basal metabolic rate decreases and the level of activity of the affected person will fall. In 
hyperthyroidism the thyroid gland is active and produces an excessive amount of thyroid 
hormones that primarily affects the heart (cardiopalmus) [36]. 
Table 1.1 represents the effects of iodine deficiency on human health at different life stages. 
A longitudinal study of parents and children in Avon, UK, has revealed that even in mild-to-
moderate iodine deficiency of pregnant women there is an adverse influence on the cognitive 
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development of infants, and hence on their future study at school. Reporting such findings, 
Bath et al. [31] stated that the iodine situation in the UK needs urgent review. Table 1.2 
represents WHO recommendations for iodine intake by age and Table 1.3 represents the 
tolerable upper intake level for iodine, estimated by the European Commission/Scientific 
Committee on Food (EC/SCF) and the Institute of Medicine (IOM). 
 
Figure 1.2. Summary of thyroid hormone production and regulation. Adapted from [9]. 
 
Figure 1.3. Synthesis of thyroid hormones. Adapted from [37]. 
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Table 1.1. The impact of iodine deficiency on human health at different life stages. Adapted 
from [9]. 
Life stage Effects 
Foetus Abortions 
Stillbirths 
Congenital anomalies 
Increased perinatal mortality 
Increased infant mortality 
Neurological cretinism: mental deficiency, deaf mutism, spastic 
diplegia, and squint 
Myxedematous cretinism: mental deficiency, hypothyroidism and 
dwarfism 
Psychomotor defects 
Neonate Neonatal goitre 
Neonatal hypothyroidism 
Child and 
adolescent 
Goitre 
Juvenile hypothyroidism 
Impaired mental function 
Retarded physical development 
Adult Goitre with its complications 
Hypothyroidism 
Impaired mental function 
Iodine-induced hyperthyroidism 
Table 1.2. Recommended iodine intake by age and population group. Adapted from [22]. 
Age and population group WHO (μm day ˉ1) 
Children 0–5 years 90 
Children 6–12 years 120 
Adults ≥ 12 years 150 
Pregnant women 250 
Lactating women 250 
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Table 1.3. Tolerable upper intake level for iodine (μg/day). Adapted from [26]. 
Age group EC/SCF, 2002 IOM, 2001 
1–3 years 200 200 
4–6 years 250 300 
7–10 years 300 300 
11–14 years 450 300 
15–17 years 500 900 
Adult years 600 1100 
Pregnant women >19 years 600 1100 
Iodine absorption 
Mostly, I2 exists in foods as potassium or sodium iodide and as an organically bound complex, 
or as KIO3 (a fortified compound used in bread and salt) [37, 38]. The majority of organic 
bound iodine releases iodine before absorption, which is reduced to iodide. As for iodate, it 
is reduced to iodide by glutathione (GSH) at pH 7.4 in GI within 2-3 min. The proposed 
stoichiometry of that reaction is 6GSH + IO3- → 3G-S-S-G + I- + 3H2O. Iodate can be also 
reduced to iodide when administered intravenously because red cells and most tissues 
contain GSH. More information about conversion of iodate to iodide in vitro and in vivo is 
given elsewhere [39]. Iodide is then absorbed rapidly by the stomach and the upper part of 
the small intestine [35] and it immediately appears in the blood stream. If iodine intake is 
sufficient, less than 10 % of iodide will be taken up by the thyroid gland, whereas in iodine 
deficiency it can reach up to 80 %, and the rest will be taken up by the kidney, where it will 
be excreted in the urine (Figure 1.2) [22]. 
Iodine interaction with other nutrients 
The influence of selenium on thyroid functions is still being questioned due to the uncertainty 
of epidemiological surveys and clinical trial results. In Central Africa, where the iodine and 
selenium microelement intake is insufficient, myxedematous cretinism is the most common 
form; this leads to the assumption that selenium deficiency might subject the thyroid gland 
to free radical damage caused by hydrogen peroxide. However, the same iodine and selenium 
status in Tibet and in China has revealed no prevalence of myxedematous cretinism, 
suggesting that other factors can play a role [40]. 
Chapter 1 
10 
 
There is strong evidence that iron supplementation or salt fortification along with iodine 
improve thyroid metabolism. Similarly, to iron, zinc [40], vitamin A [41] and copper deficiency 
is connected with hypothyroidism [42]. 
1.2.2 Vitamin E 
Vitamin E is an essential micronutrient for humans and is obtained exclusively from the diet. 
The main biological role of vitamin E is its effective antioxidant properties in the cell 
antioxidant defence system that is attributed to the hydroxyl (-OH) group on the aromatic ring 
(Figure 1.4), which donates the hydrogen to free radicals, making them unreactive. Because 
vitamin E is mainly located within the phospholipid bilayer of cell membranes, it is particularly 
effective in preventing lipid peroxidation of polyunsaturated fatty acids (PUFAs), low-density 
lipoprotein and other components of cell membrane [9]. In addition, it has been reported that 
hypothyroidism is accompanied by an increase in oxidative stress, however, vitamin E 
supplementation, in this effect, could reduce oxidative damage [43]. Therefore, a water 
soluble source of vitamin E (discussed below) was used as a beneficial component for multiple 
micronutrient formulation to prevent iodine deficiency in Chapter 4. Besides, vitamin E has 
other multiple biological activities, including the regulation of inflammatory response, 
modulation of cellular signalling, membrane-bound enzymes, gene expression and cell 
proliferation [44], and it can be used therapeutically in doses of 200–400 mg/day to moderate 
some aspects of degenerative diseases such as Parkinson’s disease, reduce the severity of 
neurological disorders such as tardive dyskinesia, prevent periventricular haemorrhage in pre-
term babies, reduce tissue injury arising from ischemia and reperfusion during surgery, delay 
cataract development, and improve mobility in arthritis sufferers. However, very high doses 
(>1000 mg/day) may induce pro-oxidant damage; nevertheless, it has been reported in one 
study that a dose of 200 mg/day also causes an indication of a pro-oxidant effect in patients 
over 60 with respiratory tract infections. 
The term vitamin E includes a group of eight naturally occurring homologues, classified into 
two classes, namely tocopherols that have a saturated 16-carbon phytyl side chain and 
tocotrienols that have three double bonds on the side chain. In turn, these classes each 
include four isoforms that differ in the number and position of methyl groups on the ring 
structure. The isoforms are 𝒹-𝛼-, 𝒹-𝛽-, 𝒹-𝛾-, and 𝒹-𝛿-tocopherol and 𝒹-𝛼-, 𝒹-𝛽-, 𝒹-𝛾-, and 
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𝒹-𝛿-tocotrienol (Figure 1.4) [9]. They are a yellow viscous oil/liquid that oxidizes readily when 
exposed to light, oxygen and transition metal ions and they are fat soluble; however, they can 
be dissolved in alcohol and organic solvent too [45]. 
 
Figure 1.4. Chemical structures of tocopherol and tocotrienol. The value of the R groups for 
each isoform are listed in the table. Adapted from reference [46]. 
As the vitamin E family are all fat soluble, as with any other dietary lipid, they need to meet 
the following conditions to be absorbed: efficient emulsification, solubilization within mixed 
bile salt micelles, uptake by enterocytes and secretion into the circulation via the lymphatic 
system. Initially, emulsification occurs in the stomach and then in the small intestine in the 
presence of pancreatic and biliary secretions. As a result, vitamin E is solubilized and 
transported to the brush border membrane of the enterocyte, where it is incorporated into 
chylomicrons, then secreted into the intracellular space and lymphatic system, and 
subsequently into the blood stream. Tocopherol esters must be hydrolyzed in the small 
intestine before absorption. In the blood stream, vitamin E is transported via plasma 
lipoproteins and erythrocytes [9] from where it is transferred to the liver, which in turn 
separates out 𝛼-tocopherol and preferentially secretes it within very low-density lipoproteins 
and high-density lipoproteins into the bloodstream for distribution in the body. Therefore, 𝛼 
form predominates in blood and tissue, followed by 𝛾-tocopherol [47], whereas a 
biodistribution study of tocotrienols shows an accumulation of them in peripheral tissues, 
such as the bones, brain, lung, muscle, and skin [44]. 
There is also available a water-soluble derivative of natural vitamin E, D-α-tocopheryl 
polyethylene glycol 1000 succinate (TPGS), that is widely used as a source of vitamin E 
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nutrients for foods and supplements. TPGS contains 27 % d-alpha-tocopherol, 65 % 
polyethylene glycol 1000 and 8 % succinic acid. The total alpha-tocopherol potency of this 
source is 260 mg/g TPGS (387 IU/g), after saponification of the esters. In addition, TPGS is 
used for special medical purposes in patients, mainly infants and children, with impaired 
vitamin E absorption due to fat malabsorption. For example, it can be utilized when 
insufficient amounts of bile are secreted, such as in cholestatic liver disease (at a dose level of 
20–25 IU/kg bw/day (body weight per day) or 51.7–64.5 mg/kg bw/day), or when an 
insufficient amount of pancreatic enzymes are secreted, such as in cystic fibrosis, or in 
individuals with genetic anomalies in transport or binding proteins [9]. In addition, TPGS 
supplements have been given during post-surgical treatment in cardiac transplant recipients, 
as an oral coadministration with retinyl palmitate to improve vitamin A absorption in chronic 
cholestatic liver disease and to enhance vitamin D absorption in children with severe chronic 
cholestasis [48]. Moreover, TPGS has numerous applications in drug delivery systems (DDSs), 
and good reviews are given elsewhere [48-50]. Examples of commercially available 
supplements include NovaSOL® E (TPGS 100IU and 400 mg crystalline vitamin C), vitamin E 
solubilized liquid and oral tocofersolan [48]. The safety and bioavailability of TPGS was 
acknowledged by the European Food Safety Authority in 2007. From a toxicology study 
performed with rats and mice, the panel established an overall no-observed-adverse-effect 
level to be equivalent to 1000 mg TPGS/kg bw/day. However, the panel advised to avoid TPGS 
treatment in children with a severe impairment of kidney function and to apply fat-soluble 
vitamin E in healthy humans with normal fat absorption levels, because the administration of 
TPGS could only slightly elevate the plasma 𝛼-tocopherol level compared to fat-soluble 
vitamin E [51]. 
In dietary regulation, vitamin E activity is expressed as 𝛼-tocopherol equivalents (𝛼-TEs), i.e. 
one 𝛼-TE is the activity of 1 mg d-𝛼-tocopherol. In a mixed diet containing different natural 
forms of vitamin E, the 𝛼-TE is estimated as follows: the number of milligrams of 𝛽-
tocopherols is multiplied by 0.5, 𝛾-tocopherols by 0.1, and 𝛼-tocotrienols by 0.3. The synthetic 
𝒹ℓ-𝛼-tocopherols are multiplied by 0.74. One milligram of acetate form is equivalent to 1 IU 
of vitamin E [9]. The recommended intake for vitamin E in different countries varies between 
3 and 15 mg/day. In the US, the Recommended Dietary Allowance (RDA) for both men and 
women adults from 14 years is 15 mg of 𝛼-tocopherol. Whereas, recently, the European Food 
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Safety Authority suggested replacing the present RDA for vitamin E with a newly defined 
Adequate Intake as follows: men 13 mg/day, women 11 mg/day, infants/children 5–13 mg/day 
(depending on the age) [47]. However, based on the evidence in different animals that low 
levels of vitamin E combined with an excess of PUFAs gives rise to a wide variety of clinical 
signs, the WHO published the best estimate of requirements of vitamin E by age, calculated 
using a suggested d-𝛼-tocopherol/PUFA ratio of 0.4 mg/1 g. Nonetheless, WHO specifies that 
the diets high in PUFAs are also usually high in vitamin E, so the median intake of vitamin E 
will deviate considerably in most populations of industrialized countries. Therefore, they 
reported that the accumulated data about vitamin E deficiency was not strong enough to 
formulate a recommended nutrient intake for vitamin E and pointed out that the 
recommendation they provide can only represent the best estimate of requirements (Table 
1.4). There are no specific recommendations for vitamin E requirements in pregnancy and 
lactation because there is no evidence that the vitamin E requirement is different from the 
standard adult requirement [9]. 
Table 1.4. The best estimate of Vitamin E requirement provided by WHO. Adapted from [9].  
Group Fat-soluble 
vitamin E 
(mg 𝜶-TE/day) 
Group Fat-soluble 
vitamin E 
(mg 𝜶-TE/day) 
Infants  Adults  
0–6 m 2.7 Females 19–50 y (premenopausal) 7.5 
7–12 m 2.7 Females 51–65 y (menopausal) 7.5 
Children  Males 19–65 y 10.0 
1–3 y 5.0 Elderly  
4–6 y 5.0 Females 65+y 7.5 
7–9 y 7.0 Males 65+y 10.0 
Adolescents  Pregnant women –  
Females 10–18 y 7.5 Lactating women – 
Males 10–18 y 10.0 
Vitamin E deficiency in humans causes muscle damage and neurological lesions. However, 
WHO published a book for mineral and vitamin requirements in 2005, where it says that there 
is very rare occurrence of clinical signs of deficiency (leakage of muscle enzymes into plasma, 
increased levels of lipid peroxidation products in plasma, and increased erythrocyte 
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haemolysis) in healthy individuals, suggesting that the average diet contains enough vitamin 
E to satisfy nutritional needs. In addition, they reported that the estimation of optimum 
intake, which may be implied when plasma concentration of vitamin E exceeds 25–30 μmol/L 
of lipid-standardized 𝛼-tocopherol, should be treated with caution, because only 1 % of total 
tocopherol may be in the blood and its concentration is influenced by circulating lipid. 
Therefore, plasma vitamin E concentration does not necessarily reflect intake or tissue 
reserves. Thus, WHO recommended assessing vitamin E status by calculating a lipid-vitamin E 
concentration as μmol/mmol, e.g. a tocopherol-cholesterol ratio greater than 2.25 is believed 
to represent satisfactory vitamin E status and levels below this value should be taken as an 
indication of biochemical deficiency [9]. Whereas, the Institute of Medicine in the US 
established a status of serum-𝛼-tocopherol concentration below 12 μmol/L as deficient, 
because that concentration level was deemed sufficient to prevent peroxide-induced 
haemolysis and improve cell survival. Galli et al. [47] in a recent review of vitamin E, reported 
that vitamin E intakes in both developing and industrialized countries are below the RDA and 
the Estimated Average Requirements of 12 mg/day (the protective 12 μmol/L serum 𝛼-
tocopherol threshold level). For example, more than two-thirds of South Korean adults have 
suboptimal vitamin E status (12–30 μmol/L (the optimum concentration is set at 30 μmol/L 
and above by the German Federal Ministry of Health Consensus Statement) and almost one-
quarter are deficient (<12 μmol/L). In rural Nepal, about one-third of pregnant women have 
severe vitamin E deficiency (<10 μmol/L), while in Bangladesh, almost two-thirds of the 
women in early pregnancy have more severe vitamin E deficiency (<9.3 μmol/L). American 
adults have suboptimal vitamin E status and about 90 % of the population has vitamin intakes 
below the Estimated Average Requirements. The low vitamin E intake is also observed in the 
United Kingdom (UK), Germany and the Netherlands. 
1.2.3 Polyunsaturated fatty acid 
Polyunsaturated fatty acid (PUFA) (used in this study in Chapter 4) is a class of fatty acid that 
contains more than one double bond in their backbone. PUFA includes a group of fatty acids 
that are essential to the human body because they cannot be synthesized by the body and, 
therefore, must be obtained from the diet. These are α-linolenic acid (ALA) (C18:3n-3) and 
linoleic acid (LA) (C18:2n-6), which are converted into long chain PUFA in the endoplasmic 
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reticulum of the liver and retina after they are taken in by dietary sources. ALA is a precursor 
for docosahexaenoic acid (DHA) (C22:6n-3) and its substrate eicosapentaenoic acid (EPA) 
(C20:5n-3), two key long chain ω-3 (n-3) EFAs. LA is a precursor for arachidonic acid (ARA) 
(C20:4n-6) a long chain ω-6 (n-6) EFA  [52, 53]. 
In 2002, the Food and Nutrition Board, at the Institute of Medicine of the National Academies 
in the USA, established the Adequate Intake level for n-6 and n-3 fatty acids (Table 1.5). 
Table 1.5. Adequate intake for n-3 and n-6 fatty acids, taken from [54]. m – Month, y – Year. 
Life stage group n-3 (source ALA) 
g/day 
n-6 (source LA) 
g/day 
Infants   
0–6 m 0.5 4.4 
7–12 m 0.5 4.6 
Children   
1–3 y 0.7 7 
4–8 y 1.2 10 
Males   
9–13 y 1.2 12 
14–18 y 1.6 16 
19–50 y 1.6 17 
51 > y 1.6 14 
Females   
9–13 y 1.0 10 
14–18 y 1.1 11 
19–50 y 1.1 12 
51 > y 1.1 11 
Pregnancy   
14–50 y 1.4 13 
Lactation   
14–50 y 1.3 13 
Omega-6 has important biological functions relating to growth, development and brain 
function as well as being a precursor of lipid mediators. It is especially important for ARA, 
which is found in breast milk and plays a crucial role in infant growth and mental development. 
A neuropsychological assessment study proposed that ARA supplementation might improve 
cognitive function and learning behaviour in the elderly [55]. Omega-3s, however, play an 
important structural role in cell membranes as components of phospholipids, especially DHA, 
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which appears in high levels in the retina, brain, and sperm [56]. The function of DHA in the 
brain was gleaned from animal experiments (young monkeys were given a diet deficient in n-
3 fatty acids), which demonstrated poor visual acuity and an increase in stereotypical 
behaviour suggesting that brain development had been impaired. n-3 PUFA deficiency in 
humans has not been created because it is unethical; however, examinations of the cadavers 
of premature babies demonstrated a rapid accumulation of DHA and ARA in foetal brain tissue 
during the third trimester of pregnancy [57] and this accumulation continues throughout the 
first 2 years after birth. A similar finding was observed with the DHA concentration in the 
retina, in which accumulation is completed by birth [56]. The importance of dietary DHA and 
ARA intake during pregnancy and infancy for foetal growth and development has been 
recognised and has influenced the international food standards for infant formula. Thus, in 
2007, the Codex Committee on Nutrition and Foods for Special Dietary Uses (the Codex 
Alimentarius international food standards meeting) recommended adding DHA and ARA to 
infant formula [55]. Moreover, omega-3s along with omega-6s serve as an energy supplier for 
the body and the energy is spent to form eicosanoids, which are signalling molecules that have 
a variety of effects on cardiovascular, pulmonary, immune and endocrine systems [56]. The 
UK dietary guidelines advocate the benefits of EPA and DHA consumption in improving 
cardiovascular risk factors.  
A number of studies show the importance of the ratio of n-6/n-3 essential fatty acids intake. 
For example, a ratio of 4/1 resulted in a 70 % decrease in total mortality from cardiovascular 
disease; a ratio of 2.5/1 reduced rectal cell proliferation in patients with colorectal cancer, 
whereas a ratio of 4/1 had no effect; a ratio of 5/1 had a positive effect on patients with 
asthma, whereas a ratio of 10/1 had an adverse effect [58]. 
Deficiency of n-3 or n-6 PUFAs can affect the skin; for example, rough, scaly skin and dermatitis 
can be developed. In addition, if n-3 deficiency occurs, the DHA concentration in plasma and 
tissue decreases. However, there is no established critical concentration of DHA and EPA, 
which will affect the visual or neural function or the immune response [56]. 
Today industrialized societies are deficient in n-3 fatty acid and, particularly, Western diets are 
characterized by an increase in n-6 fatty acid and a decrease in n-3 fatty acid intake [58], with 
ratios at 7:1 and 17:1 for the UK and USA, respectively. In comparison, the Japanese diet, 
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which is a fish-eating diet, has a 4:1 ratio and has the lower risk of cardiovascular disease [57]. 
Therefore, supplementation strategies, which offer one of the approaches to improving PUFA 
consumption, mainly focus on the delivery of n-3 fatty acids. However, due to difficulties 
swallowing capsules or the unpleasant aftertaste, the rates of compliance are generally low. 
In addition, the use of gelatine, a main encapsulation material, makes supplementation 
strategies an unsuitable tool for most vegetarians and certain religious groups. Food-based 
strategies provide an alternative approach to improving omega-3 status and the population 
health. Tables 1.6 and 1.7 represent a summary of n-3 fatty acid delivery systems and their 
production methods [59], and methods of incorporation of n-3 fatty acids into foods [60], 
respectively. 
Table 1.6. Different encapsulation methods used to produce two types of delivery systems for 
n-3 fatty acid encapsulation, taken from [59]. 
Type of encapsulation Method of encapsulation 
Beads Spray-, freeze-drying 
 Emulsification/internal gelation 
 Co-crystallization 
 Emulsion extrusion 
 Solvent evaporation 
 Ionic gelation 
Capsules Coacervation 
 Extrusion 
 Condensation and interfacial polymerization 
 Microfluidic devices 
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Table 1.7. Summary of methods used to incorporate n-3 fatty acids into foods, taken from 
[60]. 
Method Example 
Food 
fortification 
Oat and soy based nutrition bar treatments 
Snacks bars and muffins 
 Yogurt (as emulsion) 
 Jalapeno or olive flavoured hummus type dip (as microemulsion) 
 Powdered milk 
Encapsulation Soup powder 
 Spray dried emulsions to form powders suitable to add to food matrices 
 Milkshake 
 Milk, yogurt and bread 
Nanoemulsion Yogurt 
1.3 Active pharmaceutical ingredients (APIs) 
There are two major classification systems for active pharmaceutical ingredients (APIs) that 
have been acknowledged and used in drug development. These are the Anatomical 
Therapeutic Chemical Classification system (ATC), regulated by the WHO Collaborating Centre 
for Drug Statistics Methodology (WHOCC), that were established in 1982 [61], and the 
Biopharmaceutical Classification System (BCS), proposed by Amidon et al. [62] that was 
introduced in 1995. 
In the ATC classification system, the drugs are divided into groups at five different levels 
specifying the organ or system on which they act and their chemical, pharmacological, and 
therapeutic properties (Table 1.8) [63]. The first level has fourteen main 
anatomical/pharmacological groups (Table 1.9), which in turn are divided into 
pharmacological subgroups (2nd level). The 3rd and 4th levels are classified into chemical, 
pharmacological or therapeutic subgroups and the 5th level specifies the chemical substance.  
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Table 1.8. The structure of the code according to the ATC classification system. Adapted from 
[63].  
A anatomical main group (1st level) 
A10 therapeutic subgroup (2nd level) 
A10B pharmacological subgroup (3rd level) 
A10BA chemical subgroup (4th level) 
A10BA02 chemical substance (5th level) 
Table 1.9. The ATC system main groups or the 1st level of the classification. Adapted from [63]. 
A Alimentary tract and metabolism L Antineoplastic and 
immunomodulating agents 
B Blood and blood forming organs M Musculo-skeletal system 
C Cardiovascular system N Nervous system 
D Dermatologicals P Antiparasitic products, insecticides, 
and repellents 
G Genito urinary system and sex 
hormones 
R Respiratory system 
H System hormonal preparations, 
excluding sex hormones and insulins 
S Sensory organs 
J Antiinfectives for systemic use V Various 
The ATC assigns a unique ATC code for each drug that specifies its drug class within the ATC 
system; however, one drug may have more than one ATC code if the drug has two or more 
strengths or routes of administration with different therapeutic effects. For instance, 
metoprolol and ketoconazole, used in this study (Chapter 5) have several ATC codes (Figure 
1.5), which can be found on the official website of the WHOCC (www.whocc.no). 
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Figure 1.5. The ATC codes (on the right) and a description of one of the codes (on the left) of 
metoprolol (a) ketoconazole (b). DDD – defined daily dose, U – unit, Adm. R – route of 
administration, g – gram, O – oral, P – parenteral. Adapted from [61]. 
The BCS classification divides the drugs into four groups (class I, II, III, IV) according to their 
aqueous solubility and intestinal permeability (Figure 1.6). It is a useful tool at the early 
development stage of new drug products to establish a preliminary BCS classification for 
further improvement. For example, as shown in Figure 1.6 the absorption of a class II drug can 
be improved by modification or changing the formulation design. The class III drug can be 
improved by adding absorption enhancer and class IV by a combination of approaches used 
for BCS class II and III. It can also be used to select suitable dissolution test conditions for new 
drugs and as a guide to determine whether in vitro-in vivo correlation (IVIVC) can be expected 
for an immediate release drug [62, 64]. 
According to the FDA, a drug is classified as highly soluble when its highest clinical dose 
strength is soluble in ≤250 ml of aqueous media over a pH range of 1–7.5 at 37.5 ⁰C, and as 
highly permeable if the drug absorption, administered orally, is >90% in comparison to an 
intravenous reference dose or when determined using mass balance [65]. Thus, metoprolol 
and ketoconazole are classified as class I and class II drugs, respectively [66]. 
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Figure 1.6. The Biopharmaceutical Classification System and possible formulation options 
based on the BCS. IR – immediate release. Adapted from [67]. 
Another sub classification of the drugs relates to the measurement of their physical nature. 
The dissociation constant, pKa, is a measure of the strength of an acid or a base. It allows you 
to determine the ionization state with respect to pH. Strong acids and bases are those that 
are completely ionised in the pH range 0 – 14. Whereas weak acids and bases are those that 
are incompletely ionised in the pH range 0 – 14 [68]. An ionized drug is more aqueous soluble 
and less membrane permeable than a non-ionized form. The extent of ionization of a drug 
plays a crucial role in the characterization of its absorption, distribution, metabolism and 
excretion (ADME) profile [69]. The partitioning coefficient, log P, is a measure of how well a 
substance dissolves in the water phase versus an organic phase, usually 1-octanol and water. 
Substances that are predominantly dissolved in the water phase are hydrophilic and those 
predominantly dissolved in lipids are lipophilic. The log P value of a drug provides a prediction 
of its behaviour in different environments and therefore it is an important property in drug 
development that helps to determine how to deliver a drug to specific sites and understand 
the behaviour of drug molecules in the body, i.e. its ADME properties [70]. 
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1.4 Main considerations when selecting the delivery systems for drugs 
or nutrients 
The selection and design of the delivery systems depends on the site of administration, the 
targeted group and the physicochemical properties of the active ingredient (either being a 
nutrient or a drug). 
1.4.1 Intrinsic physicochemical properties  
Drugs and nutrients have several characteristics, such as absorption in the intestine, the ability 
to change physiological processes and the possibility to cause toxicity in high doses. 
One of the challenges of nutritional supplements is their high instability in nature. They are 
unstable and reactive substances, mostly susceptible to moisture, light, pH, and temperature. 
They can decompose and degrade during processing and storage depending on the 
surrounding conditions. In pharmaceutical formulations, vitamin and mineral degradation is 
related to micronutrient interaction with environmental conditions and the impact of gastric 
acidity (pH <2.0). Therefore, to provide protection from chemical and physical degradation 
and at the same time ensure bioavailability, encapsulation systems are commonly used as a 
carrier matrix [71]. In addition, by manipulating the structure of encapsulation systems, it is 
possible to deliver several substances with different chemical and physical properties 
simultaneously. However, considering their great probability to react with other ingredients 
and potential premature release, the challenging issues are to find an appropriate coating 
material as well as a suitable technology to produce a complex formulation. Secondly, the 
most problematic issue in nutrition supplementation is that the materials used as a carrier for 
nutritional supplements must be biodegradable, food grade, inexpensive, capable of 
protecting the internal phase from surrounding conditions and have high loading capacity to 
encapsulate a large amount of vitamins [72]. Furthermore, nutritional supplements are 
classified as food, yet the carrier materials accepted in pharmaceutical production have not 
been certified for food application. Thus, the available number of existing well-established 
carrier materials in the pharmaceutical industry is reduced significantly, leaving a limited 
number of possible carrier materials. However, all nutritional supplements may be treated 
and act as drugs, as mentioned earlier, i.e. the nutrient dosage must be a strictly accurate 
Chapter 1 
23 
 
amount. If the dose of micronutrient is higher than the tolerable upper intake level, it may 
have adverse health effects or even be toxic, or if it is less than the recommended dose then 
there is no effect. In addition, the selection of a delivery system for nutritional supplements 
is based on the same approach as in pharmaceutical formulation. Thus, when formulating a 
nutritional dosage form, the targeted group of population should be considered. Another 
aspect that should also be considered when formulating a nutritional dosage form is that the 
most vulnerable group of population affected by the deficiency of nutrients are women of 
reproductive age, pregnant women, lactating women, children and the elderly. The 
preference of these groups should be considered in the design, i.e. taste, appearance, dosage 
form, route of administration and so on. Finally, the majority of nutrient deficient people live 
in developing countries; hence, the cost of the end product is probably the most important 
challenge. There are numerous types of nutritional supplements available in the market; 
however, only a few of them have been adopted by the WHO in fighting nutrient deficiency 
on a mass scale. One of the main reasons behind this fact is simply the cost of these products. 
For instance, for the prevention of iodine deficiency, universal salt iodization was adopted as 
a cost-effective measure, in spite of knowing the direct adverse effect of table salt on a 
cardiovascular system and other organs in the body. 
The main challenges with drugs are related to their poor aqueous solubility and dissolution 
rate, which limit formulation approaches, clinical application and marketability. At present 
about 40 % of the pipeline drugs are poorly soluble, i.e. belong to BCS II and IV compounds; 
hence, a delivery system that can improve the dissolution and/or apparent solubility of poorly 
soluble drugs should be selected for such compounds [73]. Whereas with highly water-soluble 
drugs it is difficult to achieve sustainable release, due to their high solubility, rapid dissolution 
and tachymetabolism; therefore, an appropriate loading system should be designed for them 
[74]. Other important properties of drugs are the Log P and pKa values, which help in many 
aspects of drug design. 
1.4.2 Paediatric targeted group 
A variety of different dosage forms are available for oral administration to paediatric and 
geriatric patients, such as solutions, syrups, suspensions, powders, tablets and capsules. 
However, despite extensive development of medicines for children for different types of 
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disease, and pharmaceutical companies bringing them to the market, according to a WHO 
report, the global mortality rate in children under five years due to the lack of appropriate 
paediatric dosage forms remains a significant problem for a group of diseases such as malaria, 
HIV (Human Immunodeficiency Virus), tuberculosis, pneumonia, diarrhoea and neonatal 
infections. In 2008, at the Informal Expert Meeting on Dosage Forms of Medicines for 
Children, WHO established the desirable criteria for dosage forms of medicines for children, 
with particular attention being paid to conditions prevailing in the developing countries and 
recommended preferred dosage forms of medicines for children (Table 1.10). Among the 
reported recommendations, a flexible solid dosage form, such as tablets that are 
orodispersible and/or that can be used for preparation of oral liquids (suspension or solution), 
was proposed to use for treating the diseases that are the major causes of mortality and 
morbidity of children under 5 years. In addition, solid formulations are the most convenient 
and acceptable forms in pharmaceutical formulations today since liquid formulations, 
although it is a preferred dosage form of paediatric patients, have short half-lives once 
opened, increased contamination risk for multiple dose formulations, are bulky to handle and 
store, and are relatively costly [75]. 
Table 1.10. Desirable requirements for dosage form of medicines for children identified by 
WHO. Adapted from [76]. 
1. Minimal administration frequency 
2. Minimal impact on life style 
3. Minimum, non-toxic excipients 
4. Convenient, easy, reliable administration 
5. Palatable 
6. Requiring minimal manipulation by health professionals 
or carers prior to use 
7. Transportable and low bulk/weight 
8. Easily produced, stable in a variety of climates 
9. Affordable 
10. Commercially viable 
1.4.3 Oral route of administration 
Drugs and nutrients can be administered via a number of routes, e.g. orally, topically, rectally, 
and intravenously. However, the oral route of administration remains the most popular and 
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preferred way of dosing by paediatric patients. This is because it is the easiest, painless and 
most convenient way of administering drugs/nutrients in contrast, for example, to intravenous 
administration which can be complicated with extravasation of the drug or blood, catheter 
infections, and thrombosis [77]. When a complex pharmaceutical dosage form is administered 
perorally, it sequentially breaks down into its elemental components in the GI tract and they 
are selectively absorbed/transferred in an organized manner from/through the gut and enter 
into blood circulation, where they are then distributed to various tissues [78, 79]. The human 
intestinal epithelium is highly absorptive due to numerous villi, which increase the total 
absorptive surface area of the gastrointestinal (GI) tract by up to 300–400 m2 [80]. The factors 
that can limit the oral bioavailability of drugs/nutrients are the slow release of the 
drug/nutrient from the dosage form, instability of the drug/nutrient in the GI tract, poor 
permeability of the GI mucosa to the drug/nutrient, complexation with food and first-pass 
metabolism of the drug/nutrient [64]. In addition, drugs/nutrients administered orally 
experience a harsh environment when they pass through the GI tract, specifically, moving 
from 1.2 pH (in the stomach) to 6–7 pH (in the large intestine), which may cause the 
degradation or destruction of the drugs/nutrients [81, 82].  
The oral trans-mucosal administration method offers some advantages over the peroral route 
of administration, such as avoiding the number of barriers a drug/nutrient must cross during 
GI transit. The oral mucosa includes the buccal (between the gum and cheek), the sublingual 
(under the tongue), the gingival, palatal and labial mucosa. The buccal and sublingual regions 
are the most commonly used routes for effective drug delivery [81]. The high vascularity and 
permeability of the sublingual and buccal mucosa allow the rapid transmucosal absorption of 
the drug/nutrient directly into systematic circulation, avoiding first-pass drug/nutrient 
metabolism and pre-systemic elimination of the drug/nutrient in the GI. This gives advantages 
over the peroral route, such as high bioavailability and almost immediate onset of action [72]. 
In addition, the oral cavity provides relatively consistent and friendly physiological conditions 
for dosage forms due to the continuous secretion of saliva, which is a relatively mobile fluid 
with less mucin, lower enzymatic activity and no proteases, making the oral trans-mucosal 
route favourable to protein and peptide delivery [81]. However, despite the attractive 
properties of the oral mucosa, it provides some limitations and challenges as well for 
researchers developing novel delivery systems. These are the relatively small surface area of 
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the oral cavity, poor drug/nutrient permeability through the oral mucosa, the fact saliva can 
wash away [72] and the fundamental limitation of this route of administration: the lack of co-
operation of children and the risk of choking on or swallowing the delivery device or aspiration 
[83]. In addition, in order for a drug/nutrient to be formulated for delivery via the oral mucosa, 
the drug/nutrient should dissolve rapidly, produce the desirable therapeutic effects with a 
small amount of drug and have an agreeable taste [84]. 
Overcoming all these barriers and constraints related with each route of administration is an 
important aspect of the delivery systems development process.   
1.5 Solid dispersion  
Various approaches have been developed to overcome the solubility problem of poorly 
soluble drugs, including for example salt formation, prodrug formation, particle size reduction, 
complexation, solubilization (co-solvents, micelles, and emulsions), solid lipid nanoparticles 
and solid dispersion. However, of these approaches, a solid dispersion that is defined as “a 
dispersion of one or more API in an inert carrier or matrix at the solid state prepared by 
solvent, melting or solvent-melting method” [73] showed the most successful improvements 
in enhancing the dissolution profile of poorly soluble drugs. Its success is due to the 
combination of many advantageous properties, such as reducing particle size and changing 
the drug’s physical state, as dispersed molecules, amorphous or crystalline particles, 
enhancing wettability and porosity. For example, conventional particle size reduction 
techniques can reduce the size of particles down to 2-5 μm; however, these particles can easily 
agglomerate in the formulation, dissolution process or during storage. While the solid 
dispersion method can reduce the drug particle size into molecular levels, the carrier or the 
matrix can also prevent the agglomeration of drug particles, and the drug is then released in 
a supersaturated state, which is advantageous for rapid absorption. However, if the drug is 
precipitated during supersaturation, the size of the precipitated drugs in the dissolution media 
is still at submicron level (<1 μm), hence the dissolution rate is still higher than that of 
microparticles. In addition, if the drugs exist in amorphous or more soluble polymorphic 
forms, the dissolution rate can be even faster because they have lower thermodynamic 
stability (a higher energy state) than drug particles. Moreover, solid dispersion can enhance 
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the drug wettability due to the high porous structure and increased surface area, particularly 
for those prepared using solvent evaporation methods. The fast removal of the solvent leaves 
many channels in the solid dispersion structure, which increases water absorption and the 
dissolution of carrier materials, which in turn increases the wettability of the drug. In addition, 
the wettability of the drug can also be improved by incorporating surfactants or emulsifiers or 
selecting polymers that can act as solubilizers to enhance drug solubility. These reduce the 
risk of agglomeration of drug particles in the dissolution media, hence increasing the 
dissolution rate of the drug. Besides, solid dispersion can be formulated in solid oral dosage 
forms that have more advantages than a liquid product produced by the solubilization 
method. Novel nanosizing approaches can also produce drug nanocrystals in a solid state; 
however, they have quite a long and complicated preparation process, and require stabilizers 
and special equipment. In contrast, the preparation process of solid dispersions is more simple 
and applicable. 
The disadvantages of solid dispersion are related to the recrystallization of drugs from their 
amorphous state during solidification and storage, which will change a number of factors 
including the bioavailability of solid dispersion, the thermal instability of the drugs in the 
melting method, the solvent residue in the solvent method, the low IVIVC and the 
precipitation of the drugs in the dissolution media due to supersaturation. There are a 
number of strategies that have been implemented to overcome these common problems of 
solid dispersion. For example, the recrystallization of the drug can be inhibited by selecting 
polymers that have a higher glass transition (Tg) temperature then the drug, a strong 
interaction with the drug and low hygroscopicity. These can decrease the molecular mobility 
of the drug and hence decrease drug recrystallization. The addition of surfactants or 
emulsifiers into the formulation may also increase the miscibility of the drug-polymer due to 
their amphiphilic structure. Furthermore, surfactants or emulsifiers can reduce the process 
temperature in the melting method due to their plasticizing effect and, as mentioned earlier, 
improve wettability and inhibit the precipitation process as they can absorb on the surface of 
the drug particles or form micelles that encapsulate the drugs. Finally, in the solid dispersion, 
the drugs can exist in a crystalline state as well, however, they still have better stability than 
if they are in pure crystalline form because the carrier or matrix still keeps the crystals 
separate and prevents them from agglomeration. For example, the in vivo bioavailability 
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study of crystalline drugs shows a significant increase in stability in comparison with a physical 
mixture [73, 85-88]. 
The solid dispersion based formulations can be prepared by using either the melting or 
solvent evaporation based method. Figure 1.7 presents the list of techniques used to prepare 
solid dispersion. In this study, we used electrospinning to prepare solid dispersion based oral 
films. The detailed discussion on the electrostatic spinning techniques is presented in the next 
sections. 
 
Figure 1.7. Preparation methods and techniques used to prepare solid dispersion. Adapted 
from [73]. 
1.6 Electrospinning 
Electrostatic or electrohydrodynamic spinning or simply electrospinning is a simple and 
versatile technique used to fabricate nanofibres by using electrostatic forces, i.e. through an 
electrically charged polymer solution or polymer melt. In the study, which is discussed in 
Chapter 3-4, the electrospinning of a polymer solution is performed and therefore the process 
will be discussed in more detail here [89, 90]. 
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The electrospinning system consists of a sample reservoir, which is a simple syringe with a 
needle, the syringe pumping special equipment, a high voltage power supply, two electrodes 
and a grounded collector (Figure 1.8). In electrospinning, high voltage is applied to the tip of 
the needle that contains the solution that is held by its surface tension. High voltage induces 
a charge on the surface of the liquid and further increasing the electric field, usually to a level 
more than 5–6kV, leads to the elongation of the hemispherical surface of the solution and 
forms a conical shape known as the Taylor cone. As the intensity of the electric field is 
increased at a critical voltage, when the repulsive forces are larger than its surface tension, 
the repulsive electrostatic forces overcome the surface tension and a charge jet would erupt 
from the tip of the Taylor cone. The jet undergoes a bending instability and elongation stage, 
with further stretching and thinning under the electrostatic forces as the solvent evaporates. 
Long and thin fibres are then collected at the opposite site, on the grounded collector.  
 
Figure 1.8. Schematic diagram of the set-up of the electrospinning apparatus (left). Adapted 
from [91]. The lab electrospinning set-up used in this study (right). 
The diameter of the fibres created by the electrospinning process can range from nanometres 
to microns and the length can reach 1–3 metres. They are collected as non-woven fibrous 
mats that can be used in an oral dosage form by directly cutting them into pieces and then 
being packed in blister packs, or by milling and grinding or folding in many layers and further 
compressing into tablets or incorporating into capsules. 
Electrospinning can be considered as a combination of solid dispersion technology and 
nanotechnology. The main advantages of this technique are the high surface area, high 
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porosity, high drug loading of produced delivery systems (e.g. 21 % w/w without changing the 
nanofibres morphology and up to 86 % w/w but with particulate beads as shown in this study 
(Chapter 3), and 1:1 indomethacin:PVP and 4:1 aliskiren:PVP without changing the nanofibers 
morphology and forming a solid solution as reported by Brettmann et al. [92]) and the fast 
and efficient solvent evaporation, generally leading to the dispersion of the drug in the form 
of amorphous or nanocrystals and a more homogeneous distribution of API [73]. Yu et al. 
compared a polyvinylpyrrolidone (PVP) based solid dispersion of paracetamol 
(acetaminophen) prepared using electrospinning with other methods, namely vacuum drying, 
freeze drying, heat drying and pure paracetamol particles. In vitro dissolution testing was 
conducted in 900 ml 0.1 mol/L phosphate buffer solution with a rotating paddle at 50 rpm, 
37 °C, and sink conditions C<0.2 Cs. The results showed that the electrospun nanofibre-based 
solid dispersion had a faster dissolution profile followed by freeze-dried membrane and 
vacuum-dried membrane then heat-dried membrane and lastly pure paracetamol particles 
(Figure 1.9). The authors reported that about 93-94 % of paracetamol was released in the first 
2 min and completed within 5 min from electrospun nanofibres.  Whereas the complete drug 
release from the freeze-dried membrane and vacuum-dried membrane was within 20 min, 
followed by heat-dried membrane, 30 min, all with zero-order kinetics. And it took 60 min for 
pure paracetamol for complete dissolution which in fact showed a fast release rate at the 
beginning but was followed later by prolonged tailing-off effect that is common for 
conventional tablets due to the large size of the drug particles. The solid dispersion 
membranes avoided the tailing-off effect due to the even distribution of the drug within PVP 
matrix and the amorphous state of the drug in electrospun, freeze-dried and vacuum-dried 
membranes. The drug in heat-dried membrane may have mixed amorphous, nano- and 
micro-particles.    
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Figure 1.9. Paracetamol dissolution profile from membranes prepared by: a) electrospinning; 
b) freeze drying; c) vacuum drying; d) heat drying; e) pure paracetamol particles. Adapted 
from [87]. 
In addition, the fast disintegration and dissolution of electrospun prepared solid dispersions 
addresses the needs of paediatric, geriatric and dysphagic patients who often have difficulties 
in swallowing or taking medicines. Fast-dissolving electrospun solid dispersions, also known 
as oral fast-dissolving membranes or strips, or orodispersible films, can dissolve readily on the 
tongue and deliver drugs to a patient rapidly without the need to swallow and to take water 
[93]. The large surface area available in the strip dosage form allows rapid wetting and the 
moisture in the oral cavity is sufficient to dissolve it. The drug can be absorbed by the 
conventional gastrointestinal route and/or directly though the highly vascularized oral and 
buccal mucosa by entering the systemic circulation without undergoing first-pass hepatic 
metabolism, which in turn can improve the bioavailability of the drug and can reduce the dose 
of the drug. The fast-dissolving oral strip can be classified as an oral disintegrating tablet, 
which has been defined by the FDA as “solid oral preparations that disintegrate rapidly in the 
oral cavity, with an in vitro disintegration time of approximately 30s or less, when based on 
the United States Pharmacopeia (USP) disintegration test method or alternative” [94]. Other 
important advantages of the electrospinning process are that it does not employ thermal 
treatment and can be processed without using organic solvents. Therefore, it is perfectly 
suited for the production of heat sensitive nutritional supplements and APIs and can be 
considered as a green technology. Finally, yet importantly, the electrospinning technique 
involves a very compact and relatively cheap instrument that does not require special 
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conditions to maintain and which occupies a small space in the laboratory. The process is 
simple, fast, straightforward, and requires only a small amount of starting material. All these 
advantages make electrospinning technology relatively cost-effective. 
Today, one of the leading research areas in electrospinning is to develop its industrial usage, 
due to its great potential in different applications. On the other hand, the industrial upscaling 
of electrospinning is still a challenging issue with a lot of space for further improvements. One 
of the main drawbacks of electrospinning is the low production rate. In academic research, 
electrospinning is performed with volumes in the range of millilitres and the production rate 
is several g·h-1. However, the production rate can be improved up to several kg·h-1 and is 
mainly based on the modification of the polymer injection system: 1) the introduction of 
multi-spinneret components (Figure 1.10) and 2) the development of free surface 
electrospinning methods (Figure 1.11) [95]. The multi-spinneret system can produce 1 kg·h-1 
for a typical spacing of 1–3 nozzles per cm2 [96]. However, one of the main drawbacks of the 
multi-spinneret system is the alteration of the electric field (non-uniform electric field) profile 
due to the presence of another electrospinning jet nearby [95, 96]. Thus, if lab experimental 
studies, where a single spinneret is used, show good fibre production, transferring the lab 
processing parameters to industry may alter the fibre properties. Many approaches have 
been proposed to overcome this problem, including introducing a secondary electrode or an 
additional auxiliary electrode with charge of either the same polarity as the electrospinning 
jet or with opposite polarity, or increasing the collector dimension. However, all these 
modifications require additional studies and time to optimise the processing parameters, and 
operational and quality control to prevent nozzle clogging. The free surface electrospinning 
method is a very promising approach that can generate fibres two or three orders of 
magnitude higher than spinneret based methods. The principle of this method is based on 
generating jets from the rotating cylinder that are periodically dipped into the polymer 
solution, which is connected to a high voltage. The cylinder rotates slowly, at about 2.5 – 18 
rpm, and the downward and upwards movement of the cylinder results in a thin layer of 
polymer solution on its surface. Upon applying a high voltage, an enormous number of jets 
are generated from that thin layer of polymer and collected conventionally on a collector [96]. 
Variations of an industrial electrospinning set up have been developed and are available 
commercially from Inovenso Ltd. and Elmarco Co. 
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Another drawback related to solvent electrospinning is the solvent residues that can be 
trapped inside the produced nanofibres. Therefore, novel formulations that can be processed 
by aqueous solutions should be developed [95]. 
 
Figure 1.10. Schematic illustration of possible types of electrospinning spinneret. Adapted 
from [95]. 
 
Figure 1.11. Schematic illustration of a free surface electrospinning apparatus. Adapted from 
[97]. 
Processing parameters influencing electrospinning 
As with any other technological processes that are controlled by different parameters, the 
electrospinning process also involves many parameters that have an impact on the resultant 
fibres. Depending on the process parameters, the morphology of the end fibres might be 
varied, ranging from beaded fibres to porous nanofibres. 
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The primary aspects that affect fibre formation include: 
• Choice of electrospinning set up (horizontal or vertical, one electrode set up or two 
electrode set up, type of collectors, single needle electrospinning or coaxial needle 
electrospinning); 
• Choice of materials (type of polymer and its concentration and molecular weight, 
solution viscosity and conductivity, type of solvent, additional substances such as inorganic 
salts, surfactants, nanoparticles, drugs, carbon nanotubes, catalyst, liquid crystals, enzymes, 
emulsions); 
• Choice of spinning parameters (feeding rate, distance between the needle and the 
collector, applied DC voltage, diameter of spinneret orifice) [98]. 
In order to obtain the fibres with the desired properties, the following are the key 
characteristics of the solution and the operational parameters: 
• Suitable solvent to dissolve the polymer; 
• The vapour pressure of the solvent should be appropriate so that it evaporates quickly 
enough to allow fibre formation before it reaches the target, but not too quickly to harden 
fibres before they reach the nanometre range; 
• The viscosity and surface tension of the solvent should be neither too large to prevent 
jet formation nor too small to allow flowability of the polymer solution; 
• The power supply should be sufficient to overcome the viscosity and surface tension 
of the polymer solution to form a stable jet; 
• The distance between the tip of the needle and collector should be large enough to 
allow the solvent to evaporate, but not too large as this could lead to low yield. A small 
distance creates sparks between the electrodes; 
• The optimum humidity is considered to be about 30–40 %, as the high humidity causes 
the formation of pores on the fibre surface and it is used successfully in the formation of 
porous nanofibres due to controllability [99]. 
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Choice of electrospinning set up 
There are two main electrospinning set ups used currently: vertical and horizontal. There is 
no difference on the resulting fibre morphology between the vertical and horizontal set up 
[91]. Another type of electrospinning set up was introduced by R. Jaeger et al. [100], which is 
the one electrode set up and two electrode set up. The one electrode set up is traditional 
electrospinning set up with one high voltage source, while the two electrode set up utilizes 
two high voltage sources, one conventional and the second a ring electrode, as shown in 
Figure 1.12. The second electrode in the two electrode set up is used to reduce the 
electrostatic field at the capillary tip. In the study described in Chapters 3–4, we used a 
horizontal one electrode set up.  
 
Figure 1.12. One electrode set up (left) and two electrode set up (right): a) experimental lay-
out, b) electrostatic field. Adapted from [100]. 
There are more than 10 different types of collector designed nowadays and a comprehensive 
review on this aspect of electrospinning can be found elsewhere (Figure 1.13) [90]. In this 
project, the stationary plate and rotating drum collectors were used. 
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Figure 1.13. Schematic illustration of the main possible types of electrospinning collectors. 
Adapted from [95]. 
Choice of materials 
There are many different types of polymer used in electrospinning. The selection of the 
material depends on the application, as some materials such as polymer and polymer 
nanofibre composites can be electrospun directly. For example, natural polymers such as 
chitosan, gelatine, collagen and cellulose, synthetic biodegradable polymers – poly (lactic 
acid) (PLA), poly (ε-caprolactone) (PCL), poly (ethylene oxide) (PEO), and copolymers, such as 
poly (L-lactide-co-caprolactone) (PCLA) and poly (lactic-co-glycolic acid) (PLGA). Other 
materials such as ceramics and carbon nanotubes require post processing after 
electrospinning. Therefore, it is important to have a basic understanding of the different types 
of materials to choose appropriate electrospinnable materials for specific applications [91, 
101].  
The type of the materials influences the solution properties, which play a significant role in 
the electrospinning process and fibre diameter and morphology as they are responsible for 
the surface tension, viscosity and charge density of the solution.  
The viscosity of the solution affects the morphology of the obtained nanofibres. When the 
viscosity of the polymer solution is high, the beads become bigger and the spherical beads 
change to a spindle-like morphology, where the average distance between the beads are 
longer and the fibre diameter larger. Two polymers, namely, PEO dissolved in ethanol-to 
water solution and cellulose acetate (CA) dissolved in 2:1 acetone/DMAc 
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(dimethylacetamide), showed different viscosity ranges for producing smooth nanofibres 
without beads. For PEO in an ethanol-water solution the viscosity range was between 1–20 
poises, and droplets were formed when the viscosity level was below 1 poise, where the 
viscosity range is too low. Above 20 poises, electrospinning was not possible because of flow 
instability caused by the high cohesiveness of the solution [102]. As for electrospun CA 
dissolved in acetone/DMAc, the acceptable viscosity range was between 1.2 and 10.2 poises. 
Similarly, below 1.2 poises, droplets were formed because of the low viscosity; the fluid jet 
broke up into droplets [103]. The lower the molecular weight of the polymer, the higher the 
solubility of the polymer; however, viscosity, flexibility and the degree of molecular chain 
entanglement increases with the increase of molecular weight. Therefore, a minimum 
concentration of the polymer is required to have the highest possible percentage of polymer 
while still having low viscosity to allow jet formation. Below this critical value a different 
process called electrospraying is taking place, instead of electrospinning or beaded fibres 
being formed [104].  
The morphology of the fibres can be changed by changing the surface tension of the solution 
too. For example, changing the surface tension of the PEO solution by adjusting the ethanol-
to-water ratio in the solvent system changes the fibre morphology from beaded to smooth 
nanofibres. The surface tension coefficient was between 35 and 55 dyne/cm, and above 55 
dyne/cm beaded fibres were formed [89]. Similarly, experiments with cellulose acetate 
showed that the smooth fibre forming surface tension coefficient was 26–27 dyne/cm. A 
higher surface tension, namely 30 dyne/cm, produces beaded nanofibres [103]. Doshi and 
Reneker [105] also highlighted that fibres without beads could be obtained by reducing 
surface tension. However, this approach should be applied with caution, because it is not 
necessarily the case that a lower surface tension of a solvent will always facilitate smooth 
fibre formation. For example, Liu and Hsieh [103], in their work with CA dissolved in acetone, 
DMAc and a mixture of both solvents, demonstrated that no fibres but only beads were 
obtained for a sample dissolved only in DMAc and short fibres with diameter of around 1 μm 
and beads on the string morphology were obtained for a sample dissolved only in acetone, 
although their surface tension coefficient was 32.4 dyne/cm and 23.7 dyne/cm respectively. 
However, they could yield CA nanofibres without beads when they used the mixture of two 
solvents with a ratio of 2:1 acetone:DMAc; here the surface tension was 26–27 dyne/cm. The 
Chapter 1 
38 
 
variation in polymer concentration from 15 wt. % to 25 wt. % does not change the fibre 
morphology and surface tension, confirming that the polymer concentration has no effect on 
surface tension. Very smooth and uniform diameters of around 700 nm were obtained with 
a solvent ratio of 10:1 acetone:DMAc and 15 wt. % of CA [89]. Conversely, the study of the 
effect of diameter of the needle recommends increasing the surface tension [104].  
Net charge density depends on the applied electrostatic field and to a lesser extent is 
influenced by the conductivity of the solution. If we increase the net charge density, the beads 
become smaller, more spindle-like and the fibre diameter also decreases. For example, Zong 
et al. [106] found that adding 1 wt. % salt into biodegradable poly(D,L-lactic acid) PDLA 
polymer solution will result in a uniform fibre diameter ranging from 200 nm to 1000 nm, 
where a no beads-on-string structure was formed. They suggested that the addition of salts 
increases charge density on the surface of the erupted jet during electrospinning, bringing 
more electric charges that are carried by the spinning jet. With the increase of charges carried 
by the jet, the elongation forces imposed to the jet increase under the electrical field. This 
results in smaller beads and thinner fibre diameter. The conductivity of the solution can be 
improved by using organic acid as the solvent too. Huang et al. [107] used formic acid as the 
solvent and a small amount of pyridine to dissolve the nylon and could obtain ultrathin (3nm) 
nylon fibres. 
Fong et al. [102] studied all three parameters on PEO fibre formation and reported that non-
beads fibres were obtained with higher viscosity. A higher net charge density was responsible 
for not only non-beaded fibres but also the formation of thinner fibres. Higher surface tension 
favours the formation of beaded fibres, hence the reduced surface tension produces fibres 
without beads. The viscosity depends on the polymer concentration and molecular weight, 
while the surface tension depends on the polymer and the solvent types. 
Choice of spinning parameters 
A crucial element in the electrospinning process is the applied voltage to the solution. Fibre 
formations occur only after reaching the threshold voltage to induce the necessary charges 
on the solution with the electric field, which initiates the electrospinning process [91]. Deitzel 
et al. [108] studied the influence of electrical potential on an example of PEO nanofibres. They 
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represented that with the increase of the electrical charge the nanofibres became beaded 
and rougher (Figure 1.14). Whereas, Reneker and Chun [109] using the example of PEO 
demonstrated that there is not much impact of the electric field on fibre diameter. However, 
Zhang at al. [110] and Demir et al. [111] suggested that with the higher voltage there is more 
polymer ejection, which facilitates the formation of a larger fibre diameter. On the other 
hand, Larrondo and Manley [112-114] observed a decrease in fibre diameter by 
approximately half by doubling the applied electric field. Similarly, other authors have 
reported that an increase in the applied voltage increases the coulomb force in the fluid jet 
as well as the electric field and this favours the narrowing of fibre diameter and also the rapid 
evaporation of solvent from the fibre [91]. However, other researchers have reported that at 
higher voltage there is a greater probability of beads formation [108, 111, 115-122]. 
 
Figure 1.14. SEM images of PEO nanofibres electrospun at different electrical potentials. 
Adapted from [89]. 
The feeding rate of the polymer solution from the syringe is one of the important factors 
influencing the jet velocity and the material transfer rate. Low flow rates are more desirable 
as they allow enough time for evaporation. High feed rates result in beaded fibres because 
there is not enough time for solvent evaporation. Therefore, there should be a minimum flow 
rate of the electrospinning solution. On the example of polystyrene (PS) it has been observed 
that the fibre diameter and the pore diameter increases with an increase in the polymer flow 
rate [91]. Megelski et al. [116] and Zong et al. [106] investigated the relationship between the 
solution flow rate and fibre morphology and size. They showed a formation of beaded fibres 
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with a high flow rate due to the unavailability of a proper drying time before reaching the 
collector [91]. 
The distance between the tip of the needle and the collector has no significant impact on fibre 
morphology. This has been observed with the electrospinning of (polyvinyl alcohol) PVA [110], 
gelatine [123], and poly(vinylidene fluoride) (PVDF) [124]. However, there should be an 
optimum distance between the tip to the collector to allow enough time for the solvent to 
evaporate from the nanofibres [91]. Electrospinning of a silk-like polymer with fibronectin 
functionality resulted in a flatter fibre with a close distance and rounder fibres with an 
increase in distance [115]. The effect of the tip of the needle to collector distance was 
investigated by other researchers too and they found that distances that were either too close 
or too far fabricated beaded fibres [117, 123]. 
The diameter of the needle orifice also has an impact on fibre diameter. A larger needle 
diameter may cause clogging at the tip of the needle [118]. This is because of the surface 
tension, which can be increased by reducing the radius of the droplet by decreasing the 
diameter of the needle. Increasing the surface tension at the tip of the needle, while keeping 
the electrostatic field strength at a constant rate, serves to decrease the initial acceleration 
of the jet and the average velocity. This results in increasing the flight time from the tip of the 
needle to the collector. Thus, fibres with a smaller diameter and narrower size distribution 
can be fabricated with a smaller diameter of the needle. However, the droplet may be difficult 
to form if the diameter of the needle is too small, depending on the surface tension of the 
solution[104]. Yamashita et al. [125] demonstrated that there is no correlation between the 
nozzle diameter and the fibre diameter.  
1.6.1 Emulsion and coaxial electrospinning 
Emulsion electrospinning (EE) is similar to conventional electrospinning except the polymer 
solution contains an emulsion, either water-in-oil (w/o) or oil-in-water (o/w). EE enables the 
production of core-sheath nanofibres with desired functionalities, whereby two different APIs 
can be delivered at two different release rates. The mechanism of the formation of the core-
sheath structure of emulsion is mainly due to de-emulsification. A number of researchers 
have suggested different mechanisms of the formation of the core tube: emulsion droplets 
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break up [126] and stretching and elongation [127, 128] induced by high voltage are examples 
reported in the literature. The oil phase is usually composed of amphiphilic polymers 
(poly(ethylene glycol)-poly(L-lactic acid) (PEG-PLA) diblock copolymer [127], poly(ethylene-
co-vinyl acetate) [129], or any spinnable polymer dissolved in organic solvent immiscible with 
water phase such as chloroform, dimethylformamide, dichloromethane (DCM) or toluene and 
a water phase is comprised of hydrophilic polymers, with PEO and PVP being the most 
commonly used polymers [130, 131]. However, liquid oils were also incorporated in fibre by 
means of EE, but this fact is scarcely reported in the literature. For example, Angeles et al. 
[126] first reported successful electrospinning of oil-in-water (o/w) emulsion using 7 wt. % 
PEO, dissolved in water as a continuous phase, and mineral oil as a dispersed phase (2.5 wt. 
%),  and Pluronic P105 (BASF) (0.5 wt %) as a surfactant. The optical microscope study showed 
that the produced fibres contain oil droplets within them and the diameter of the fibres was 
mostly less than 2 μm. Then, Kriegel et al. [132, 133] and Camerlo et al. [134] reported 
encapsulation of an antimicrobial essential oil, namely eugenol, and a highly volatile 
fragrance, namely (R)-(+)-limonene, in PVA nanofibres by means of EE. Moomand and Lim 
[135, 136] encapsulated fish oil (30 w/w %) in zein fibres using ethanol-isopropanol as a 
solvent (good oxidative stability for 14 days); however, the current production method of zein 
is costly which makes it an uneconomical material for food application [137]. Recently, García-
moreno et al. [137, 138] encapsulated fish oil (1.5-5 w/w %) in nanofibres using EE. However, 
the first experiment, where they used PVA polymer as the continuous phase, was not 
successful, as although fish oil was encapsulated successfully in fibres as small droplets, the 
oxidative stability test showed the inability of the PVA fibres to protect the fish oil against 
oxidation. The authors concluded that PVA has trace metals, e.g. Fe, which catalysed lipid 
oxidation [137]. In the second experiment, when they used pullulan, the oxidative stability of 
the fish oil was superior for the sample prepared with emulsified neat oil compared to the 
sample prepared with emulsified fish oil [138]. 
Coaxial electrospinning is also another way of producing core-sheath structured nanofibres, 
although, unlike EE, it requires a special coaxial needle (Figure 1.10) and an extra solution 
pump. The configuration of the coaxial electrospinning setup is shown in Figure 1.15. As in 
conventional electrospinning, different types of collector can be utilized although here a 
rotating collector is illustrated. 
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Figure 1.15. A schematic representation of coaxial electrospinning set-up with a rotating 
collector (left). The lab coaxial electrospinning set-up used in this study (right). 
Coaxial electrospinning has some advantages over EE. In coaxial electrospinning, a material 
constituting the core solution does not need to be electrospinnable, as good spinnability of 
the outer solution is important [128, 131]. Two different polymer solutions are ejected 
through the concentric capillary spinneret; the core solution is enclosed in the outer solution 
producing core-sheath structured nanofibres. Based on the reasonable selection of the core-
sheath constituent, biphasic drug release can be obtained where an immediate drug release 
is followed by a sustained release. Such systems have a wide application to deliver non-
steroidal anti-inflammatory drugs (NSAIDs), antihypertensive, antihistaminic and anti-allergic 
agents [139]. 
1.7 Structured oil systems  
Delivery systems for the encapsulation of micronutrients can be classified into four main 
groups according to the material used to formulate the delivery systems: protein-based 
delivery systems, lipid-based delivery systems, carbohydrate-based delivery systems, and 
mixed systems (Figure 1.16) [140]. 
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Figure 1.16. Commonly used food-grade delivery systems, as classified by Benshitrit et al. 
Adapted from [140]. 
Lipid-based delivery systems are the most efficient carrier system for the incorporation of 
lipophilic and hydrophilic ingredients and they constitute a considerable number of most food 
and pharmaceutical products. A lipid-based delivery system can be constructed as solid lipid 
nanoparticles, as self-micro-emulsifying systems and as micro- and nanoemulsion or 
structured emulsion systems. They provide good chemical protection for sensitive vitamins, 
better stability and controlled release with a wide range of materials and the most simple 
techniques are used to create them [140, 141]. 
Microemulsion or structured emulsion systems are defined as thermodynamically 
unfavourable systems; however, their kinetic stability can be improved by selecting the right 
emulsifiers and viscosity modifiers. Small molecule surfactants, polysaccharides, proteins, 
protein-polysaccharide complexes and amphiphilic biopolymers are emulsifiers which form 
an interfacial membrane, reducing interfacial tension by rapidly adsorbing at the oil-water 
interface [142]. Protein-polysaccharide complexes tend to form more stable emulsions, 
particularly o/w emulsions, in reaction to environmental stresses such as pH variation, 
thermal processing, freezing and dehydration. This property is widely used in the food and 
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pharmaceutical industries to produce a solid form of emulsions, which are the most 
preferable formulation, by freeze or thermal drying of stable emulsions. Proteins themselves 
are good emulsifiers; being surface active, they can adsorb at fluid interfaces by forming a 
thin and electrically charged layer. Thus, they prevent droplet aggregation by an electrostatic 
repulsion mechanism. Proteins have polar and non-polar amino acid residues. At the oil-water 
interface, non-polar residues orient in the hydrophobic phase and form a viscoelastic 
adsorbed layer. The extent of adsorbtion of proteins is related to the structural properties of 
the proteins, surface hydrophobicity and charge density. Mixing or deposition of 
polysaccharide on top of an adsorbed layer of proteins ensures better stability and resistance 
against environmental stresses [143, 144]. They can form covalent [145] and non-covalent 
interactions, mainly through hydrogen bonding, electrostatic interactions, steric exclusion, 
and hydrophobic interactions at the oil-water interface. Polysaccharides are the polymer of 
monosaccharides and have a large number of reactive groups. They can adsorb onto the 
surface of proteins by attractive electrostatic interaction, or compete with proteins to adsorb 
at the oil-water interface because of the repulsive interaction of two uncharged or similarly 
charged polymers [143, 144]. The strength of polymer interactions may switch from net 
attractive to net repulsive upon varying the pH and/or ionic strength. At pH < pI of protein 
solution a strong attractive electrostatic complex forms with positively charged proteins and 
negatively charged polysaccharides. Weaker reversible complexes form when proteins pH > 
pI and pH ≈ pI, representing a net negative and nearly zero charge, respectively [144, 146]. 
In this study, we also created a soft solid structured oil system (SOS) made from protein and 
polysaccharide using a freeze drying technique. The obtained SOS can hold a large amount of 
oil and can be used as a carrier to deliver highly water-soluble, poorly water-soluble and oil-
soluble drugs or nutrients.  
The protein and polysaccharide that were used in this study to create an SOS were gelatine 
and xanthan gum (G/X). Being surface active, gelatine (G) adsorbs at the oil-water interface 
and xanthan gum (X) is non-surface active and forms an interfacial complex with gelatine 
through attractive electrostatic interactions and/or hydrogen bonding. They can be 
introduced to the oil continuous phase simultaneously (co-adsorption) or sequentially (layer-
by-layer adsorption) forming a viscoelastic or tightly adsorbed layer stable against thermal 
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processing, freezing and dehydration [147]. However, Patel et al. in their research found no 
difference in the sequence of addition on product quality [147]. 
The drying technique used in this study was freeze drying. Freeze drying or lyophilisation is a 
widely used technique in the food and pharmaceutical industry to remove the water content 
of heat sensitive products. A freeze-died formulation provides very low moisture content, 
therefore, improved long term stability and storage. In addition, automated processing with 
less human involvement, easy handling and shipping of the end product are advantageous 
elements of the freeze drying technique. However, the length of processing time, ranging from 
one day to one week, makes the technique relatively costly. 
The freeze drying process consists of three stages: freezing, when water forms ice; primary 
drying or ice sublimation, when the chamber pressure goes down below the vapour pressure 
of ice and secondary drying, involving the complete removal of the rest of the ice from the 
solute, when the temperature is elevated and the pressure is very low. In mass production, 
the control of ice nucleation can significantly reduce the drying duration [148]. The impact 
and methods of control ice nucleation are discussed elsewhere [149]. We did not study the 
effect of ice nucleation and, therefore, it is not covered here. 
1.8 Motivations and aims of the study  
Despite tremendous progress in correcting nutritional deficiency in the global population over 
the last century, an estimated 3.5 million lives are lost each year due to undernutrition, more 
specifically, deficiency in essential nutrients, and most of the casualties are children and 
pregnant women (data from 2008) [150]. Over 100 million children are still vitamin A deficient 
[151], resulting in about 0.8 million annual deaths in total [152],  while up to 4–5 billion people 
may suffer from iron deficiency [153] accounting for 841,000 deaths and 35 million disability-
adjusted life years lost [154]. Meanwhile, 30 per cent of households are not consuming iodized 
salt, leaving 41 million newborns at risk of brain damage and impaired learning capability 
[151]. In addition, over 8 million children under five years of age die each year from illnesses, 
such as diarrhoea, malaria, HIV/AIDS (Acquired Immune Deficiency Syndrome), tuberculosis 
and pneumonia, due to the lack of medicines suitable for use by children, yet effective 
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treatments exist for most of these diseases. Even if the correct dosage forms do exist for 
children, there is a lack of access to them [155]. For comparison, cancer is the second leading 
cause of death globally, with 9.6 million deaths in 2018. However, while cancer involves many 
uncontrollable risk factors causing the cancer burden and encompasses one or more 
modalities to treat the disease, such as surgery, radiotherapy, and chemotherapy [156], 
nutrient deficiency can be prevented and/or corrected by simple nutrient intervention and 
over 8 million children’s lives can be saved by simply improving the dosage form and making 
it accessible. One of the key challenges remaining today are the lack of cost-effective delivery 
mechanisms [151] to provide an adequate amount of essential nutrients  and medicines for 
children and other vulnerable groups of population, especially for those living in developing 
countries. There is a scarcity of research regarding the paediatric dosage form. Therefore, the 
primary aim of this study was to address the needs of paediatric populations and make a 
contribution into the research area in the development of paediatric dosage forms, i.e. 
formulate oral delivery systems capable of delivering multiple micronutrients and which can 
be potentially adopted for delivering any other water-soluble and poorly water-soluble APIs. 
Thus, the objective of this study are 1) to design an oral delivery system that can be used in 
two separate contexts: the delivery of drugs or the delivery of nutrients; 2) to investigate 
various processing parameters to improve the characteristics of delivery systems; 3) to ensure 
the development of safe, effective, cheap and easy administered dosage forms with 
sustainable mass-scale production technology. The following steps were undertaken to 
achieve them: 
1. A fast-dissolving orodispersible film loaded with KIO3 as an alternative solid form of 
iodine delivery was prepared using emerging electrospinning technology. All 
processing parameters were investigated in order to identify the effect of each 
processing parameter on the final product and to select the optimum processing 
parameters to obtain an effective delivery system for iodine. Characterization of the 
end product was performed to ensure the stability and effectiveness of the dosage 
form. The results are given in Chapter 3.  
2. This study explored emulsion and coaxial electrospinning to produce core-sheath or 
oil-containing fibres for dual nutrient delivery, i.e. water-soluble nutrient, KIO3 and fish 
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oil and a number of vegetable oils that have essential nutrients. The results are given 
in Chapter 4. 
3. The study investigated a novel structured oil system capable of holding large amounts 
of oil prepared by means of a freeze drying technique. The research studied the effect 
of processing parameters on the formation of structured oil systems and characterized 
the end product using analytical techniques to understand the oil holding capacity and 
ensure the stability of the system. Dissolution testing was performed to assess the 
applicability of the system for delivery of highly water-soluble API. The results are given 
in Chapter 5. 
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2 Chapter 2. Materials and Experimental Methods 
2.1 Introduction 
This chapter provides detailed information regarding the physicochemical properties of the 
materials used in this study. Following this, the detailed sample preparation methods and 
characterization methods used throughout the project along with their working principles are 
discussed. 
2.2 Materials 
Table 2.1 represents information regarding the grades and suppliers of all chemicals and 
materials used in this study. All reagents and substances were employed without further 
purification.  
Table 2.1. List of sources, chemicals and materials used in the study and their key 
physicochemical properties as highlighted by the manufacturer (taken from manufacturer 
data sheets). 
Substance Source Description 
Potassium iodide  
(KI) 
Sigma-Aldrich, UK ACS ≥ 99% 
Potassium iodate  
(KIO3) 
Sigma-Aldrich, UK ACS 99.5%  
Sunflower oil Sigma-Aldrich, UK – 
Flaxseed oil Biona, UK Virgin cold press 
Olive oil Sigma-Aldrich, UK Ph.Eur. 
Fish oil  
(liver oil from Gadus morrhua) 
Sigma-Aldrich, UK Ph.Eur. 
Squalene oil Sigma-Aldrich, UK ≥ 98%    
Ketoconazole Afine Chemicals Ltd., 
China 
– 
Metoprolol succinate Colorcon Ltd., UK – 
Poly (ethylene oxide) Sigma-Aldrich, UK 3 × 105 g/mol (PEO 300K) 
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(PEO) 6 × 105 g/mol (PEO 600K) 
Polyvinyl pyrrolidone 
(PVP) 
Sigma-Aldrich, UK 1 × 106 g/mol (PVP K90) 
[157] 
TPGS 
(Kolliphor® TPGS) 
BASF, Germany – 
Gelatine type B 
(bovine skin) 
Sigma-Aldrich, UK 50,000 – 100,000 g/mol 
Xanthan gum Sigma-Aldrich, UK 4 × 106–12 × 106 g/mol 
Hydroxypropyl methylcellulose  
(HPMC K4M – Methocel® K4M) 
Colorcon Ltd., UK 95,000 g/mol [158] 
86,000 g/mol [159] 
Methylcellulose (MC) Dow Chemical Co., UK – 
PEG-20 sorbitan monolaurate 
(Tween 20) 
Sigma-Aldrich, UK – 
Sorbitan monooleate 
(Span 80) 
Sigma-Aldrich, UK – 
Sodium chloride 
(NaCl) 
Sigma-Aldrich, UK ACS 99% 
Sulphuric acid 
(H2SO4) 
Sigma-Aldrich, UK ACS 95.0−98.0% 
Coumarin 6 Sigma-Aldrich, UK 98% 
2.2.1 Nutritional supplements (KI and KIO3) 
Potassium iodide (KI) is a chemical compound made up of 76% of the halogen iodine and 23% 
of the alkali metal potassium by weight [160]. It is considered to be a relatively unstable 
compound; on long exposure to air, light and moisture, potassium iodide becomes yellow due 
to the oxidation of iodide to iodine [161]. KI has many applications, including organic 
synthesis, photography and biomedical research [162]. In the pharmaceutical and food 
industries it is used as medication, a dietary supplement and as a source of iodine in salt 
iodization. As a medication, KI is used to treat dermatoses (300 mg 3 times daily followed by 
weekly increases as tolerated), thyrotoxicosis (250 mg 3 times daily as a Lugol’s solution or 
saturated solution of KI) [163, 164], to protect against radiation (130 mg single dose) [165], 
as an expectorant (100 mg/5 ml 3–4 times daily) [166, 167] and as an antiseptic agent [168]. 
Reported uses for KI for inflammatory dermatoses and the related pharmacology, mechanism 
of action, contraindications and adverse effects of KI are reviewed by Sterling and Heymann 
[160]. As a supplement it is given on a daily basis to pregnant and lactating women, and to 
children less than 2-years old either alone or in combination with other minerals and vitamin 
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supplements so the total iodine intake meets the recommended nutrient intake of iodine per 
day [169]. In this study, KI was first selected as a source of iodine to be delivered by oral 
formulations for treating iodine deficiency in children (Chapter 3). 
Potassium iodate (KIO3) is a chemical compound made up of K+ ions and IO3− ions in a 1:1 
ratio. It undergoes five phase transitions as a result of temperature change at atmospheric 
pressure (Appendix 4). At room temperature phase III, it has a triclinic structure (P1) with a 
very pronounced pseudo-rhombohedral symmetry [170, 171]. KIO3 has greater stability and 
a longer shelf life than KI and, therefore, is used as an alternative to KI for iodination of table 
salt in areas with severe climatic conditions [172]. Potassium iodate, according to the EU 
Member States legislation which was entered into force in July 2002, is a permitted source of 
iodine in iodine containing supplements [173]. It is also used in bread baking as a fast acting 
oxidant [174, 175] and in iodination of irrigation water [176, 177]. As medication, it is also 
used as in the case of KI for radiation protection (170 mg single dose) [165]. In this study, KIO3 
was subsequently selected as a more stable iodine source than KI (Chapter 3). 
The physicochemical properties of KI and KIO3 are presented in Table 2.2. 
Table 2.2. Physicochemical properties of KI and KIO3, taken from [178, 179] and [180, 181], 
respectively. 
Property KI  KIO3 
IUPAC name Potassium iodide Potassium iodate 
Chemical formula KI KIO3 
Molecular weight 166.00 g/mol 214.00 g/mol 
Physical state White crystalline solid White crystalline powder 
Odour Odourless Odourless 
Specific density 3.1 g/cm3 3.89 g/cm3 
Boiling point 1330 ⁰C (sublimes) –  
pH 7–9 (saturated solution) – 
Solubility –  Soluble in KI solution; insoluble in 
alcohol, liquid ammonia, nitric acid 
Solubility in water 1280 mg/ml (0 ⁰C) 
1400 mg/ml (20 ⁰C) 
1760 mg/ml (60 ⁰C) 
2060 mg/ml (100 ⁰C) 
4.74 g/100 ml (0 ⁰C) 
9.16 g/100 ml (25 ⁰C) 
32.3 g/100 ml (100 ⁰C) 
Melting point 681 ⁰C 560 ⁰C (decomposes) 
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2.2.2 Oils 
All the oils used in this study were selected due to their positive effect on human health.  
Sunflower oil 
Sunflower oil is a fatty oil obtained from the seeds of the sunflower. Sunflower oil’s chemical 
structure is depicted in Figure 2.1. The viscosity is 47.4 cSt (at 20 °C ±2) [182].  
 
Figure 2.1. Chemical structure of sunflower oil. 
Sunflower oil has various applications on a domestic and industrial level. In some countries, 
sunflower oil is a common edible oil, where it is used as a salad dressing and cooking oil. In 
industry, sunflower oil is used as a frying oil, a health food formulation [183] and in the 
manufacture of mayonnaise and oil-based dressings due to its comparatively high oxidative 
stability [184, 185]. In pharmaceutical formulations, it is used as a diluent, emollient, 
emulsifying agent, solvent and tablet binder. Therapeutically, sunflower oil is used for 
parenteral nutrition to provide energy and essential fatty acids, and in intramuscular 
injections because it does not induce tissue damage [157]. In this study, sunflower oil was 
used as a model oil for the oil phase in o/w emulsion to produce core-sheath nanofibres 
(Chapter 4) and within the SOS (Chapter 5). 
Flaxseed oil (Linseed oil) 
Flaxseed oil or Linseed oil is a fatty oil obtained by cold expression from the ripe seeds of flax 
[186]. The viscosity is 51.2 cSt (at 20 °C ±2) [182]. Flaxseed oil has a low level of saturated fatty 
acids (9%), a moderate level of monosaturated fatty acids (18%) and high levels of 
polyunsaturated fatty acids (PUFA) (73%) [187]. Oils rich in PUFAs have beneficial effects on 
human health [188] and a wound-healing action [189]. However, one of the concerns 
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associated with oils having a high content of PUFAs is their susceptibility to oxidation, 
resulting in the production of off-flavours and toxic peroxides on heating [190, 191]. 
Flaxseed oil is widely used in the pharmaceutical and food industry because it contains the 
richest vegetarian source of EFAs: linoleic acid (LA) (ω – 6 fatty acid) and α-linolenic acid (ALA) 
(ω – 3 fatty acid). It is used in pharmaceutical and food formulations in the form of neat oils, 
stable emulsions, microcapsules [192] and micro- and nano-encapsulated powders [188, 190, 
191, 193, 194]. In this project, flaxseed oil was used as a functional food ingredient for the oil 
phase of o/w emulsion to produce core-sheath nanofibres (Chapter 4). 
Olive oil 
Olive oil is a fatty oil obtained from the ripe drupes of olive by cold expression or other suitable 
mechanical means. The viscosity is 84.0 cSt (at 20 °C ±2) [182]. It is slightly soluble in ethanol 
(95%), miscible with ether, chloroform, light petroleum (50–70 ⁰C), and carbon disulphide 
[157]. 
The major groups of compounds that are ascribed to have nutritional and healthy values are 
monounsaturated fatty acids (MUFAs) and PUFAs, squalene, phytosterols, triterpenic acids 
and dialcohols, pigments, tocopherols, and polyphenols [195, 196]. In pharmaceutical 
formulations, olive oil has been used in enemas, liniments, ointments, plasters, topically 
applied lipogels, as oral capsules and solutions, as a vehicle for oily injections and targeted 
delivery systems, emulsions for use in pre-term infants and ear drops [157]. In the food 
industry, it is widely used as a cooking oil and salad dressing. In this study, olive oil was 
selected as a functional food ingredient for the oil phase of o/w emulsion to produce core-
sheath nanofibres (Chapter 4). 
Fish oil 
Fish oil is a purified fatty oil obtained from the fresh livers of farmed cod [186]. The major 
contents of cod liver oil are presented in Table 2.3. The viscosity is 42.0 cSt (at 20 °C ±2) [182]. 
Unfortunately, the unpleasant odour of fish oil, its low solubility in most food systems and 
high susceptibility to oxidative degradation of ω – 3 PUFA, limits their use in the food and 
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pharmaceutical industry. However, encapsulation technology is commonly carried out to 
overcome these drawbacks [138, 197]. 
Table 2.3. Cod liver oil contents. EPA – eicosapentaenoic acid, DHA – docosahexaenoic acid. 
Adapted from [186]. 
Content Percentage (%) and mass (μg) 
Sum of the contents of EPA and DHA 
(expressed as triglycerides) 
10.0%–28.0% 
Vitamin A 50 IU (15 μg) to 500 IU (150 μg) per gram 
Vitamin D3 maximum 50 IU (1.3 µg) per gram 
Fish oil has numerous beneficial effects on human health due to its high concentration of ω – 
3 PUFAs, particularly docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), which 
have been documented to prevent many diseases [57-60, 198]. It also has been used as a 
source of vitamins A and D in the pharmaceutical industry. In the food industry, fish oil is used 
as a functional food ingredient and can be encapsulated in emulsions [199], liposomes [200], 
solid lipid particles [201], micro- and nano-particles [197, 202, 203], and nanofibres [137]. In 
this project, fish oil was selected as a functional food ingredient for the oil phase of o/w 
emulsion to produce core-sheath nanofibres (Chapter 4). 
Squalene oil 
Squalene oil is a linear triterpene hydrocarbon consisting of six isoprene units (Figure 2.2) 
[204, 205]. Squalene and its hydrogenated form, squalane, are approved for human use, as 
they are non-toxic. It is widely present in nature and is synthesized in all types of cells. In 
humans, it is present in sebum at approximately 13%. However, the highest source of 
squalene is shark liver oil (60 w/w %), while substantial amounts are also found in olive oil 
and olive leaves [204, 206]. It is a highly hydrophobic compound due to the hydrocarbon 
composition of the molecules [204]. In addition, squalene is not very stable due to its chemical 
structure and high degree of unsaturation, and it is therefore easily oxidized [206]. The 
viscosity is 15.9 cSt (at 20 °C ±2) [182]. 
Squalene oil has many applications in the pharmaceutical and food industry. In the 
pharmaceutical industry, it is used for numerous vaccine [207] and drug delivery emulsions, 
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because squalene facilitate solubilization, modified release, and cell uptake of drugs and 
adjuvants [204, 208, 209]. In addition, it has stability-enhancing effects and is biocompatible. 
The biological and pharmacological activities of squalene are reviewed elsewhere [204, 206, 
210, 211]. In this project, squalene oil was selected as a functional food ingredient for 
composing the oil phase of o/w emulsion to produce core-sheath nanofibres (Chapter 4). 
 
Figure 2.2. Chemical structure of squalene. Adapted from [204]. 
2.2.3 Model drugs 
Ketoconazole  
Ketoconazole is a broad-spectrum antifungal agent used primarily for the treatment of 
mucocutaneous fungal infections caused by the Candida species [212, 213]. The molecular 
weight is 531.431 g/mol [186]. The chemical formula is C26H28Cl2N4O4 (Figure 2.3). It is an 
imidazole derivative and its structure presents two basic groups, a piperazine and an 
imidazole with pKa values of 2.94 and 6.51 respectively [212]. Thus, it readily dissolves in a 
solution with low pH rather than at higher pH [214]. Ketoconazole is rather lipid soluble, its 
octanol-water partitioning coefficient, log P, is 3.73 [215]. It is insoluble in water, soluble in 
methylene chloride and in methanol, and sparingly soluble in ethanol (96%) [186]. According 
to the BCS, ketoconazole is classified as a a class II drug due to its high permeability and low 
aqueous solubility [216]. The melting point is between 148 °C and 152 °C [186].  
Ketaconazole is administered topically (creams, shampoos, solutions). It has been reported 
to have a positive effect in the treatment of systemic blastomycosis, candidiasis, 
coccidioidomycosis, histoplasmosis, paracoccidioidomycosis, and tinea of skin and nails when 
given orally [216]. However, the drug was discontinued in Europe and Australia in 2013 due 
to the risk of serious hepatic side effects. In the US and Canada strict restrictions and 
cautionary advisements were added to the labelling of oral ketoconazole [217]. In this study, 
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ketaconazole was used as a model of a poorly soluble API incorporated in the oil phase of SOS 
(Chapter 5). 
 
Figure 2.3. Chemical structure of ketoconazole. Adapted from [186]. 
Metoprolol succinate (MS) 
Metoprolol succinate (MS) is a ß1 selective adrenoceptor antagonist used to treat high blood 
pressure, chronic heart failure [218], angina pectoris, arrhythmia [219] and reduce chest pain 
[220]. The chemical formula is C34H56N2O10 (Figure 2.4). The molecular weight is 652.826 
g/mol. Metoprolol is a basic drug with a pKa of 9.6; however, the pH of 6 % w/v aqueous 
solution of its succinate drug is 7–7.6 [221]. The log P is 1.88. It is freely soluble in water (276 
mg/ml at 37 °C [222]), soluble in methanol, slightly soluble in ethanol (96%), and practically 
insoluble in ethyl acetate [186]. The melting point is 135–137 °C [223-225].  
 
Figure 2.4. Chemical structure of metoprolol succinate. Adapted from [226]. 
MS is commonly formulated as an extended-release (ER) tablet [222-224, 227, 228] since it 
has a relatively short elimination half-life of 3–4 hours [219]. The ER tablet is dosed at 100 
and 200 mg once daily [229]. MS is absorbed rapidly throughout most of the gastrointestinal 
tract when administered in the conventional dosage form [228, 230]; however, its absorption 
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mainly takes place in the duodenum and jejunum [231]. In this study, MS was used as a water-
soluble model drug incorporated in the aqueous polymer phase of SOS (Chapter 5). 
2.2.4 Excipients 
Poly (ethylene oxide) (PEO K300 and K600) 
PEO is a semi-crystalline, thermoplastic, hydrophilic and biocompatible polymer that is a non-
ionic homopolymer of ethylene oxide [157, 232]. The structural formula is [H(-OCH2CH2-)nOH] 
(Figure 2.5) [157]. PEO has a range of molecular weights starting from 105 to 7 × 106 g/mol. 
The melting temperature (Tm) is 57–73 ⁰C [233] and the Tg ranges from (-60 ⁰C) to (-70 ⁰C) 
[234]. It is freely soluble in water and organic solvents such as acetonitrile, chloroform, 
methylene chloride [157], ethanol and dimethylformamide [235], and insoluble in aliphatic 
hydrocarbons, ethylene glycol and most alcohols [157]. 
 
Figure 2.5. Chemical structure of PEO. Adapted from [236]. 
The main functional properties of PEO, as used in pharmaceutical and food technology, are 
its excellent mucoadhesive, lubricant and tablet binding properties. In addition, it can be used 
in coating and thickening agents, drug/nutrient delivery systems and as a food packing 
material for longer shelf life [237, 238]. Its E number is E1521 [239]. As a tablet binder, it can 
be used at concentrations of 5% to 85%. At low levels, it is an effective thickener. As a 
drug/nutrient delivery system, it can be used for immediate-, delayed-, or sustained-release 
matrix formulations because there is a good relationship between the swelling capacity and 
molecular weight of PEO, which is used as a guide to select the right molecular weight grades 
(Figure 2.6). 
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Figure 2.6. Swelling capacity of PEO tablets with d-28 mm in 300 ml water prepared with four 
different grades. Adapted from [157]. 
PEO was selected as a safe, inexpensive, water-soluble and good spinnable polymer to 
develop ultra-rapidly disintegrating orodispersible film in Chapter 3 and in developing oil 
containing electrospun films in Chapter 4. The PEO used in this study has the molecular weight 
of 3 × 105 g/mol (PEO 300K) and 6 × 105 g/mol (PEO 600K) [157]. 
Polyvinyl pyrrolidone (PVP K90)  
PVP is an amorphous synthetic polymer that has been regarded as essentially non-toxic and 
an official excipient in pharmacopoeia. One mono unit of PVP consists of 1-vinyl-2-pyrrolidone 
groups (Figure 2.7). It has been classified as an extremely hygroscopic substance (class IV) by 
Callahan et al. [240]. The hydroscopic nature of PVP is attributed to the electronegativity of 
the carbonyl group that can form hydrogen bonding with water [241]. There are different 
grades of PVP available in the market that are grouped according to their viscosity of 1% w/v 
aqueous solution, expressed as a K-value calculated via Fikentscher’s equation. The higher 
the K-value, the higher the molecular weight and viscosity. PVP is soluble in water, acids, 
chloroform, ethanol (95%), ketones and methanol, and insoluble in ether, hydrocarbons and 
mineral oil. The melting temperature is 150 ⁰C (softens) [157]. 
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Figure 2.7. Chemical structure of PVP monomer unit. Adapted from [242]. 
PVP is one of the most frequently used polymers in the food and pharmaceutical industry. In 
the food industry, it is approved as a food stabilizer, E1201 [243]. In pharmaceutical 
technology, PVP is mainly used as a disintegrant, dissolution enhancer, suspending agent and 
tablet binder. In particular, PVP is widely used in a solid-dosage form due to its amorphous 
nature and high water solubility [157]. Recently, electrospinning has been introduced as one 
of the methods to produce PVP solid dispersion. However, only PVP K30 and K90 grades have 
been reported to be spinnable grades [244]. The typical concentration of PVP K30 and K90 
required for fibre formation are 30–40 and 5–15% w/v solutions in ethanol, respectively [93, 
245, 246]. In this study, PVP K90 was used in a blend with PEO to enhance the aqueous 
solubility of electrospun fibres as carriers for iodine delivery and for comparison purposes 
when the effect of polymer on the formation of inorganic nanocrystals was studied (Chapter 
3). 
D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) 
TPGS is a water-soluble derivative of natural vitamin E that is formed by esterification of the 
acid group of crystalline D-α-tocopheryl acid succinate by polyethylene glycol 1000 [157]. As 
such its chemical structure comprises both a lipophilic alkyl tail (tocopherol succinate) and a 
hydrophilic polar head (polyethylene glycol) (Figure 2.8) exhibiting amphiphilic properties 
[247]. The hydrophile-lipophile balance (HLB) value is 13.2. TPGS, being one of the novel non-
ionic surfactants, displays significant surface activity and can solubilize a variety of both 
water-soluble and water-insoluble compounds. It is completely miscible with water and also 
miscible with other surfactants, oils (soybean oil and medium-chain triglycerides), and 
cosolvents such as propylene and polyethylene glycols [48]. The physical form is a waxy solid 
at room temperature with a melting point of 37–41 ⁰C [157] and a degradation temperature 
of 199.3 ⁰C [248]. The molecular weight is 1513 g/mol [157]. 
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Figure 2.8. Chemical structure of TPGS. Adapted from [249]. 
TPGS is a GRAS (Generally Regarded As Safe) listed excipient [250] and an FDA approved 
pharmaceutically safe adjuvant [48]. It has many potential applications including as an 
absorption enhancer, antioxidant [249], emulsifying agent, granulation aid, ointment base, 
solubilizing agent, surfactant [250], suspending agent, tablet binder and as a water-soluble 
vitamin E nutritional supplement. It has been proven to have high drug encapsulation 
efficiency (up to 100%) [247], high cellular uptake in vitro and high therapeutic effects in vivo 
when used as an emulsifying agent for the synthesis of nanoparticles [49]. TPGS is readily 
absorbed in the GI tract and has an inhibitory effect on P-glycoprotein (P-gp). As a result, it 
enhances the cytotoxicity and oral bioavailability of anticancer agents such as doxorubicin, 
vinblastine and paclitaxel. Moreover, it can also act as an anticancer agent because it has the 
ability to induce apoptosis and develop a synergistic effect with other anticancer drugs [48]. 
TPGS could also enhance the absorption of vitamin D in chronic cholestatic liver disease of 
infancy and childhood, and provide a safe and effective form of vitamin E for preventing 
vitamin E deficiency during chronic childhood cholestasis and other forms of lipid 
malabsorption [248]. In this study, TPGS was used as an emulsifying agent and as a source of 
vitamin E nutritional supplement (Chapter 4). 
Gelatine (Type B)  
Gelatine is an inexpensive, non-irritating, biocompatible, and biodegradable protein [251] 
derived either by partial acid hydrolysis (Type A) or by partial alkaline hydrolysis (Type B) of 
animal collagen [157] with an average molecular weight of 65–300 g/mol [252]. Its chemical 
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structure is illustrated in Figure 2.9. The physicochemical properties of gelatine vary, 
depending on the source (cattle and pig bone or skin, and fish skin) and preparation methods 
[253]. For example, the isoelectric point of type A is 7.0–9.0, whereas for type B it is 4.7–5.4. 
Accordingly, with a pH of 1% w/v aqueous solution at 25 ⁰ C, the pH of type A is 3.8–5.5 and 
the pH of type B gelatine is 5.0–7.5 [157]. Gelatine is soluble in organic solvents such as acetic 
acid, 2,2,2-trifluoroethanol (TFE), hexafluoroisopropanol (HFIP) and hexafluoro-2-propanol 
(HFP) [251]. However, it is insoluble in acetone, chloroform, ethanol (95%), ether and 
methanol. In water, gelatine swells and softens, absorbing water at a rate of about 5–10 times 
of its own weight; however, it is soluble in water above 40 ⁰C, forming a colloidal solution and 
thermally reversible gel on cooling. This gel-sol system is, in addition, thixotropic. The stiffness 
of gelatine gels is expressed as the Bloom number, which is proportional to the average 
molecular mass.  
 
Figure 2.9. Chemical structure of gelatine. Adapted from [254]. 
Gelatine has been approved as a GRAS material by the FDA [251]. It is widely used in a variety 
of pharmaceutical formulations such as hydrogels and in wound dressings, and functions as a 
tablet binder, coating agent, film forming agent, gelling agent, suspending and viscosity-
increasing agents [157]. However, it has been mainly used for the production of tablets, 
hard/soft capsules and microspheres [157, 255]. Furthermore, it is highly effective in drug 
encapsulation and can be utilized for the fabrication of controlled drug delivery systems [256, 
257]. The good emulsifying properties and the high water binding capacity of gelatine (E441) 
[147] have found an application in the production of candies, sausages, ice creams, gel 
desserts and instant noodles, as well as in the development of edible films due to its gel and 
film forming ability [258]. Recently, soft solids and oleogels containing above 97 w/w % of 
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liquid oil were formulated using gelatine and xanthan gum for bio- and non-bio-related 
applications [147]. Based on that research, gelatine type B with Bloom number 225-325 was 
used in this study as a surface active protein to prepare G/X SOS as a drug or a nutrient 
delivery system (Chapter 5). The reported Tm of gelatine type B with Bloom number 225-325 
is 93.8 ⁰C and its Tg is 35 ⁰C [259]. 
Xanthan gum  
Xanthan gum is a high molecular weight polysaccharide with branched chains and anionic 
characteristics produced industrially by a pure-culture aerobic fermentation of a 
carbohydrate using predominantly the Gram-negative bacterium Xanthomonas campestris 
[157, 260]. The molecular weight distribution ranges from 2 × 106 to 20 × 106 g/mol and 
depends on the variation of the fermentation conditions, and the association between chains, 
i.e. formation of aggregates [261]. The primary structure of xanthan gum consists of repeating 
units of five sugar residues: two glucose, two mannose and one glucuronic acid. The polymer 
backbone consists of four (1–4)-linked β-D-glucose units similar to a cellulose backbone; 
however, trisaccharide side chains attached to alternate glucose units in the main chain 
distinguish xanthan gum from cellulose (Figure 2.10) [157, 261]. Due to the presence of 
glucuronic and pyruvic acid groups in the side chain, xanthan gum has anionic characteristics 
[262]. It is insoluble in ethanol and ether, and soluble in cold or warm water. Xanthan gum 
has very high viscosity at low concentration (the dynamic viscosity is 1200–1600 mPa·s for a 
1 % w/v aqueous solution at 25 ⁰ C) and stable rheological properties over a broad range of 
temperature (10–60 ⁰C) and pH (pH 3–12) [157]. In addition, xanthan gum gels show 
pseudoplastic behaviour [263] and can form hydrogels by annealing the solution in sol state 
and subsequently cooling [264, 265]. Its melting point is 270 ⁰C (chars) [157] and the reported  
Tg are 46.5 ⁰C [266] and 143 ⁰C [267]. 
Xanthan gum has a wide variety of industrial applications due to its pseudoplasticity, high 
viscosity and stability to acid, salt and temperature, non-toxicity, and compatibility with most 
other ingredients. It is commonly used as stabilizer, thickening (E415 [268]) and suspending 
agents in many foods [263]. In pharmaceutical technology, it is also widely used in oral and 
topical pharmaceutical formulations such as gelling, stabilizing, suspending, emulsifying, 
sustained-release and viscosity-increasing agents. Furthermore, it has shown the best release 
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profile for the colon-specific compression coated systems of 5-fluorouracil for the treatment 
of colorectal cancer when used with boswellia gum [269] and guar gum [270]. Xanthan gum 
has been used as a gelling agent for topical formulations of solid lipid nanoparticles containing 
vitamin A and for the microemulsion of ibuprofen [271]. It produces superior results when 
used as an excipient for spray-drying and freeze-drying processes [157]. In this project 
(Chapter 5), xanthan gum was selected as a non-surface active polysaccharide to prepare G/X 
SOS. 
 
Figure 2.10. Chemical structure of xanthan gum. Adapted from [272]. 
Hydroxypropyl methylcellulose (HPMC K4M) 
Hydroxypropyl methylcellulose (HPMC) is a semi-synthetic and non-ionic cellulose derivative. 
It belongs to the group of surface active polysaccharides due to the methyl substitutions that 
compose hydrophobic zones along the cellulose backbone and hydroxypropyl groups which 
are more hydrophilic (Figure 2.11) [273]. The physicochemical properties depend on: 1) the 
methoxy group content; 2) the hydroxypropoxy group content; and 3) the molecular weight. 
Therefore, the Tg values of HPMC range from 154 to 184 ⁰C; however, values of 57 ⁰C [274] 
and 186 ⁰C [159] were also reported. In addition, different methods used to measure the Tg 
often lead to different values [274]. It is a cold water-soluble compound and has been 
classified as a moderately hygroscopic substance (class III) by Callahan et al. [240]. 
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Figure 2.11. Chemical structure of HPMC. Adapted from [275]. 
Its capacity to form thermo-reversible gels that melt on cooling, alongside its good solubility 
in water and tastelessness, have resulted in wide usage in the food and pharmaceutical 
industries [276]. In the food industry, HPMC (E464) is used as a stabilizer and binder, as a 
barrier to oil and in moisture retention. In pharmaceutical formulations, HPMC is used in 
numerous oral, ophthalmic and topical nasal drug product preparations as a dispersing and 
thickening agent [277]. It is also an excellent carrier material due to its non-toxicity, GRAS 
status, ease of handling, ease of compressing, high drug load capacity and relatively simple 
tablet manufacturing technology [278, 279]. However, it is mainly used in the formulation of 
controlled release dosage forms as a swellable and hydrophilic polymer [277]. The mechanism 
of drug release is believed to be drug diffusion through the hydrated HPMC gel layer for 
soluble drugs and hydrated HPMC gel layer erosion for poorly water-soluble drugs or a 
combination of the two mechanisms above with one of them being dominant [280-282]. 
A number of studies have reported on the use of HPMC in oil-in-water emulsions due to its 
ability to reduce the surface tension and increase the viscosity of the water phase [273, 283]. 
It has also been used as an admixture to proteins, mainly to enhance the stability of dispersed 
systems [284], and as a replacement for fat and as a non-caloric bulking agent [277]. For 
example, structuring edible oils (oleogels) were evaluated using HPMC to replace fat-based 
building blocks [285]. Based on those studies, HPMC K4M was used as a surface active 
polysaccharide to prepare HPMC/X SOS (Chapter 5). The K letter indicates the HPMC 
chemistry, where R group is –OCH3 (Figure 2.11). The number 4 identifies the viscosity of the 
2% w/v aqueous solution at 20 ⁰C [280], which is 3,000–5,000 mPa·s. The Tg of HPMC 4KM is 
186 ⁰C [159]. 
 
Chapter 2 
64 
 
Methylcellulose  
Methylcellulose (MC) is a water-soluble and long-chain cellulose polysaccharide derivative in 
which about 27–32% of the hydroxyl groups are substituted by methoxyl groups (CH3O) 
(Figure 2.12). The molecular weights are in the range 10,000–220,000 g/mol. The 
physicochemical properties of MC depend on the degree of substitution (DS) (1.64-1.92), 
which is defined as the average number of methoxyl groups attached to each of the 
anhydroglucose units along the chain. At 190–200 ⁰C MC begins to brown and at 225–230 ⁰C 
it begins to char. The viscosity depends on the concentration and the temperature. The higher 
the concentration, the higher the viscosity will be. Increasing the temperature reduces the 
viscosity of the solutions until gel formation occurs at 50–60 ⁰C. However, the process is 
thermo-reversible, as a viscous solution can be reformed on cooling. MC is practically 
insoluble in acetone, methanol, chloroform, ethanol (95%), ether, saturated salt solutions, 
toluene and hot water. It is soluble in glacial acetic acid and a mixture of equal volumes of 
ethanol and chloroform. In cold water, MC forms a clear to opalescent, viscous, colloidal 
dispersion by slow swelling and dispersion [157].  
 
Figure 2.12. Chemical structure of MC. 
The functional categories of MC include its application as coating, emulsifying and suspending 
agents, and as a tablet and capsule disintegrant, tablet binder and viscosity-increasing agent. 
In the pharmaceutical industry, MC is widely used in oral, injectable and topical formulations. 
Low or medium grades of MC are used in tablet formulations as a binding agent or to emulsify 
olive, peanut and mineral oils, whereas high viscosity grades are used as a disintegrant in 
tablet formulations or as a thickening agent for topically applied products such as creams and 
gels. Tablet cores may also be spray-coated to mask an unpleasant taste and to modify the 
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release or to produce sustained release of a drug. MC is a GRAS listed compound and is 
accepted as a food additive, i.e. as emulsifier, stabilizer, thickener and gelling agents [157] 
under the E number E461 [239]. For example, edible oleogels (containing >97 wt.% of 
sunflower oil) as shortening alternatives were developed using MC and xanthan gum [286]. 
Based on that study, methylcellulose polymer were used as a surface active polysaccharide 
to prepare MC/X SOS (Chapter 5). 
Carboxymethyl cellulose (CMC) 
Carboxymethyl cellulose (CMC) is a high molecular, amphiphilic [287], anionic linear 
polysaccharide and semi-synthetic derivative of cellulose which is manufactured by the partial 
substitution of the 2, 3, and 6 hydroxyl groups of cellulose by carboxymethyl groups (-
CH2COOH) (Figure 2.13) [288]. Since the reaction occurs in an alkaline medium, the product 
is normally sold in the form of either sodium or as calcium salts of carboxylic acid (R-O-
CH2COONa or Ca) [142, 289]. The physicochemical characteristics of CMC depend on the 
molecular weight and DS. Commercial products usually have DS values ranging from 0.7 to 
1.5 [290] and the molecular weight ranges from 21,000 to 500,000 g/mol. Depending on the 
degree of esterification, the viscosity of 1% w/v aqueous solution of CMC varies from 5 to 
2,000 mPa·s. Its solutions are stable in the pH range 2–10 and precipitate below pH 2, and the 
viscosity decreases rapidly above pH 10. CMC is soluble in either cold or hot water but 
insoluble in organic solvents [289]. The reported Tg values of CMC with Mw. = 250,000 g/mol 
are about 55 ⁰C [287] and 75 ⁰C [291]. Thermal degradations are described in one source at 
172–327 ⁰C while in another source they are given at 100–300 ⁰ C and 300–800 ⁰C in a two-
step process [292]. 
 
Figure 2.13. Chemical structure of CMC. 
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CMC has many desirable qualities, which include being non-toxic and non-allergenic, as well 
as its capacity for filming, thickening, emulsification, suspension, water binding and 
maintaining, combined with the low cost of the material [142, 291]. In the pharmaceutical 
industry, CMC has been successfully used for drug delivery and tissue engineering purposes. 
Applications include, for example, gastroretentive DDS [293], colon-targeted oral drug 
delivery [294] and nasal drug delivery [295]. It has been used in preparation of hydrogels with 
superabsorbent properties [296] and in bio-nanocomposite hydrogel beads as an anticancer 
drug carrier agent [297]. CMC (E466 [298]) is also commonly used in food, such as beverages, 
desserts, dressings and bakery products, to inhibit the gravitational separation of colloidal 
particles and to produce desirable textural attributes and mouthfeel [142]. In this study, CMC 
was used as a negatively charged polysaccharide, as an alternative to replace xanthan gum, 
to prepare G/CMC SOS (Chapter 5). 
Tween 20 and Span 80 
Tween 20 is hydrophilic and Span 80 is lipophilic. They are both non-ionic surfactants that are 
used as emulsifying, solubilizing and wetting agents in concentrations from 1–15% w/v, 1–
15% w/v and 0.1–3% w/v, respectively. They are also dispersing and suspending agents. The 
acceptable daily intake of Tween 20 and Span 80, as estimated by WHO, is up to 25 mg/kg 
body weight calculated as total polysorbate esters and as total sorbitan esters, respectively 
[157]. Their chemical structures are illustrated in Figure 2.14. The detailed physicochemical 
properties of Tween 20 and Span 80 are presented in Table 2.4. 
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Figure 2.14. Chemical structure of Tween 20 (a) and Span 80 (b), adapted from [299] and 
[300], respectively. 
Table 2.4. Physicochemical properties of Tween 20 and Span 80, taken from [157]. 
Physicochemical 
properties 
Tween 20 Span 80 
Chemical/common name Tween 20/Polysorbate 20/PEG-
20 sorbitan monolaurate 
Span 80/Sorbitan 
monooleate 
Empirical formula C58H114O26 C24H44O6 
Molecular weight (g/mol) 1128 429  
Physical state at 25  ⁰C Yellow oily liquid Yellow viscous liquid 
Odour Characteristic odour Bland fatty odour 
Specific density (g/cm3) 1.1 1.01 
Solubility Soluble in water and ethanol, 
insoluble in mineral and 
vegetable oils 
Soluble or dispersible in oils 
and most organic solvents, 
insoluble in water 
 
Incompatibilities With phenol, tannins, tars and 
tarlike materials 
– 
Pour point ( ⁰C) – -12 
Flash point ( ⁰C)  149 >149  
HLB value 16.7 4.3 
CMCn (10-5 mol/L) 8.04 [301] 1.7–1.9 depending on the 
oil phases, which are given 
elsewhere [302] 
Surface tension of 1% 
aqueous solution (mN/m) 
–  30 
Viscosity at 25 ⁰C (mPa·s)  400 970-1080 
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In pharmaceutical formulations, Tween 20 and Span 80 are used as emulsifying agents in the 
preparation of stable o/w emulsions and w/o emulsions, respectively. In addition, Tween 20 
has been used as a solubilizing agent for essential oils and oil-soluble vitamins and as a wetting 
agent in the formulation of oral and parenteral suspensions. Whereas, Span 80 has been used 
in combination with varying proportions of a polysorbate to produce w/o or o/w emulsions 
or creams, as well as in self-emulsifying DDS for poorly soluble drugs and in Span 80 vesicular 
DDS for actively targeting specific cancer cells [303]. In the food industry, Tween 20 and Span 
80 have the E numbers E432 and E494, respectively [239]. In this study, Tween 20 and Span 
80 were used as emulsifiers to prepare core-sheath nanofibres (Chapter 4) and Tween 20 was 
additionally used as a surface active surfactant to prepare Tween 20/X SOS (Chapter 5). 
2.3 General introduction to preparation techniques 
2.3.1 Electrospinning general set up 
Conventional electrospinning and coaxial electrospinning were performed using a solution 
pump (Cole-Parmer, UK) and high voltage power supply (Gamma High Voltage Research, Inc., 
Ormond Beach, FL, USA). In all experiments, the electrospun fibres were collected using the 
custom-made stationary collector, except when the effect of the drum collector was studied, 
when a custom-made drum collector was used, which is indicated with a given rpm in 
electrospinning processing parameters (EPPs). For the conventional electrospinning, a 5 ml 
plastic syringe (BD PlastipakTM, Fisher Scientific), with an open end fitted with a blunt needle 
(Terumo, Tokyo, Japan), was used as a solution reservoir from which a polymer solution or a 
polymer solution containing an active ingredient were fed by means of a solution pump 
operating at a controlled rate. The size of the needle used in all the experiments was 18G (G-
gauge), except when the effect of the needle gauge was studied, when 18G, 20G, 21G and 
23G needles were employed (Chapter 3). In the case of the coaxial electrospinning, a single 
spinneret sealed coaxial needle (Linari Engineering S.r.l., Pisa, Italy) was used as a dual 
solution supplier. The needle was connected with two 5 ml plastic syringes (BD PlastipakTM, 
Fisher Scientific), containing two different solution compositions, through two pieces of PVC 
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tubing (d≈0.5 mm, wall≈1 mm, L≈150–200 mm). The solutions in the syringes were fed by 
means of two solution pumps (Cole-Parmer, UK) at a controlled rate. 
In terms of the EPP, the direct current (DC) voltage is given as a range from minimum to 
maximum. The reasoning for this is because, depending on the solution concentration and 
content, the applied DC voltage can be varied and therefore was adjusted accordingly during 
the processing until a stable jet was observed. All samples for electrospinning were prepared 
under room temperature at 26–35 % relative humidity (RH). 
 
2.3.2 Homogenizing instruments 
2.3.2.1 High-performance dispersing instrument (HPDI) 
Basic principle 
High-performance dispersing instruments (HPDI) are used for a variety of applications in 
pharmaceutical and food research for homogenization, emulsification, dispersions, particle 
reduction, and reaction enhancements. It uses the rotor-stator principle. The system consists 
of an outer stationary tube (stator) and an inner turning shaft (rotor) that is connected to a 
motor. The instrument works at a range of speeds from 8,000 to 30,000 rpm. The bottom of 
the rotor and the stator contain slots. When running at a high speed, samples pressed into 
the slots of the rotor-stator arrangement are subjected to high circumferential speed and 
extremely strong shear forces, due to the high speed and minimal gap between the rotor and 
the stator which results in better dispersion (Figure 2.15) [304, 305]. 
 
Figure 2.15. Schematic representation of the principle of dispersing the sample using a high 
performance dispersing instrument. Adapted from [305]. 
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Technical characteristics 
Emulsion was homogenized with an Ultra Turrax dispersing instrument (IKA T10 basic S2 from 
IKA Werke GmbH and Co., Germany). The rotation speed can retard slightly depending on the 
viscosity of solution, but the variance is insignificant. 
 
2.3.2.2 High pressure homogenizer (HPH) 
Basic principle 
A high pressure homogenizer (HPH) is a continuously operated emulsifying device that is used 
in the food and pharmaceutical industries to create submicron emulsions in materials of low 
and intermediate viscosity. The HPH is a purely mechanical device that uses intense disruptive 
forces that mechanically break-up the larger droplets into tiny droplets. It consists of a high-
pressure piston pump that pulls the crude emulsion into a chamber on its backstroke, and 
then forces it through a narrow valve at the end of the chamber on its forward stroke (Figure 
2.16). As the crude emulsion passes through the valve, it experiences a combination of 
extremely high turbulence, shear and cavitation that causes the grinding of the droplets [142]. 
 
Figure 2.16. Schematic representation of the principle of operation of a high pressure 
homogenizer. Adapted from [142]. 
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Technical characteristics 
Emulsions were prepared using an EmulsiFlex-C5 High Pressure Homogenizer from Avestin, 
Ottawa, ON, Canada. The maximum homogenizing pressure is 30,000 psi. The maximum 
sample batch size is 5,000 ml and the minimum sample volume is 10 ml (the data is taken 
from the manufacturer’s manual). 
 
2.3.3 Freeze drying 
Basic principle 
Freeze drying, also known as lyophilization, is a widely used process for dehydration and 
improving the stability of various food and pharmaceutical products. It is based on the 
dehydration by sublimation of frozen products and consists of three process steps: freezing, 
primary drying and secondary drying. During freezing, an aqueous solution is frozen and then, 
during the primary drying phase, water is removed by sublimation under vacuum. In the final 
secondary drying stage, non-frozen water is removed by diffusion and desorption [149, 306]. 
Technical characteristics 
The SOSs were lyophilized by using a VirTis AdVantage 2.0 freeze dryer (SP Scientific, Gardiner, 
NY, U.S.A). The lowest shelf temperature is -57 ⁰C and the lowest condenser temperature is -
67 ⁰C. The defrost type is hot gas, the condenser type is internal and the refrigerator type is 
CFC free (taken from the manufacturer’s manual). 
2.4 General introduction to characterization techniques 
2.4.1 Imaging techniques  
One of the imaging techniques often used in science is the microscope. There are broad 
ranges of different types of microscope available in the market, which are grouped according 
to the way the instrument interacts with a sample to create images. Figure 2.17 represents 
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the schematic illustration of the working principle of two categories of microscope used in 
this project. The featured characteristics of each type of microscope are described below. 
Another category of imaging technique used in this project is X-ray micro computed 
tomography (XμCT). This imaging technique functions using a different principle than 
microscopes and is also described in this section. 
 
Figure 2.17. Schematic representation of principles of imaging using optical microscope 
compared with electron microscope techniques, transmission electron microscope (TEM) and 
scanning electron microscope (SEM). Adapted from [307]. 
2.4.1.1 Optical microscopes 
Optical or light microscopes (LM) are a type of microscope using a visible light and lenses to 
produce a magnified image of the specimen. In the LM, the light passes through the 
condenser and then through the specimen. The underlying principle of LM relies on there 
being different optical densities for different parts of the sample. The dark sections have high 
optical density whereas the light sections do not and the light passes through them. As a 
result, the pattern of light and dark areas produces what we recognize as an image of the 
specimen. The eye lens of the eyepiece further magnifies the image and finally projects it on 
to a camera [308]. The main components of LM are the base, light source or illumination, 
Chapter 2 
73 
 
condenser, stage, the objectives, eyepiece and the fine and course adjustment knobs [309]. 
In addition, most of the modern microscopes are equipped with a fluorescent camera. The 
maximum magnification of LM is around 1300x and the resolution is around 200 nm [310]. It 
has tremendous applications in all areas of research. 
LMs are available in two orientations, upright or inverted microscopes, and two designs, 
simple or compound microscopes. Besides, there are various modified optical microscopes 
equipped with an additional light path to improve the image, such as light polarized 
microscope (LPM), confocal laser scanning microscopes (CLSM) and stereoscopic 
microscopes. The distinguishing features of each type of optical microscope used in this 
project are described below. 
2.4.1.1.1 Upright microscope 
Basic principle 
The upright microscope is the type of optical microscope that is designed so that the objective 
lens is pointing down onto the coverslip surface and the specimen is placed at the bottom 
with the light source and condenser. Other than the orientation of the specimen, the principle 
is the same as an optical microscope [311]. 
Operating conditions 
An upright microscope was used to analyse the morphology and nature of emulsion, i.e. o/w 
or w/o emulsions (Chapter 5). Samples were imaged on a Zeiss AxioPlan 2ie microscope. 
Brightfield and fluorescent images were captured using a 10x Plan-Neofluar objective (0.3 
NA), a 20x Plan-Apochromat objective (0.6 NA), or a 40x Plan-Neofluar objective using an oil-
immersion objective lens (1.3 NA), alongside a Zeiss AxioCam HRm charge-coupled device 
(CCD) camera and AxioVision software (Carl Zeiss, Cambridge, UK). Fluorescence was excited 
at 300–400 nm and emission collected at 410–475 nm. All samples examined under 
fluorescence microscope were loaded with the fluorescence marker coumarin-6 in the oil 
phase, at a quantity of about 1 mg. 
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2.4.1.1.2 Stereomicroscope 
Basic principle 
The stereomicroscope is a type of optical microscope in which the light runs from two separate 
optical paths due to two objectives and two eyepieces that provide the opportunity of viewing 
the specimen from two slightly different angles. Thus, the image produced by a 
stereomicroscope is perceived by the human mind as three-dimensional. Modern 
stereomicroscopes provide both incident light and transmitted light. It has low magnification, 
at a little more than 300x, but a longer working distance; therefore, it allows inspection of 
large specimens [312]. 
Operating conditions 
A stereomicroscope was used to visualize the dispersion of oil inside G/X SOS (Chapter 5). 
Brightfield and fluorescent images were acquired using a Zeiss M2 Bio Quad SV11 
stereomicroscope. The samples were illuminated either using a halogen lamp (brightfield) or 
a 100W Hg arc lamp (fluorescent), and the reflected-light images were captured with a Zeiss 
AxioCam HRc CCD camera and AxioVision software (Carl Zeiss, Cambridge, UK). Fluorescence 
was excited with light passed through a 470 nm filter (40 nm bandpass) and the emission 
collected through a 525 nm filter (50 nm bandpass). All samples examined under 
stereomicroscope using fluorescent light were loaded with the fluorescence marker 
coumarin-6 in the oil phase.   
2.4.1.1.3 Confocal laser scanning microscope (CLSM) 
Basic principle 
A confocal laser scanning microscope (CLSM) is a type of optical microscope that provides a 
fundamental improvement in imaging, in terms of high resolution and contrast, compared to 
a normal LM [313]. This is because of a pinhole aperture located in the image plane before 
the objective which blocks out-of-focus light (Figure 2.18) and point by point illumination of 
the specimen that minimizes aberrant rays of scattered light [314].  In addition, it is capable 
of distinguishing particular components within a complex matrix via the use of various 
fluorescent dyes and can directly create digital three-dimensional (3D) images by combining 
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a series of thin sections of specimen without needing to physically dissect the item. This is 
achieved due to a laser scanning function performed along the vertical axis of the specimen 
[315].  
 
Figure 2.18. Schematic illustration of principle of imaging by CLSM. Adapted from [316]. 
Operating conditions 
In this study, CLSM was used to analyse emulsion for comparison purposes, as it provides 
higher resolution and better contrast than the other microscopes (Chapter 5). Samples were 
imaged using a Zeiss LSM 510 META confocal microscope. The samples were loaded with the 
fluorescence marker coumarin-6 in the oil phase and fluorescent images were captured using 
a 40x Plan-Neofluar, an oil-immersion objective lens (1.3 NA) and LSM software. Fluorescence 
was excited with the 488 nm laser-line of an Argon ion laser and emission was collected at 
505–550 nm.  
2.4.1.2 Electron microscopes 
The electron microscope (EM) is a type of microscope that uses a beam of accelerated 
electrons as a source of illumination instead of visible light and offers extremely high 
magnification with a maximum at or below 1 nm. There are different types of EM, which are 
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grouped according to the way the instrument interacts with the specimen to create images. 
The detailed features of the different types of EM used in this project are discussed below. 
2.4.1.2.1 Scanning electron microscope (SEM) 
Basic principle 
A Scanning Electron Microscope (SEM) is a high-resolution electronic microscope that is 
employed to determine the surface properties and spatial relationships of the materials [307]. 
A low-energy electron beam (with a maximum accelerating voltage of 30 kV [307]) is 
produced by an electron gun focused into the sample and the surface of the probe is scanned 
in a raster fashion [317]. Various signals are generated as a result of the interactions between 
the incident electron beam and the atoms in the sample which are collected by various 
detectors in the specimen chamber to provide an image of the surface topography (Figure 
2.17) [318]. The electron sources used in the SEM are a tungsten hairpin filament, or a 
lanthanum hexaboride LaB6 or Schottky emitter, or a field emission gun [317, 319]. 
Magnification in a SEM can be achieved up to 1,000,000x with a maximum resolution of 1 nm 
[319]. The samples are normally pre-coated with conductive material, e.g. gold, and examined 
at ambient temperature within a high vacuum chamber [320]. 
SEM is a powerful tool to image at high magnification a large area of the surface or cross-
section of pharmaceutical formulations and compounds as well as engineered nanomaterials 
in food matrices [307]. It is commonly used to study the orientation, diameter and the 
morphology of electrospun fibres, as well as crystalline materials and the recrystallization of 
APIs in solid dispersion formulations [93].  
Operating conditions 
In this project, SEM was utilized to investigate the morphology of the electrospun nanofibres 
(Chapter 3) and core-sheath nanofibres (Chapter 4) which were visualized using a JSM5900 
LV SEM (JEOL Ltd., Japan) equipped with a tungsten hairpin filament and operating at an 
acceleration voltage of 5–20 kV. The samples were fixed on aluminium stubs using double-
sided adhesive carbon tape and then Au coated using a Polaron High Resolution SC7640 gold 
coater (Quorum Technologies, Newhaven). 
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2.4.1.2.2 Cryo-scanning electron microscope (Cryo-SEM) 
Basic principle 
Cryo-scanning electron microscope (Cryo-SEM) is a modification of SEM, i.e. it is an SEM with 
a cryo-chamber attached to it. It was developed with the aim of preserving the microstructure 
of hydrated biological specimens in amorphous ice. However, it has been finding increasing 
application in many other fields, including pharmaceutical [321] and food [307] sciences when 
the preservation of the structural integrity of a porous structure or of hydrated, liquid and 
semi-liquid systems is required. In Cryo-SEM, the specimens are first rapidly frozen and then 
fractured. The fractured surfaces of the frozen specimens are deposited with conducting 
metal to avoid charging and are then viewed in an SEM which is equipped with a cryo-stage 
[322]. Typically, Cryo-SEM samples are frozen by plunging into a nitrogen slush (-210  ⁰C); 
however, other coolants such as liquid propane and ethane can also be utilized [307]. Sample 
preparation and microscope operation are carried out between -180 and -60 ⁰ C depending 
on the purpose of the study and sample properties [320]. 
Operating conditions 
In this project, a Cryo-SEM instrument was used to investigate the internal structure of semi-
solid G/X SOS (Chapter 5). The microscope that was used in this study was a Zeiss SEM fitted 
with a Gatan cryosystem. Samples were attached to the sample holder and immediately 
plunged into liquid nitrogen slush at approximately -210 °C to cryo-preserve the material.  This 
material was transferred onto the cryo-stage of an ALTO 2500 cryo-transfer system (Gatan, 
Oxford, England) and attached to a Zeiss Supra 55VP FEG scanning electron microscope (Zeiss 
SMT, Germany). The samples were fractured at -100 °C before sputter coating with platinum 
for 90 seconds at 10mA, at a temperature colder than -110°C. After sputter coating, the 
sample was moved onto the cryo-stage in the main chamber of the microscope and held at 
approximately -130°C. The sample was imaged at 3kV and digital TIFF files were stored. 
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2.4.1.2.3 Transmission electron microscope (TEM) 
Basic principle 
Transmission electron microscope (TEM) is another type of electron microscope which allows 
the examination of the morphology and the internal structure of nanosized objects [307]. The 
resolution of TEM is about 0.07 nm. In TEM, a high-energy electron beam (100-300 kV [317]) 
is transmitted through a thin layer of the specimen while some of the electrons are scattered 
[307]. The transmitted electrons bombard a fluorescent (phosphor) screen, which converts 
the electron images to a visible form (Figure 2.17) [317]. Alternatively, a high-resolution 
phosphor screen may be coupled to the sensor of a charge-coupled device (CCD) camera 
which allows the capture of digital images [321]. The contrast in TEM images is based on the 
detection of interactions of the electron beam with the sample and therefore, more dense 
materials create more intense shade [307]. As in the case of an SEM, the TEM also uses an 
electron gun (thermoionic or field emission sources) to generate the electron beam and 
focuses it on the specimen by using electrostatic and electromagnetic lenses [321]. 
TEM is an essential tool in pharmaceutical and food engineering for the exact characterization 
of novel vehicles, which are constantly decreasing in size range to provide efficient delivery 
and to decrease side effects [307, 321]. Different nanoparticles within composite matrices 
[323, 324], which cannot be seen by SEM, as well as semi-liquid [325, 326] and liquid systems 
were characterized by means of TEM. Beside, TEM analysis provided information about the 
physical stability of the different nanoemulsions [327]. 
Operating conditions 
In this study, the TEM instrument was used in two separate chapters: 
1. To visualize inorganic nanocrystals (KIO3 and NaCl) within polymer nanofibres (PEO 
and PVP) (Chapter 3). Samples were electrospun directly onto TEM grid support 
films of holey carbon on 300 mesh Cu. The TEM instrument used was a Philips 
CM30 operating at 300 kV.  
2. To investigate the internal structure of semi-liquid G/X SOS (Chapter 5). The 
freeze-dried SOS was cut into approximately 1 mm3 cubes. The cubes were fixed 
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in 2.5% glutaraldehyde/0.1 M PIPES buffer (pH 7.4) for 2 hours at room 
temperature and then transferred to fresh fixative overnight at 4 °C. After 3 
washes in the 0.1M PIPES buffer, the cubes were placed in 2% aqueous osmium 
tetroxide for 48 hours, washed 3 times with distilled water, then dehydrated 
through an ethanol series (10, 20, 30, 40, 50, 60, 70, 80, 90%). After 3 washes in 
100% ethanol, the last wash was replaced with a 1:1 mix of LR White medium 
grade resin (London Resin Company Ltd) to 100% ethanol for 1 hour. This was 
followed by a 2:1 and a 3:1 mix of LR White resin to 100% ethanol and finally 100% 
resin, with at least 1 hour between each change. The resin was changed twice 
more with fresh 100% resin, after periods of at least 6 hours between changes. 
Five blocks from each sample were each put into BEEM capsules with fresh resin 
and polymerised overnight at 60 °C. Sections approximately 90nm thick were cut 
using an ultramicrotome (Ultracut E, Reichert-Jung) with a glass knife, collected on 
Formvar/carbon coated copper grids, and stained sequentially with 2% uranyl 
acetate and 0.5% lead citrate. Sections were examined and imaged in a FEI Tecnai 
G2 20 Twin transmission electron microscope at 200kV. 
2.4.1.3 X-ray micro computed tomography (XμCT) 
Basic principle 
X-ray micro computed tomography (XμCT) is a non-destructive tomographic technique that 
uses X-rays to detect the internal defects of different materials and is classified as a 3D 
imaging technique with a high resolution to several microns [328]. The principle of visualizing 
material properties is premised on the material’s electron density difference, which absorb 
X-rays differently. When analysing the object with XμCT, the specimen is placed on a rotating 
stage and rotated stepwise about its axis with a defined angular step. At the same time, a 
conical beam from a microfocus X-ray source illuminates the specimen (Figure 2.19) [329]. 
Some X-ray photons are attenuated, whereas others will transmit through the sample and 
reflect in the shadow images produced on the detector. Then, XμCT can assemble the 
accumulated data of 2-D cross-sectional images or slices into a volumetric dataset and can 
form a virtual 3-D image through mathematical operation (reconstruction) with 
accompanying software [330]. In addition, due to the pseudo-colouring function of the 
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software being linked to the density of the material, different phases can be distinguished.  
Therefore, XμCT has been widely used in pharmaceutical science to control the quality of 
tablets, study the presence of various material sub-components and their local distribution, 
and examine the presence of cracks, voids, and the shape and size of the enclosure [329]. 
 
Figure 2.19. Schematic illustration of principle of imaging by XμCT. Adapted from [316]. 
Operating conditions 
XμCT imaging was used to observe the inner structure of G/X SOS without dissecting it 
(Chapter 5). The samples were scanned using a SkyScan1172 high-resolution X-ray micro 
computed tomography scanner (Bruker microCT, Kontich, Antwerp, Belgium). The total scan 
time was 25 minutes. The samples were fixed on the rotation stage using a plastic tube and 
the samples were rotated over 360° in steps of 0.5°. 
2.4.2 Energy-dispersive x-ray spectroscopy (EDS) 
Basic principle 
Energy-dispersive x-ray spectroscopy (EDS) is the most popular non-destructive analytical 
technique used in conjunction with SEM or TEM and is employed to quickly determine the 
elemental composition in solid materials with an atomic number greater than 5 [331]. The 
principle of this technique is premised on the detection of radiation. Characteristic radiation 
is emitted by atoms of the sample when excited by a high-energy beam of photons, electrons 
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or X-rays. During the bombardment of a sample with an incident beam, electrons are ejected 
from the inner-energy shell creating an empty hole, and these ejected electrons are replaced 
by electrons from the higher-energy shell. As a result, characteristic X-rays are emitted in 
order to compensate for the energy differences between electrons during this transition. The 
emitted X-rays are analysed by the EDS detector and the elemental composition of the sample 
is determined [312]. However, the data obtained from this technique is generally indicative 
and only the relative atomic proportions are estimated. Nevertheless, EDS can show the 
spatial distribution of elements and can help to determine the phases present in a sample, 
i.e. producing an element map, by progressively rastering the electron beam point by point 
across the surface of a sample [331]. 
Operating conditions 
In this project, the distribution of inorganic salt KIO3 within PEO nanofibres was determined 
using EDS (INCA Energy manufactured by Oxford Instruments) in conjunction with SEM 
(Chapter 3). The instrument is capable of detecting chemical elements using a spot mode 
manually chosen in the SEM scanned area. Resolution: 131 eV (Mn Kα). Acquisition time: 
30−60 s. At least 5−10 spots at different locations were examined for each sample. 
2.4.3 Powder x-ray diffraction (PXRD) 
Basic principle 
Powder x-ray diffraction (PXRD) is a non-destructive and rapid analytical technique used to 
identify chemical composition and the structure of all crystalline compounds. 
In 1913, Bragg devised a theory to explain the relationship between diffraction data and 
crystal structure, based on the evidence that atoms in crystals are arranged periodically as 
parallel plates and separated by a definite distance. When X-rays strike the surface of a 
crystal, they are scattered by parallel planes of atoms and each plane of atoms acts as a half-
silvered mirror, reflecting the incident radiation. In order for an X-ray to diffract, the distance 
between the atom planes must be comparable to the wavelength of the radiation. X-rays are 
electromagnetic waves with the wavelength of the order of 1 Å = 1 × 10-10 m, which is similar 
to the distance between atoms, a suitable radiation to be diffracted [332]. Diffracted radiation 
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is produced by constructive and destructive interferences and its intensity has strong angular 
dependence. When waves interfere constructively, the diffraction pattern shows a peak, 
whereas destructive interference produces a low intensity [333]. This is explained by Bragg’s 
Law: 
nλ = 2d sin 𝜃. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (2.1) 
Where λ is the wavelength of the radiation, n is an integer number of the diffracted beam, 𝜃  
is the angle between the lattice planes and the incident beam and d is the distance between 
the lattice planes [334]. 
Since a highly regular structure is needed for diffraction to occur, crystalline materials 
produce sharp intense peaks. The position of each peak determines the crystal structure and 
symmetry of the contributing phase, which can be used to elucidate different chemical 
compounds including the polymorphs of crystalline pharmaceuticals [335]. In contrast, 
randomly oriented powders of small crystals and nanocrystals cause a broadening of 
diffraction peaks due to the absence of total constructive and destructive interferences of X-
rays in a finite-sized lattice [336]. Amorphous materials show a halo pattern and do not 
produce a diffraction pattern at all because they do not have a periodic array with long-range 
order. Therefore, PXRD can also characterize the mixture of amorphous and crystalline 
materials; for example, semi-crystalline polymers will produce sharp peaks and a halo. For 
these reasons, PXRD is the key technique in all stages of drug development as it can elucidate 
different forms of drug moiety and drug delivery systems, which in turn have a great impact 
on quality, bioavailability and drug stability [337]. 
Operating conditions 
In this study PXRD was utilized to study the physical form of KIO3 with the increase of the 
loading into a PEO polymer chain, as well as the impact of KIO3 on the degree of crystallinity 
of a semi-crystalline PEO polymer (Chapter 3). Also, new crystal modfication of PEO was 
identified with the help of PXRD (Appendix 4). Diffraction peaks were measured with a 
Thermo ARL X’TRA Diffractometer (Thermo Scientific, UK) with a step size of 0.01°, 0.5 second 
time per step, from 3° to 60° 2θ. The wavelength was 1.54 Å, and the X-ray source was Cu Kα1 
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with a power of 45 kV and a current of 40 mA. Samples were accurately folded and placed 
onto the sample holder with zero background and incorporated onto a spinner stage. 
2.4.4 Attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FT IR) 
Basic principle 
IR spectroscopy studies the interaction of infrared light with matter. When the IR beam 
radiates the sample, the absorbance of infrared light by molecules excites vibrations such as 
stretching, bending and rocking at specific frequencies and creates characteristic absorption 
bands for each functional group. The intensity of these bands is determined by the change in 
the dipole moment of the bond and the number of the specific bonds present. Thus, an 
infrared spectrometer gives you information about which molecules are present in a sample 
and at what concentration they appear. Many molecules have strong absorbance in the mid-
infrared region (4,000 to 400 cm-1) and, therefore, most of the samples are measured in this 
region. However, molecules with heavy atoms, such as inorganics, absorb far-infrared light 
(400 to 10 cm-1) and near-infrared light (14,000 to 4,000 cm-1) and IR spectroscopy is 
frequently used to measure sample properties in difficult environments. IR spectra are 
plotted in terms of the % transmittance or absorbance intensities on the y-axis against 
wavenumber (cm-1) on the x-axis. 
The Attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FT IR) is a 
specific type of infrared spectrometer that uses the technological advances of Fourier 
transformation and ATR. At the heart of all FT IR is an optical device called an interferometer 
that optically transforms the spectrum of the infrared beam into an interference pattern (the 
interferogram), which in turn is converted into a spectrum by using the Fourier 
transformation (a mathematical process). The main advantage of FT IR is the ability to scan 
the sample in a shorter time with a higher signal-to-noise ratio and wavenumber precision. 
The use of ATR, a sample preparation technique, makes the sample analysis fast and easy. 
This is attributed to the fact that the ATR crystal (internal reflection element) is used to take 
the spectrum of nearly any sample without the need for complicated sample preparation 
[338]. 
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ATR-FT IR has gained wide application in pharmaceutical science as it is capable of identifying 
polymorphic contents in pharmaceutical materials [339], oxidation of oils [340] and drug-
carrier [242] and carrier-carrier interactions [341, 342], such as hydrogen bonding and 
complexation. 
Operating conditions 
In this project, ATR-FT IR spectroscopy was used to study the structural confirmation and 
degree of crystallinity of PEO and the physical form of KIO3 in the formulation (Chapter 3). 
Also, FT IR has been applied extensively to examine organic compounds and therefore was 
used to identify any interactions between protein and polysaccharide on the surface of 
oil/water interfaces (Chapter 5). Infrared absorption peaks were measured with an IFS 66/S 
FT IR spectrometer (Bruker Optics Ltd., Coventy, UK), fitted with a Golden Gate ATR accessory 
with a heated top plate equipped with a diamond internal reflection element. The spectral 
resolution was 2 cm−1 with 64 scans taken for each measurement. Triplicate measurements 
for each sample were performed. 
2.4.5 Differential scanning calorimetry (DCS) 
Basic principle 
Differential scanning calorimeter (DCS) is a type of thermoanalytical technique that is used to 
identify thermal transition, such as melting, crystallization, glass transition, and the thermal 
degradation of analysed material by measuring the small heat changes between a specimen 
and an inert reference as a function of temperature. As both specimen and reference are 
subjected to thermal treatment, heating, cooling or an isothermal process at an identical and 
controlled rate, the specimen undergoes a thermal event, which results in heat either being 
absorbed or released. This creates the temperature and energy differences between the 
specimen and reference. The DSC instrument examines these differences and a peak is 
produced. 
In pharmaceutical product development, DSC has been mostly used to study the melting 
responses of the sample to the heating. However, many studies have also been carried out 
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on the crystallization, glass transitions, kinetic reactions and differentiation between 
polymorphs [343, 344]. 
Operating conditions 
In this project, DSC analysis was performed to analyse the physical properties of G/X SOS and 
G/X SOS with and without loading of APIs (Chapter 5). DSC measurements were conducted 
on a TA Instruments DSC Q2000 (New Castle, DE, USA), equipped with an RSC 90 cooling unit 
which had been calibrated with indium, tin, and N-octadacon. The sample weights were 
between 2–3 mg with a heating rate of 10 °C/min over the temperature range 0−250 °C 
(Chapter 5). Triplicate measurements for each sample were performed. 
2.4.6 Thermal gravimetric analysis (TGA) 
Basic principle 
Thermal gravimetric analysis (TGA) is another type of thermoanalytical technique that is used 
to evaluate the thermal performance of a material by accurately measuring the material 
weight loss over time as the temperature changes, under a controlled atmosphere. When the 
sample is subjected to a heating or isotherm at a certain temperature, the chemical and 
physical processes occur, e.g. decomposition, oxidation or sublimation. These processes are 
accompanied by mass loss. These mass changes are constantly measured by thermobalance, 
consisting of an electronic microbalance, a furnace and appropriate temperature controller, 
and is plotted as temperature/% mass or time/% mass on x- and y-axes.  
TGA methods have been employed successfully in pharmaceutical studies to obtain 
information regarding thermal and oxidative stability, life expectancy, decomposition profile, 
moisture and volatiles content and partial chemical analyses that occur at a temperature 
characteristic for producing a particular reaction [343, 345]. 
Operating conditions 
Thermal stability and moisture uptake of raw material, physical mixture and processed 
samples (5–7mg) (Chapter 5) were studied using a TGA Q5000 (TA Instruments, New Castle, 
DE, USA). The experiments were carried out at atmospheric pressure, under a nitrogen 
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atmosphere, with a flow rate of 60 ml/min, at linear heating rates of 10°C/min, in the range 
0–400 °C. All experiments were performed in triplicate (n=3). 
2.4.7 Texture analyser 
Basic principle 
A texture analyser provides a versatile technique and it is commonly used in industry to study 
the mechanical response of the materials that are linked to the surface or the internal 
structure of materials. The testing is performed by physically deforming the analysed sample 
in a controlled manner and measuring its response [346]. The following mechanical 
parameters can be described: 
1. deformability (force required to achieve certain deformation); 
2. adhesiveness (the work required to overcome the attractive forces that exist between 
the surfaces of the sample by the probe); 
3. compressibility (the flow of the sample in response to compression) [347]. 
These parameters can give an indication of the sensory properties and provide an evaluation 
of the textural behaviour of the product [348]. Therefore, it is very useful in drug and food 
product development, quality control and manufacturing. In addition, it has been used to 
analyse the texture of a wide range of protein gels, including gelatine [349]. 
Operating conditions 
The textural properties of SOS subjected to compression were measured using a TA-XT2 Plus 
Texture analyser (Stable Micro Systems Ltd, UK). A compression test mode was conducted 
with the following test sequence: zero force, remember position in memory location 1, move 
to force of 1 gram at 0.5mm/sec, move force to 30,000 grams at 0.5mm/sec, wait for 30 
seconds, move to position stored in memory location 1 at 1 mm/sec. The load cell is 30 kg 
with a 25mm diameter aluminium cylinder. All experiments were performed in triplicate 
(n=3). 
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2.4.8 Particle size analysis 
2.4.8.1 Dynamic light scattering (DLS) 
Basic principle 
Dynamic light scattering (DLS), which is also known as photon correlation spectroscopy or 
quasi-elastic light scattering, is a particle size distribution characterization technique 
commonly used to measure nanoparticulate colloidal systems, such as emulsions, micelles, 
liposomes and nanosuspensions. The technique particle sizing can be as low as 2 nm. 
However, larger particles (>3 μm) may cause misrepresentation of the measurements and, 
therefore, additional corroboration with laser diffraction (LD) or a laser scattering technique 
is recommended. The operation principle is that DLS calculates the diffusion coefficients of 
particles undergoing Brownian motion. When a laser beam is passed through a colloidal 
solution, the light is scattered off the particle and its intensity experience fluctuates [350] . 
The important characteristic of larger particles is that they have slower Brownian motion and 
the light propagates slowly, whereas small particles have faster Brownian motion and 
fluctuate quickly [351]. The DLS measures this fluctuation rate at a given scatter angle as a 
function of time and generates an exponentially decaying autocorrelation function [350]. This 
function is then analysed to determine the diffusion coefficient (Dt), which in turn can be used 
to measure the hydrodynamic diameter (DH) of spherical particles using the Stokes-Einstein 
equation: 
DH = 
𝑘𝐵𝑇
3𝜋𝜂𝐷𝑡
. . . . . . . . . . . . . . . . . . . .  . . . . . . . . . . . . (2.2) 
Where DH is the hydrodynamic diameter, Dt is the translational diffusion coefficient, kB is 
Boltzmann’s constant, T is temperature and 𝜂 is dynamic viscosity. For rod-like particles, the 
equation for Dt is given elsewhere [351]. Thus, DLS calculates the hydrodynamic size and, 
therefore, the particle diameter measured in DLS is inferred as being the particle size or 
hydrodynamic diameter.  
 
 
Chapter 2 
88 
 
Operating conditions 
First, emulsions were characterized using a DLS technique using a Zetasizer Nano ZS 
instrument (Malvern Instruments Ltd., Worcestershire, UK) with the assumption that they 
have smaller particle size distribution (Chapter 4). A prepared O/W emulsion was divided into 
two parts, one part to be stored at room temperature and the other part at fridge 
temperature. The particle size distribution was measured immediately after emulsification 
and again after 7 days. All samples were highly diluted in Milli-Q water and measured in Milli-
Q water. The results of DLS analysis were reported as the average of 3 measurements. 
2.4.8.2 Laser diffraction (LD) 
Basic principle 
Laser diffraction (LD) is the most popular particle size distribution characterization technique 
in the pharmaceutical industry due to its ease of use, high precision, reproducibility and short 
analytical time [350]. Its range of applicability includes powders, suspensions and emulsions 
with a particle size distribution ranging from 0.1 μm to 3000 μm [352]. The basic principle is 
based on the evidence that particles of a given size diffract light though a given angle that 
increases logarithmically with decreasing size and vice versa [353]. The interaction of light 
with matter is calculated based on the algorithm of the Mie scattering theory, with its 
assumption that all particles have spherical morphology. The algorithm, at its core, consists 
of an optical system for Fourier transformation of the diffracted light onto a position-sensitive 
detector [350]. Additionally, users need to provide the refractive index of particles and 
dispersing medium. The instruments used mainly consist of a standard He-Ne laser high 
intensity light source, a sample handling system and an array of high quality photodiodes that 
record the angle and intensity of scattered light. The main drawbacks relate to particles 
having small sizes (<1 μm), non-spherical morphology and a low refractive index [354]. 
Operating conditions 
Emulsions were analysed in a laser diffraction Helos/Rodos 1636 (Sympatec GmbH, Germany), 
as from the DLS results we concluded that emulsions have larger particle size distribution 
(Chapter 4, 5). All emulsions were highly diluted in an aqueous phase before analysing. All 
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experiments were performed in triplicate (n=3). The obtained data was evaluated using 
volume distribution as diameter (d) values of 10%, 50% and 90%. The diameter values show 
the percentage of particles that have a diameter equal to or lower than the given value. 
2.4.9 In vitro dissolution testing 
Basic principle 
Dissolution testing is an important aspect in the development and quality control of 
pharmaceutical products, and it is employed to measure the dissolution rate of an API from a 
dosage formulation according to standardized conditions reported in official pharmacopoeia. 
It is an in vitro method used as a predictive tool for the in vivo performance of the drug and 
consequently its bioavailability. The dissolution testing of solid oral dosage forms is generally 
performed using USP-approved apparatuses and different dissolution media, listed in Table 
2.5. The principle of dissolution testing is that the dosage unit is placed within the medium 
that simulates gastric and intestinal fluids, and the dissolution apparatus keeps the 
temperature of the medium at 37  °C±1 and provides hydrodynamics (a fixed speed of 
agitation). As a result, the delivery system starts to solubilize in a given solvent and releases 
the drug. Then, a small amount of aliquot is withdrawn from the dissolution media within the 
specified time interval and is analysed by high-pressure liquid chromatography (HPLC) or UV-
Vis spectroscopy to estimate the amount of drug released per unit time. 
Table 2.5. USP-approved apparatuses for dissolution testing and different dissolution media 
used in experiments provided by British Pharmacopoeia (BP). 
Dissolution testing apparatus Dissolution media 
Basket apparatus (USP 1) Water 
Paddle apparatus (USP 2) Buffers 
Reciprocating Cylinder apparatus (USP 3) HCl solution 
Flow through cell (USP 4) Simulated gastric fluid 
Paddle-over-disk (USP 5) Simulated intestinal fluid 
Cylinder (USP 6) Surfactant solution 
Reciprocating holders (USP 7)  
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In this study, the USP apparatus 2 and UV-Vis spectroscopy were used to perform dissolution 
testing of G/X SOS in Chapter 5. USP apparatus 2 is the most commonly employed dissolution 
method to characterize oral solid-dosage forms of immediate-, modified-, and extended 
releases along with the basket method (USP1) [355], due to their simplicity, robustness and 
flexibility, and the fact they are well standardized and used worldwide [356]. It is the assembly 
from apparatus 1, i.e. it consists of a vessel, a motor and water bath, and in addition to that 
it uses a paddle formed from a blade and a shaft as the agitating element. The dosage unit 
can be sunk using a small piece of nonreactive wire helix or alternative sinker to prevent the 
unit from floating [357].  
All drug concentrations of the dissolution testing samples were analysed using an ultraviolet–
visible (UV-Vis) spectroscopy. UV-Vis spectroscopy measures the absorbance of ultra violet 
(UV – 190–400 nm) or visible light (Vis – 400–800 nm) of a sample and can provide both 
quantitative and qualitative information. The UV-Vis spectroscopy either performs a scan 
over a range in the spectrum or at a single wavelength. When light passes through the sample, 
some of the light is absorbed and some of the light is transmitted. Absorption of UV and Vis 
radiation induces electron transition from a ground state to an excited state. The UV-Vis 
spectroscopy process identifies which wavelengths were absorbed by the sample and to what 
extent the absorption occurred. It presents the results as a diagram with maximum absorption 
peak at specified wavelength and transmitted troughs. 
UV-Vis spectroscopy can provide quantitative information according to the Beer-Lambert law, 
which states that the absorbance is proportional to the concentration of the substance in 
solution, as follows: 
A = ℰ𝒸𝑙. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (2.3) 
Where A is absorbance, ℰ is molar extinction, which is constant for a particular substance at 
a particular wavelength (dm3 mol-1 cm-1), 𝒸 is concentration of solution (mol dm-3) and 𝑙 is 
optical path length, i.e. the dimension of the cell or cuvette (cm) [358]. 
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Operating conditions 
The in vitro dissolution testing of MS was performed using the BP paddle method using 
dissolution apparatus No. 2. The dissolution runs were carried out at 37 °C±1 and an agitation 
speed of 100 rpm. The dissolution medium was 500 ml of pH 1.2 to simulate gastric juice 
prepared according to BP. The concentration of the drug in the dissolution media was 0.18 
mg/ml. A basket sinker was used to prevent a dosage form from floating.  A 5 ml aliquot of 
filtered medium was withdrawn at specific time points (3, 6, 9, 12, 15, 20, 30, 45, 60 and 90 
minutes), and the drawn volume was replaced with a blank dissolution medium. An aliquot 
was filtered using a 0.22 μm Polyethersulfone membrane (EMD MilliporeTM, Fisher Scientific) 
and the absorbance of the filtrate was measured by UV-Vis spectroscopy (Perkin-Elmer 35 
UV-Vis double-beam spectrometer) in a quartz cuvette (HellmaTM SuprasilTM, Fisher Scientific, 
with a path length of 10 mm) over the range 240-– 350 nm. The λmax of the drug was at 263–
274 nm. The λmax of MS given in the literature are 274 nm [228] and 222 nm [222]. The amount 
of released MS was calculated in a calibration curve. The calibration curve for MS was 
obtained by measuring the series of a standard solution with concentration from 0.00625 to 
0.2 mg/ml with UV-Vis spectroscopy and a plot was made from the absorbance as a function 
of their concentration. The R2 values for the calibration curve were 0.999.
Chapter 3 
92 
 
3 Chapter 3. Development of an orodispersible film for delivering 
hydrophilic nutritional supplements 
3.1 Introduction 
As with pharmaceutical active ingredients, nutritional supplemental compounds can be 
loosely categorised by their solubility in aqueous media. The development of a novel delivery 
method for hydrophilic compounds with good aqueous solubility is the focus of this chapter. 
Iodine is used as the targeted nutritional compound. 
As discussed in Chapter 1, iodine deficiency is still a major health problem in many developing 
countries and in some developed countries [25-30]. Therefore, in particular for developing 
countries, there is an increasing demand for new cost-effective iodine 
medicaments/supplements, especially to meet the needs of the paediatric population. This 
study reports the development of ultra-rapidly dissolving orodispersible films as an 
alternative solid form of iodine delivery, which can meet this urgent need for tackling 
paediatric iodine deficiency. 
In this chapter, we propose and demonstrate the use of orodispersible films that are made 
with an overlapping iodine loaded nanofibre network to provide ultra-rapid disintegration 
and dissolution once wetted. Additional water, as is commonly used when taking 
conventional tablets and capsules and for the swallowing of bulky solids, is not required for 
the administration of this orodispersible film. The child only needs to put the film on the 
tongue, the formulation will dissolve rapidly in saliva, and the iodine can be largely absorbed 
by a conventional gastrointestinal route. It is anticipated that a small proportion of the saliva-
dissolved iodine may also be absorbed via the buccal mucosa within the oral cavity, which has 
the advantage of both rapid uptake and the bypassing of the hepatic metabolism [72, 82]. 
This delivery concept can also benefit other unfulfilled therapeutic needs, such as providing 
emergency medications for patients who are unable to swallow conventional tablets and 
capsules, such as geriatric patients with dysphagia and unconscious patients who are in 
seizure. 
Chapter 3 
93 
 
The nanofibre-based orodispersible films were produced using electrospinning, which has 
recently attracted increased interest in the pharmaceutical, biomedical, food, and tissue 
engineering fields [89, 91, 359-362] (a detailed description of the electrospinning technology 
can be found in Chapter 1, section 1.6). The main advantages of nanofibres as a delivery 
system are their high surface to volume ratio, enhanced drug loading capacity, and relative 
cost effectiveness [234, 363, 364]. However, the characterization of the nanofibres can be 
challenging as a result of their submicrometre dimensions, but this characterization is crucial 
for understanding and thereby controlling the in vitro and in vivo performance, and the 
stability of the formulations. In this study, KIO3, which is the most stable form of iodine source 
under stressed conditions [365], was used as the active ingredient. In order to maximize the 
stability of KIO3 and be able to form films that can be easily handled in practice and with a 
uniform distribution of a low dose of KIO3, PEO was used to form a solid dispersion with KIO3. 
PEO is easily processed by electrospinning and is water soluble [102, 235], which makes it a 
good carrier material for KIO3. 
Despite a rich literature base that has provided insight into solid dispersion-based 
formulations, there is a lack of information regarding their use in the delivery of inorganic 
molecules. This study provides a thorough investigation into the behaviour of such a system. 
The results reveal the formation of nanocrystals of KIO3 within the nanofibres at relatively 
lower loading concentrations than is the case with many organic, low molecular weight drugs 
[366]. The results of this chapter have demonstrated two significant outcomes: (1) the 
development of a prototype form of a novel solid oral paediatric iodine formulation which 
requires no water and swallowing for administration and (2) a considerable contribution to 
improving the understanding of solid dispersions containing inorganic molecules and the 
production of inorganic nanocrystals using a quick, simple, and organic solvent-free 
electrospinning method. 
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3.2 Materials and methods 
 
3.2.1 Materials  
The materials used in this Chapter are KI, KIO3, PEO 300K, PEO 600K, PVP 90K, NaCl, H2SO4 
and methylene blue dye. Their physicochemical properties are described in Chapter 2 
sections 2.2, 2.2.1 and 2.2.4. 
3.2.2 Methodology 
3.2.2.1 Electrospinning 
The electrospinning setup is given in Chapter 2, section 2.3.1. 
PEO placebo nanofibres preparation 
PEO 600K and PEO 300K were dissolved in aqueous media in 5 and 7 w/v % concentrations. 
The EPPs were as follows: the distance between the tip of the needle and the collector was 
250mm, the flow rate was 0.1 ml/h, 0.5 ml/h and the applied DC voltage was from 12 to 15 
kV (250 mm – 0.1 ml/h, 0.5 ml/h – 12–15 kV). 
PEO/KI nanofibres preparation 
We studied two grades of PEO with an average Mw of 6 × 105 g/mol and 3 × 105 g/mol, and 
two total solution concentrations of 5 and 7 w/v %. This is because their solutions have 
different viscosities which could affect the obtained fibres produced using electrospinning. 
The solution of PEO and KI was prepared by dissolving them in aqueous media in different 
w/w %, namely 99.86/0.14, 98/2, 90/10 w/w % (Table 3.1). Also, PEO and KI were dissolved 
in the ethanol/water (Eth/w) media, where the Eth/w concentrations were 30/70, 70/30, 
40/60, 60/40 v/v % and the PEO/KI concentrations were 70/30, 85/15, 95/5 w/w %. The EPPs 
were as follows: 150, 250 mm – 0.1 ml/h, 0.5 ml/h – 12–15 kV. 
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Table 3.1. The polymer and KI salt concentration in the aqueouse solution. 
Total solution  
concentration (w/v %) 
PEO/KI  
(w/w %) 
Sample N 
PEO 300K  
5 90/10 3.1.1 
PEO 600K  
5 90/10 3.1.2 
7 90/10 3.1.3 
5 98/2 3.1.4 
7 98/2 3.1.5 
7 99.86/0.14 3.1.6 
PEO/KIO3 and PEO/NaCl nanofibres preparation 
PEO and KIO3 were dissolved in water in different concentrations. The concentration of KIO3 
in the solution was calculated in molar concentration and then the mass of KIO3 was 
converted to wt. % with regard to PEO wt. % (Table 3.2), simply to make the numbers more 
convenient for a reader. Overall, the solid content concentrations of the electrospinning 
solutions were 3, 5 and 7 w/v %. The EPPs were as follows: 150 mm, 200 mm, 250 mm – 0.2 
ml/h, 0.5 ml/h, 0.75 ml/h, 1 ml/h – 12–25 kV. 
Table 3.2. Molar concentration of KIO3 in the solution and its wt. % with regard to PEO wt. %.  
Sample N KIO3 molar 
concentration (M) 
PEO/KIO3  
w/w % 
3.1 0.001 99.6/0.4 
3.2 0.002 99.1/0.9 
3.3 0.003 98.7/1.3 
3.4 0.005 98/2 
3.5 0.007 97/3 
3.6 0.01 96/4 
3.7 0.02 91/9 
3.8 0.03 87/13 
3.9 0.05 79/21 
3.10 0.07 70/30 
3.11 0.1 57/43 
3.12 0.15 36/64 
3.13 0.2 14/86 
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PEO and NaCl were dissolved in water in different w/w % concentrations, namely 87/13, 
79/21, 57/43 w/w %. The total solid content concentration of the electrospinning solution 
was 5 w/v %. The EPPs were as follows: 150 mm, 200 mm, 250 mm – 0.2 ml/h, 0.5 ml/h, 0.75 
ml/h, 1 ml/h – 12–25 kV. When the rotating drum was used the EPPs: 1,000 rpm – 150 mm – 
0.5 ml/h – 22–30 kV. 
PEO/PVP/KIO3 nanofibres preparation 
A PEO 600K/PVP 90K blend was prepared as follows: the total aqueous solution concentration 
was 5 w/v % and the PEO to PVP w/w % were 30/70 and 70/30. The KIO3 concentrations in 
the formulation were 0.4, 2, 4, 5, 21, 43 w/w %. The EPPs were as follows: 150 mm – 0.5 ml/h 
– 13–19 kV.  
PVP/KIO3 and PVP/NaCl nanofibres preparation 
PVP/KIO3 solutions were electrospun to compare with the PEO/KIO3 formulation. The total 
solution concentration was 10 w/v and the PVP/KIO3 wt. % were 87/13 and 36/64. The EPPs 
were as follows: 150 mm – 0.5 ml/h – until 26 kV. 
The electrospun PVP fibres containing lower KIO3 or NaCl concentrations were prepared to 
investigate the effect of polymer type on the formation of inorganic nanocrystals. PVP and 
crystalline salts were dissolved in aqueous solution, where the total solution concentration 
was 10 and 15 w/v % and the solid salt concentrations ranged from 4 to 14 w/w %. The EPPs 
were as follows: 150 mm – 0.5 ml/h – until 30 kV. 
3.2.2.2 Wetting and dissolution testing 
The wettability of the films was tested using a moist filter paper method described previously 
in the literature [93]. In summary, a piece of cellulose filter paper (Sigma-Aldrich, Gillingham, 
Dorset, UK) was wetted and saturated with distilled water. The filter paper was then placed 
in a Petri dish, and a piece of the electrospun film was placed on top of the wetted filter paper. 
The time taken for the film to transform from a dry and opaque colour to invisible (indicating 
complete wetting) was recorded. The tests were repeated at least three times. The dissolution 
tests of the ultra-rapidly dissolving orodispersible films were performed simply because the 
dissolution process was rapid. Placebo and KIO3-loaded films were dissolved in water by 
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gentle stirring in a Petri dish, and the time taken for the film to dissolve was recorded. In order 
to see the release of KIO3, an iodometric reaction was used. An excess amount of KI and a 
small drop of methylene blue dye were added to water. A 1M H2SO4 solution was added after 
placing the fibre film in water to see the immediate release of iodine to confirm the fast 
release of the active ingredient from the carrier material. Methylene blue dye was used as a 
colourant indicator to allow the identification of the release of active ingredient. This is 
because the fibre films were white and became transparent and difficult to see in water. KIO3 
is a good oxidizing agent which oxidizes iodide to iodine in acidic media and indicates the 
colour change via the reaction: 
KIO3 + 5KI + 3H2SO4 = 3I2 + 3K2SO4 + 3H2O 
3.2.3 Characterization techniques 
The films were characterized with a range of analytical techniques described in Chapter 2. 
The morphology of the nanofibres and the physical form of the active ingredient were 
identified by means of microscopes such as SEM and TEM. The spatial distribution of KIO3 
nanocrystals in the fibrous mat was confirmed with the SEM-EDS instrument. The effect of 
KIO3 loading on the solid-state physicochemical properties of the nanofibres was explored 
using PXRD and ATR-FT IR. The KIO3 loaded fibres demonstrated ultra-fast disintegration and 
dissolution behaviour on conducting a wetting test using a moist filter paper method. The 
detailed methodologies of the characterization can be found in the relevant sections in 
Chapter 2. 
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3.3 Results and discussions 
3.3.1 Impact of KI and KIO3 incorporation on fibre formation 
3.3.1.1 PEO loaded with KI 
The morphology of the electrospun PEO/KI solutions was evaluated using the surface 
characterizing SEM technique. Figure 1 represents the SEM images of PEO loaded with KI.  As 
can be seen, all samples failed to form fibres, except PEO 600K loaded with 0.14 w/w % of KI. 
As discussed in Chapter 1, the production rate of electrospinning can be improved by adding 
some salts into the solution [99]. However, this study shows that not all salts facilitate better 
fibre formation. Although salts can improve the fibre diameter, they do not necessarily 
prevent the break-up of the jet. KI could favour fibre formation only at 0.14 w/w % 
concentration. All other samples with 10 and 2 w/w % concentration failed to form fibres, 
irrespective of the polymer molecular weight and concentration; instead, large crystals of KI 
were seen on the SEM images (Figure 3.1). 
 
Figure 3.1. SEM images of PEO loaded with KI: a) sample N3.1.1; b) sample N 3.1.2; c) sample 
N3.1.3; d) sample N3.1.4; e) sample N3.1.5; f) sample N3.1.6 (Table 3.2). The EPPs: 150 mm, 
0.5 ml/h, 12–21 kV. 
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3.3.1.1.1 Effect of the solvent 
Fong et al. [102] reported that the additon of ethanol to the aqueous solution decreases the 
surface tension and increases the viscosity of the solution, because ethanol makes the solvent 
evaporate easier and thus increases the viscosity of the liquid jet. These two factors, the 
decreased surface tension and increased viscocity, makes the fibres smooth and non-beaded. 
Therefore, we changed the solvent to change the surface tension of the solution by varing the 
ethanol ratio. However, it was found that this does not improve fibre formation: the ethanol 
to water ratio has no effect on the fibre formation for this formulation. Fibres were obtained 
only with a sample with low KI content (Figures 3.2 and 3.3). In the first sample, when the 
Eth/w concentration was 30/70 v/v % and the PEO/KI concentration was 70/30 w/w %, fibres 
were not formed at all, whereas decreasing the KI content in the formulation by 15 w/w % 
could form fused fibres (Figures 3.2a and 3.2b). In comparison, the same concentration of 
PEO/KI, i.e. 85/15 w/w %, but with the ethanol concentration increased to 70 v/v % could 
yield smooth fibres (Figure 3.2d). However, when the KI concentration was high, as in the first 
sample, i.e. at 30 w/w %, the increased ethanol concentration to 70 v/v % does not improve 
fibre formation at all (Figure 3.2c).  The same observation was performed for samples with 
40/60  and 60/40 v/v % of Eth/w (Figure 3.3). Samples with a high ethanol content, namely 
60 v/v %, and a low KI content, namely below 15 w/w %, yielded smooth nanofibres (Figures 
3.3e and 3.3f). Smooth nanofibres were fabricated with a sample where the ethanol content 
was low, i.e. 40 v/v %; however, as in the previous experiment, the KI content was much 
lower, namely 5 w/w % (Figure 3.3c). Therefore, we concluded that ethanol decreases the 
surface tension and increases the viscosity so the fibres were formed; however when the KI 
content is high, the high ethanol concentration could not facilitate the fibre formation. These 
results suggest that KI has a greater impact on fibre formation. We anticipate that KI forms 
larger crystals in the jet, which can be seen in the figures above (Figures 3.1a-c), and thus 
break-up the jet. In addition, although, the SEM images showed that fibres could be yielded 
with a low KI content, the obtained nanofibre mat showed a yellowish colour, indicating the 
oxidation of iodide (the picture could not show the yellowish colour and therefore it is not 
given). 
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Figure 3.2. SEM images of PEO loaded with KI and the solution is Ethanol-Water: a) Eth/w-
30/70 v/v %, PEO/KI-70/30 w/w %; b) Eth/w-30/70 v/v %, PEO/KI-85/15 w/w %; c) Eth/water-
70/30 v/v %, PEO/KI-70/30 w/w %; d) Eth/w-70/30 v/v %, PEO/KI-85/15 w/w %. The total 
solution concentration was 5 w/v %. The EPPs were held at a constant for all samples: 250 
mm – 0.1 ml/h – 12 kV.  
 
Figure 3.3. SEM images of PEO loaded KI and the solution is Ethanol-Water: a) Eth/w-40/60 
v/v %, PEO/KI-70/30 w/w %; b) Eth/w-40/60 v/v %, PEO/KI-85/15 w/w %; c) Eth/w-40/60 v/v 
%, PEO/KI-95/5 w/w %; d) Eth/w-60/40 v/v %, PEO/KI-70/30 w/w %; e) Eth/w-60/40 v/v %, 
PEO/KI-85/15 w/w %; f) Eth/w-60/40 v/v %, PEO/KI-95/5 w/w %. The total solution 
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concentration was 5 w/v %. The EPPs were held at a constant for all samples: 250 mm – 0.1 
ml/h – 12 kV. 
3.3.1.2 PEO loaded with KIO3 
As PEO/KI formulations failed to form good fibres by electrospinning, an alternative iodine 
salt, KIO3 was used. From the SEM images (Figure 3.4), it can be seen that the beaded fibres 
can be obtained if PEO is loaded with KIO3, even at high concentration, namely 43 w/w % 
(N3.11). Although it was beaded, the formulation was electrospinnable. The literature says 
that actually, K+ ions form complexes with the ether oxygen of PEO and thus assist in 
separating the polymer chains and act as a plasticizer [367-370]. This increases the ionic 
conductivity of the solution and consequently should increase the production rate of fibres. 
However, this was the case with the sample with KIO3 but not with KI. As discussed earlier, 
the reason might be due to the fast crystallization rate of KI and larger crystal sizes of KI in the 
jet. 
 
Figure 3.4. PEO loaded with KIO3: a) PEO 600K/KIO3-96/4 w/w % (N3.6); b) PEO 600K/KIO3-
57/43 w/w % (N3.11). The total solution concentration was 5 w/v %. The EPPs: 250 mm – 0.1 
ml/h – 12–15 kV. 
3.3.1.2.1 Effect of the solvent 
PEO/KIO3 was also dissolved in ethanol/water to study the effect of solvent on fibre 
morphology. The results showed no significant effect on fibre morphology, indicating that the 
solution concentration is more important than the solvent properties for that formulation  
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(Figure 3.5). Therefore, it was decided to use only water for further formulations to avoid the 
use of a hazardous organic solvent. 
 
Figure 3.5. PEO 600K loaded with KIO3 and the solution is Ethanol-Water, volume ratio 40/60 
v/v: a) PEO/KIO3-70/30 w/w %; b) PEO/KIO3-85/15 w/w %; c) PEO/ KIO3-95/5 w/w %. The total 
solution concentration was 5 w/v %. The EPPs: 250 mm – 0.1 ml/h – 12 kV. 
3.3.2 Formulation optimization 
3.3.2.1 Effect of polymer concentration 
In order to study the optimum polymer concentration to produce smooth nanofibres, the 
SEM technique was used to characterize the dimensions and surface morphologies of the 
nanofibre. PEO with a Mw. of 600K yielded smooth placebo nanofibres with a uniform 
diameter range between 50 nm and 1.2 μm (measured using ImageJ analysis software), as 
seen in the images (Figures 3.6b and 3.6d). Beaded nanofibres were obtained with the sample 
prepared using PEO with Mw. 300K (Figures 3.6a and 3.6c). The solution concentration with 
the same Mw. produced insignificant variations, which resulted in the same form. 
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Figure 3.6. SEM images of placebo PEO nanofibres with different concentrations: a) 5 w/v % 
solution concentration, PEO 300K; b) 5 w/v % solution concentration, PEO 600K; c) 7 w/v % 
solution concentration, PEO 300K; d) 7 w/v % solution concentration, PEO 600K. The EPPs: 
150 mm – 0.5 ml/h – 10kV–12kV. 
3.3.2.2 Probing maximum loading of KIO3 
The addition of KIO3 up to 21 w/w % (N3.9) led to a slightly reduced fibre diameter but no 
change in the fibre morphology (Figures 3.7a to 3.7e). Using the formation of nanofibre films, 
which can be easily peeled off from the collector surface as the key measure, a maximum 
loading of KIO3 was also studied. The optimal loading range to result in an elastic and easy-
to-peel fibre film with smooth and uniform fibre was up to 21 w/w % (N3.9) of KIO3 loading 
with a 0.2 mL/h feeding rate. Further increases in KIO3 content to above 43 w/w % (N3.11) 
led to the formation of beaded (formation of small beads on the fibres) nanofibres and brittle 
films (Figure 3.7f). 
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Figure 3.7. SEM images of PEO 600K nanofibres loaded with KIO3: a) 0.4 w/w % (N3.1); b) 2 
w/w % (N3.4); c) 4 w/w % (N3.6); d) 13 w/w % (N3.8); e) 21 w/w % (N3.9); f) 43 w/w % (N3.11). 
The total solution concentration is 5 w/v %. The EPPs: 250 mm – 0.2 ml/h – 20–24 kV. 
Nonetheless, it is possible to load up to 86 w/w % of KIO3 (N3.13) into the fibre film, but the 
morphology of the fibres would be beaded and more particulate. As seen in Figure 3.8, 
beaded fibres form with a diameter of 2 µm, although the amount of KIO3 loading was very 
high, 86 w/w %, potassium iodate crystals cannot be seen. Therefore, TEM analysis was 
performed and the results are in the sample characterization section 3.3.5.2. 
 
Figure 3.8. SEM images showing the film with the maximum 86 w/w % of KIO3 (N3.13) 
concentration. The left and the right images are the lower and the higher magnifications, 
respectively. Total solution concentration was 5 w/v. The EPPs: 150 mm – 0.5 ml/h – 20 kV.  
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We checked the solution conductivity with the increase of KIO3 to put on record the impact 
of KIO3 on solution conductivity. As shown in Table 3.3, the solution conductivity increased 
proportionally to the content of KIO3. 
Table 3.3. Solution conductivity of pure PEO polymer solution and PEO loaded with KIO3. 
Solution (at 20±2 °C) Conductivity (μS/m) 
Milli-Q water 1.2 
5 w/v % of pure PEO 600K 61.9 
5% w/v (PEO/KIO3 – 99/0.9 w/w %) 198.2 
5% w/v (PEO/KIO3 – 98/2 w/w %) 464.0 
5% w/v (PEO/KIO3 – 96/4 w/w %) 998.0 
5% w/v (PEO/KIO3 – 87/13 w/w %) 3300.0 
The amount of KIO3 loading has a significant impact on fibre diameters. As seen in Figure 3.9, 
the fibre diameter size decreases with the increase of the KIO3 concentration. The diameter 
sizes of the placebo nanofibres are from 100 nm to 700 nm, whereas the diameter size of the 
nanofibres loaded with 21 w/w % of KIO3 (N3.9) are from 50 nm to 500 nm.  
 
Figure 3.9. SEM images of the (a) morphology and (b) diameter size distribution of placebo 
PEO nanofibres, respectively, (c) morphology and (d) diameter size distribution of PEO 
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nanofibres loaded with 21 w/w % of KIO3, (N3.9) respectively. The diameters of the nanofibres 
were measured using ImageJ analysis software. 
3.3.3 PVP and PVP/PEO polymer blend loaded with KIO3 
We conducted a feasibility study with PVP/PEO blend because PVP is highly water-soluble and 
adding PVP into a PEO solution could improve the dissolution rate of the fibre mat. The SEM 
images showed significant differences in fibre morphology depending on the PVP to PEO ratio. 
Smooth and uniform nanofibres were obtained with samples contatining 30/70 w/w % of PVP 
to PEO ratio and KIO3 content from 0.4 to 21 w/w % (N3.1-3.9) (Figure 3.10). As was observed 
with pure PEO, beaded fibres formed when the KIO3 content reached 43 w/w % (N3.11) 
(Figure 3.10f). On the other hand, samples with 70/30 w/w % of PVP/PEO ratio showed 
beaded fibres irrespective of the KIO3 content (Figure 3.11). Spindle-like beads converted to 
rounded beads at 43 w/w of KIO3 content (Figure 3.11f). 
 
Figure 3.10. SEM images of PVP/PEO 600K 30/70 w/w % blend with different KIO3 
concentrations: a) with 0.4 w/w KIO3, 14kV; b) with 2 w/w % KIO3, 17kV; c) with 4 w/w % KIO3, 
17kV; d) with 5 w/w % KIO3, 16kV; e) with 21 w/w % KIO3, 19kV; f) with 43 w/w % KIO3, 19kV. 
The total solution concentration was 5 w/w %. The EPPs: 0.5 ml/h – 150 mm. 
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Figure 3.11. SEM images of PVP/PEO 600K 70/30 w/w % blend with different KIO3 
concentrations: a) with 0.4 w/w % of KIO3, 13kV; b) with 2 w/w % of KIO3, 15kV; c) with 4 w/w 
% of KIO3, 15kV; d) with 5 w/w % of KIO3, 13kV; e) with 21 w/w % of KIO3, 18kV; f) with 43 
w/w % of KIO3, 18kV. The total solution concentration was 5 w/w %. The EPPs: 0.5 ml/h – 150 
mm. 
Pure PVP loaded with 13 w/w % KIO3 showed rounded beads and no fibres with 64 w/w % 
KIO3 (Figure 3.12). The results show that electrospinning of KIO3 with PVP is feasible only with 
a low concentration of KIO3 and, if the polymer concentration is decreased, it is possible to 
obtain polymer nanoparticles with smooth morphology by means of electrospraying. In order  
to obtain smooth nanofibres, probably a much higher PVP concentration is needed, for 
example 15-35 w/v %. However, in this study we did not investigate the PVP polymer solution 
concentration because it was a trial experiment. We wanted only to see if it is possible to 
obtain smooth nanofibres with PVP to increase the dissolution rate in aqueous media in the 
future. 
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Figure 3.12. SEM images of PVP loaded with KIO3: a) with 13 w/w % of KIO3; b) with 64 w/w 
% of KIO3. The total solution concentration was 10 w/v %. The EPPs: 150 mm – 0.5 ml/h – 26 
kV. 
3.3.4 Processing parameters optimization 
Once an electrospinnable formulation is established, the processing parameters need to be 
optimized in order to obtain fibres with desirable physical properties, including the required 
morphology, fibre diameters and uniformity of fibre size. There are 5 main factors 
investigated in this chapter, namely the distance between the collector and the needle, the 
diameter of the needle, the applied DC voltage, the feeding rate and the type of collector.  
3.3.4.1 Distance between the needle and collector 
A number of researchers have studied the effect of the distance between the tip of the needle 
and collector and found that if the distance is too close or too far then beaded fibres are 
fabricated [117, 123]. In our study we found no difference when the distance was varied from 
150 mm to 250 mm (Figure 3.13). This is in accordance with the studies undertaken with PVA 
[110] and PVDF [124]. Three different distances, namely 150 mm, 200 mm and 250 mm, 
yielded smooth and uniform nanofibres. However, with the increase of the distance between 
the collector and the needle, the production of nanofibres per square centimetre decreases. 
This is due to the widening of the diameter of the cone, which is formed during 
electrospinning, at a higher distance. Therefore, we concluded that the optimum distance 
between the needle and collector is 150 mm for this formulation. This distance was enough 
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for water evaporation and the fabrication of a higher amount of nanofibres per square 
centimetre in contrast to the 200 mm  and 250 mm distances. 
 
Figure 3.13. SEM images of PEO loaded with 13 w/w % of KIO3. Solution concentration was 5 
w/v %. The feeding rate and applied DC voltage was held at a constant, namely 0.5 ml/h and 
25 kV, respectively. The changing parameter is the distance between the collector and the 
needle: a) 150 mm; b) 200 mm; c) 250 mm. 
3.3.4.2 Diameter of the needle 
The variations in the diameter of the needle were 18G, 20G, 21G and 23G. There were slight 
differences observed in terms of fibre morphology, namely with the uniformity of the fibres 
affected by the 20G, 21G and 23G needle diameters. However, the applied voltage requires 
slightly less for the needle with the lower diameter size, i.e. 21G and 23G, due to the polymer 
amount at the exit (Figure 3.14). Nevertheless, the diameter of the needle of 18G was 
recommended as the optimum diameter for use in electrospinning for PEO/KIO3 solution 
because it yielded a relatively uniform fibre diameter distribution. 
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Figure 3.14. Effect of the diameter of the needle for the sample with 7 w/v % total solution 
concentration and PEO 600K/KIO3 ratio of 91/9 w/w %. The EPPs: 150 mm – 0.5 ml/h. 
3.3.4.3 Applied DC voltage 
Generally, low voltage does not form a Taylor cone and high voltage forms beaded nanofibres. 
However, if the solution concentration is right enough to form nanofibres, the applied DC 
voltage has little effect, which is seen clearly in a sample with 3 w/v % of PEO 600K and 5 w/v 
% of PEO 600K concentration (Figures 3.15 and 3.16). The sample with 3 w/v % concentration 
forms beaded nanofibres, with the amount of beaded nanofibres increasing with the increase 
of applied DC voltage. This is not observed for the sample with 5 w/v % concentration, which 
does not form beaded fibres at all and the applied DC voltage has no effect. Therefore, as long 
as the Taylor cone is formed and the jet is ejected from the tip of the needle at certain applied 
DC voltages, then this voltage level is sufficient to produce nanofibres. There is no need to 
increase the voltage further to improve the fibre morphology or production rate for that 
formulation. 
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Figure 3.15.  Effect of applied DC voltage for the sample with 3 w/v % of total solution 
concentration and PEO 600K/KIO3-87/13 w/w %. The EPPs: 0.5 ml/h – 150 mm. 
 
Figure 3.16. Effect of applied DC voltage for the sample with 5 w/v % of total solution 
concentration and PEO 600K/KIO3-87/13 %. The EPPs: 0.5 ml/h – 150 mm. 
3.3.4.4 Feeding rate 
The variation of feeding rate was 0.5ml/h, 0.75ml/h and 1ml/h. The results show no 
difference in the three samples electrospun at three different feeding rates (Figure 3.17). 
Generally, a low feeding rate yields poor collection and a high feeding rate affects fibre 
morphology because there is not enough time for solvent evaporation. Therefore, it is 
recommended to use 0.5 ml/h feeding rate to make sure that the solvent has enough time 
for evaporation for that formulation. 
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Figure 3.17. Effect of feeding rate for the sample with 5 w/v % of total solution concentration 
and PEO 600K/KIO3-96/4 w/w %. The EPPs: 250 mm – 21-23 kV. 
3.3.4.5 Type of collector 
It is desirable to develop an aligned fibrous mat in many applications because it improves 
mechanical and electrical properties, and cell adhesion and proliferation [371]. Therefore, we 
decided to study the effect of a rotating collector, which is reported to be used to fabricate 
mats with aligned fibres that depend on the rotating speed of the drum.  We studied only one 
rotating speed, namely 1,000 rpm, which was given in the literature as the optimum speed to 
fabricate aligned nanofibres [372] and used different polymers with different salts and 
concentration, namely pure PEO loaded with KIO3 and pure PEO loaded with NaCl, and pure 
PVP loaded with KIO3 and pure PVP loaded with NaCl. NaCl was used for comparison 
purposes. Pure PEO loaded with KIO3 produces beaded fibres irrespective of the PEO to KIO3 
weight ratios, i.e. 99.6/0.4, 96/4, 87/13, 57/43, 36/64 w/w % (Figure 3.18). However, PEO 
loaded with NaCl generated aligned nanofibres without beads but the fibres were broken 
(Figures 3.20a-c). Some degree of fibre direction alignment with some spherical beads was 
generated with PVP polymer solutions with both salts, KIO3 (Figure 3.19) and NaCl (Figures 
3.20d-f), except when the NaCl loading was high, namely 57/43 w/w %, where fused 
nanofibres were obtained. In comparison, PVP loaded with KIO3 showed more aligned fibre 
direction even at a high KIO3 loading, namely 64 w/w %. Interestingly, here we increased the 
total solid concentration by 15 w/v %, because in section 3.3.3. we determined that 10 w/v 
% concentration was not enough to fabricate fibres with a high loading of KIO3, and with this 
concentration we were able to yield PVP nanofibres with a high loading of 64 w/w % of KIO3. 
The principle of producing aligned fibres direction using a drum collector is that during the 
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rotation of the drum collector, the fibres are taken up on the surface of the drum and if the 
surface speed of the rotating drum matches that of the evaporated jet depositions, the fibres 
are taken up tightly in a circumferential manner and the fibres are fairly aligned. If the surface 
speed of the drum collector is slower than the fibre deposition speed, the fibres will be 
deposited randomly [89]. In addition, the deposition of randomly oriented fibres on a rotating 
drum can be due to the residual charge accumulation on the deposited fibres, interfering 
(repelling) with the alignment of the incoming fibres [90]. These two factors or one of them 
alone are possible reasons for some random deposition of the  PVP/NaCl and PVP/KIO3 
formulations. However, if the surface speed of the drum collector is faster than the fibre 
deposition speed, the fibres will be broken [89], as happened in the case of the PEO/NaCl 
formulation. The faster speed of the drum collector compared to the fibre deposition speed 
will break the fibre jet and continuous fibres cannot be collected [89]. The formation of 
beaded fibres in PEO/KIO3 is possibly also associated with droplet break up during 
electrospinning, causing reduced chain entanglement. In addition, later we found that Kessick 
et al. [373] reported that PEO nanofibres exhibited a higher degree of fibre alignment on the 
drum collector when the AC potential was applied instead of DC potential. The alternating 
polarity of the AC applied potential reduces the charge net on the fibres, resulting in the 
reduction of electrostatic forces that cause the fibre instability. However, it was observed that 
the fibre mat contained more residual solvent. 
The rotating drum was good for the PVP sample but not for the PEO sample. As the stationary 
collector worked well in yielding smooth uniform PEO nanofibres, it was decided to exclude 
the rotating drum collector when electrospinning PEO/KIO3 formulation. 
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Figure 3.18. SEM images of fibres obtained using the rotating collector for PEO/KIO3 
formulations: a) with PEO/KIO3 99.6/0.4 w/w %; b) with PEO/KIO3 96/4 w/w %; c) with 
PEO/KIO3-87/13 w/w %; d) with PEO/KIO3 57/43 w/w %; e) with PEO/KIO3 36/64 w/w %. The 
total solution concentration was 5 w/v %. The EPPs: 1,000 rpm – 150mm – 0.5ml/h – 12–
14kV. 
 
Figure 3.19. SEM images of fibre morphology obtained using the rotating collector for the 
PVP/KIO3 formulations: a) with PVP/KIO3 87/13 w/w %; b) with PVP/KIO3 79/21 w/w %; c) with 
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PVP/KIO3 57/43 w/w %; d) with PVP/KIO3-36/64 w/w %. The total solution concentration was 
15 w/v %. The EPPs: 1,000 rpm – 150 mm – 0.5 ml/h – 30kV. 
 
Figure 3.20. SEM images of fibres obtained using the rotating collector for the samples loaded 
with NaCl: a) PEO/NaCl 87/13 w/w %; b) PEO/NaCl-79/21 w/w %; c) PEO/NaCl-57/43 w/w %; 
d) PVP/NaCl-87/13 w/w %; e) PVP/NaCl-79/21 w/w %; f) PVP/NaCl-57/43 w/w %. The total 
solution concentrations were 15 and 5 w/v % when PVP 90K and PEO 600K were used, 
respectively. The EPPs: 1,000 rpm – 150 mm – 0.5 ml/h – 22–30 kV. 
3.3.5 Characterization of PEO nanofibres loaded with KIO3 
3.3.5.1 Validation of the distribution of KIO3 in the PEO fibres 
The EDS is able to detect elements with an atomic number greater than 5. In combination 
with SEM, it can be used to gain elemental distribution information [331, 374, 375]. As seen 
in Figure 3.21, the results revealed that the KIO3-loaded fibre films consist of K, I, O, C, and 
Au. The presence of Au is due to pre-treatment of the SEM sample, C and O are polymer 
constituents, and K, I, and O are constitutes of KIO3. As the electrospun films were highly 
porous, the quantitative elemental composition assignment of the EDS results would have 
limited reliability. Nevertheless, the atomic ratios between C, O, K, and I largely align with the 
molar ratios of these atoms within the formulations examined. The high similarity of the K 
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and I peak intensities in different areas of the sample using the spot mode indicates the 
homogeneity of the distribution of KIO3 in the nanofibre films. Peak intensity is related to the 
amount of substance in the formulation. As seen in Figure 3.22, the higher KIO3 loading shows 
a stronger intensity. Overall, the results confirmed that electrospinning is a suitable method 
for producing easy-to-use orodispersible films for the delivery of iodine. 
 
Figure 3.21. Representative EDS results of PEO nanofibres loaded with 4 w/w % KIO3 showing 
the detection of K, O, and I elements on the fibres. 
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Figure 3.22. Representative EDS results of PEO nanofibres loaded with 43 w/w % KIO3 showing 
the detection of K, O, and I elements on the fibres. 
3.3.5.2 Formation of KIO3 nanocrystals in PEO nanofibres 
As discussed earlier, the increases in KIO3 loading affected the mechanical properties of the 
formed fibre films by converting the smooth fibres to beaded fibres, as well as reducing the 
PEO content which is responsible for the elasticity of the film. It was also suspected that the 
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physical form of KIO3 might be altered with increasing loading. This assumption was made on 
the basis of the existing literature on polymer-based solid dispersions for delivering organic 
molecules, in which a crystalline drug is expected if the loading significantly exceeds the 
solubility limit of the organic drug in the polymer [366]. The generation of significant 
quantities of crystalline KIO3 could also reduce the mechanical strength of the fibres and result 
in weak and brittle fibre films. This hypothesis was tested using PXRD.  
 
Figure 3.23. PXRD diffraction patterns of the starting materials and electrospun nanofibres. 
The PXRD results confirm the crystalline and semi-crystalline nature of KIO3 and PEO, 
respectively. All of the characteristic diffraction peaks match those reported in the literature. 
As seen in Figure 3.23, it is evident that with increasing KIO3 loading, crystalline KIO3 was 
formed with low loadings at and above 3 w/w %. The PXRD data of each sample can be found 
in Appendix 4, Figure A4.7, where crystal formation can be seen even at lower concentration 
than that, namely at and above 1.3 w/w %. This indicates that an inorganic salt such as KIO3 
has low solubility in solid PEO, and instead of the formation of a solid solution or amorphous 
solid dispersion KIO3 is likely to form crystalline solid dispersions with PEO after 
electrospinning. However, no crystal or particulate feature was observed using SEM, which is 
an imaging technique that examines the surface of the fibres. Therefore, TEM was applied to 
further investigate KIO3 crystal formation in the PEO fibres. 
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As seen in Figure 3.24, darker, nano-size particles can be clearly seen in the TEM images of 
the fibre films. These high density nanoparticles are highly likely to be the KIO3 crystals. It is 
interesting that these nanocrystals are distributed relatively evenly within the core of the 
fibres. This confirms the earlier EDS result, which suggested a uniform distribution of KIO3 
through the fibres. There appears to be no surface accumulation of the nanocrystals. This 
finding is in contrast to the surface and bulk crystallization behaviour of other inorganic salts 
in electrospun fibres reported in the literature. 
 
Figure 3.24. Representative TEM image of PEO nanofibres loaded with 43 w/w % KIO3. KIO3 
nanocrystals can be seen as black dots in the fibres. 
Inorganic salts are employed in the electrospinning of polymers, mainly, to increase the 
surface charge density and conductivity of the solution to improve fibre morphology, i.e. to 
obtain smoother and thinner fibres. However, studies of the physical characteristics of 
inorganic salts within electrospun polymers have not been reported. All of the previous 
studies have focused on the effect of using inorganic salts on fibre morphology and fibre 
physicochemical characteristics [102, 106, 376-382]. There are a number of examples when 
salts appear on the surface of the fibres, starting from 0.2 w/w % concentration [110, 383, 
384], and only in those cases was it reported that crystals formed, albeit, that crystals can be 
entrapped within the fibres too and therefore cannot be seen in the SEM images. This salt 
crystal entrapping phenomena might be due to the salt, polymer or solvent physicochemical 
properties as well as processing parameters [384, 385]. In our case, we clearly see that KIO3 
crystals were entrapped, even with high loadings such as 43 w/w %. Nanocrystals can be seen 
Chapter 3 
120 
 
with a 3 w/w loading (Figures 3.25a and 3.25a’). The pictures taken for the PEO nanofibres 
with 13 w/w % KIO3 loading (Figures 3.25b and 3.25b’) show some aggregated but mostly 
well defined nanocrystals of different geometric shapes within the fibre core. Whereas, 
further increasing the KIO3 loading, up to 43 w/w %, forms nano-clusters with a rough width 
of 30 nm (Figures 3.25c and 3.25c’).  
 
 
 
Figure 3.25. TEM images show the presence of nanocrystals of KIO3 in the PEO nanofibres 
with loadings ranging from 3–43 w/w %. With the increasing of the KIO3 loading, the crystal 
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size and density increase: a) 3 w/w % of KIO3 (a’ higher magnification); b) 13 w/w % of KIO3 
(b’ higher magnification); c) 43 w/w % of KIO3 (c’ higher magnification). 
To support our interpretation that inorganic salts can form a crystalline solid dispersion with 
polymers during electrospinning, and that electrospinning is a means to yield nanocrystals of 
inorganic salts, we studied another commonly used inorganic salt, NaCl, within the polymer 
PVP. This interior-specific crystallization behaviour in hydrophilic polymeric fibres was also 
observed in electrospun PVP, a widely used pharmaceutical hydrophilic and hygroscopic 
polymer. Small crystals in the nano-size range were obtained from low loadings (Figure 3.26), 
as was observed with KIO3 (Figure 3.25). In addition, we checked whether nanocrystal 
formations occur because of electrospinning or the presence of a polymer. Therefore, we 
electrosprayed KIO3 without a polymer (Figure 3.27) and electrospun with another polymer, 
PVP (Figure 3.26b), and PEO was electrospun with another salt, NaCl (Figure 3.26c). The 
results showed that electrosprayed KIO3 appears in its crystal state and in the range of 
nanometres to micrometres (Figure 3.27). Thus, we have assumed that the polymer matrix 
acts as a solid dispersing agent to keep the crystals separate and produces nano-size crystals.  
 
Figure 3.26. Representitive TEM image of PVP nanofibres loaded with (a) 4 w/w % of NaCl, (b) 
14 w/w % of KIO3 and (c) PEO/NaCl-57/43 w/w %. Nanocrystals of NaCl and KIO3 (examples 
highlighted by arrows in the images) can be osberved in the core of the fibres with the 
surfaces of the fibres being largely crystal free. 
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Figure 3.27. Aqueous solution of KIO3 was electrosprayed. Yield crystals are in the range of 
nanometres to micrometres. The right and the left images are different areas in the sample. 
In the PVP/KIO3 mixture, KIO3 was also incorporated in a PVP polymer in the same way as 
observed with the PEO polymer in the nano-size range (Figure 3.26b). This indicates that the 
phenomenon of inorganic salt crystallization in the bulk of electrospun fibres is not PEO−KIO3 
system specific. Although the mechanism of this crystallization behaviour is unclear and 
further investigation is required, it is noted that both PEO and PVP are hydrophilic polymers 
which exhibit some hygroscopic behaviour. The large surface area and hygroscopic nature of 
the polymer fibres may lead to a higher moisture content at the surface layer of the fibres, 
and this may be sufficient to solubilize the surface salts. The interior core of the fibres is likely 
to be drier than the surface, with the low solubility of the salts in the dry polymer interior 
driving the crystallization. With increasing iodate loading, beading of the fibres can be seen 
and agglomeration of KIO3 nanocrystals at the beading sites is clearly evident (Figure 3.24). 
This indicates that there are significantly higher KIO3 local concentrations at the beading sites. 
It is worth mentioning that as the formation of the nanocrystals occurs at very low loading, it 
is reasonable to suggest that the presence of the nanocrystals per se is not the key factor 
responsible for the mechanical weakness of the fibre films. The formation of highly 
concentrated KIO3 nanocrystal beads at higher iodine loadings, in combination with a low PEO 
content, is more likely to be the underlying reason for the poor mechanical properties of those 
fibres with high KIO3 loadings. 
3.3.5.3 Effect of processing and KIO3 loading on the crystallization behaviour of PEO 
PEO is a semi-crystalline polymer, and the crystallinity of the polymer can be affected by the 
electrospinning process and the incorporation of KIO3. These factors could potentially lead to 
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stability concerns in the finished product. Therefore, the structural conformation and 
crystallinity of the processed PEO in the fibres were studied in depth. ATR FT-IR spectroscopy 
was used in the first instance to reveal the co-existence of helical (H) and trans (T) structure 
conformations of PEO. As seen in Figure 3.28, IR peaks at 1358, 1278, 1235, 1060, 947, and 
842 cm−1 have been specified as indicators for the thermodynamically stable helical structure 
(H) and 1341, 1240, and 961 cm−1 for the trans planar (T) conformation. Any changes in these 
peaks would indicate a change in T or H conformation [323]. All absorption peaks are due to 
the PEO polymer remaining unchanged in comparison to the placebo and are independent of 
KIO3 loading. This implies no significant change in the overall PEO chain conformation 
occurred after the incorporation of KIO3. With 43 w/w % of KIO3 loading, the absorption peak 
at 745 cm−1 was split into two bands at 756 and 738 cm−1. The band splitting at 745 cm−1 
indicates a change of symmetry in the crystal structure. However, according to the literature, 
PXRD is unable to detect such subtle changes in KIO3 crystal symmetry; thus, this change was 
not observed in the PXRD results. Nevertheless, for the purpose of this study, such subtle 
changes in KIO3 nanocrystal are not anticipated to impact the dissolution behaviour of the 
formulation because of the high solubility of KIO3. Detailed assignments of all detectable FT-
IR peaks of the PEO and KIO3 samples can be found in Table 3.4 and Table 3.5. 
 
Figure 3.28. ATR FT-IR spectra of (a) pure PEO powder and (b) electrospun placebo PEO 
nanofibres and PEO nanofibres loaded with (c) 4 w/w, (d) 21 w/w %, and (e) 43 w/w % KIO3. 
Arrows indicate the position of the KIO3 signature absorbance peak. 
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Table 3.4. Detailed assignments of all detectable ATR FT-IR peaks of the PEO 600K, 
electrospun PEO and KIO3 loaded PEO fibres. 
PEO 
reported by 
Yoshihara 
[386] 
PEO  
powder 
PEO  
Electro 
spun 
PEO/KIO3 
96/4 
w/w % 
PEO/KIO3 
79/21 
w/w % 
PEO/KIO3 
57/43 
w/w % 
Assignment  
[323, 367, 387-390] 
 
1466 ⊥ m 1466.47 1466.68 1466.76 1466.85 1466.85 CH2 bending 
1453 II m 1454.25 1454.91 1454.91 1455.08 1455.06 CH2 bending 
1358 ⊥ m 1359.44 
  
1359.59 1359.64 1359.71 1359.73 CH2 wagging 
CC stretching (H) 
1342 II s 1341.42 1341.68 1341.64 1341.67 1341.66 CH2 wagging (T) 
1278 ⊥ m 1278.97 1279.38 1279.66 1279.75 1279.79 CH2 twisting (H) 
1240 II s 1240.86 1241.38 1241.34 1241.38 1241.40 CH2 twisting (T) 
1147 ⊥ s 1144.53 
  
1145.12 1147.39 1147.57 1147.92 CC stretching 
COC stretching 
1103 II vs 1094.65 1097.08 1098.25 1098.62 1098.72 COC stretching 
1060 ⊥ m 1059.14 
  
1060.15 1060.64 1060.75 1060.78 CH2 rocking (H)  
COC stretching 
958 II s 960.76 961.53 961.61 961.74 961.78 CH2 rocking (T) 
947 ⊥ m 946.53 946.97 947.66 947.72 947.91 CH2 rocking (H) 
844 ⊥ s 841.09 841.48 841.91 842.10 842.30 CH2 rocking (H) 
Table 3.5. Detailed assignments of all detectable ATR FT-IR peaks of the KIO3 and KIO3 loaded 
fibres. 
3.3.5.4 Ultra-rapid wetting and dissolution of PEO nanofibres loaded with KIO3 
With the intention of providing rapid dissolution of these electrospun films on the tongue 
after administration, these films should first demonstrate the ability to be wetted rapidly. The 
KIO3 reported by 
Nakamoto [391] 
KIO3 reported by  
Miller and Wilkins 
[392]  
PEO/KIO3 
96/4 
w/w % 
PEO/KIO3 
79/21 
w/w % 
PEO/KIO3 
57/43 
w/w % 
 796 (A1) 800 (w) 799.43 798.35 798.27 
 745 (E) 755 (s) 763.57 760.87 756.43  
738 (vs)     738.88 
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wetted filter paper method reported in the literature was adopted for simulating the moist 
surface of the tongue . As seen in Figure 3.29, the electrospun film wetted rapidly and 
transformed from an opaque dry film to being invisible in less than 20 seconds. As indicated 
by the disappearance of the opaque films, the KIO3-loaded films showed ultra-rapid 
dissolution in the media within less than a minute.  
 
Figure 3.29. Demonstration of the rapid wetting of a piece of KIO3-loaded PEO nanofibre 
orodispersible film. The blue area was used to provide the colour contrast to allow easy 
observation of the opaque film. 
For the fibre films with 13 w/w % of KIO3 loading, delivering 0.5 and 1.1 mg of a piece of film 
with dimensions of approximately 1 × 1 and 1 × 2 cm2 is required, respectively, which meet 
the WHO recommended daily dose of 90 μg/day for children aged 0−5 years and 200 μg/day 
for pregnant and lactating women, respectively. This low mass may be difficult to handle but, 
with a reduction in the drug loading, the weight of oral film administrated can be easily 
increased into an easily manageable size. An alternative delivery method is to put the film on 
top of an edible bulky item, such as conventional children’s snacks, which may also improve 
patient adherence as they are appealing to the paediatric population.  
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In order to see the dissolution rate and release of KIO3, an iodometric reaction was used. As 
seen in Figure 3.30, the dark brown colour of the media after adding sulphuric acid indicates 
the liberation of I2, which appeared immediately after the fast disintegration and dissolution 
of the nanofibre film. The total dissolution was within less than 30 seconds.  
 
Figure 3.30. Ultra-rapid dissolution of KIO3-loaded PEO nanofibre mats. Complete release of 
KIO3 is demonstrated by the colour change of the dissolution medium containing the 
molecular indicator, methylene blue, after adding a small amount of H2SO4 solution. 
3.4 Conclusion 
This study was conducted with a clear aim of finding an alternative low-cost and easy-to-use 
oral iodine supplement formulation for the paediatric population, who often have swallowing 
and adherence difficulties. The formulation developed should fulfill the essential criteria of 
not requiring the swallowing of large solids and has the potential to be easy and fun for 
children to take. The solution proposed in this study is to use electrospinning to produce thin 
orodispersible films which can instantly dissolve on the tongue for easy administration of 
nutritional supplements to children. The key outcome reported for this proof-of-concept 
study is that this is achievable with low requirements for operational optimization and little 
effect on the structural conformation of PEO. The formation of KIO3 nanocrystals in nearly all 
Chapter 3 
127 
 
loaded fibre films indicates the low miscibility of PEO with KIO3. This provides new insights 
into the research area of using polymeric-based solid dispersions for inorganic material 
delivery which is still significantly lacking. The fact that KIO3 forms nanocrystals in the PEO 
fibres and the PEO remains in its original stable conformation is likely to ensure the physical 
stability of the finished product. 
Additionally this research has also demonstrated a novel and easy method for producing and 
harvesting nanocrystals of inorganic salts that can be potentially adopted for other relevant 
fields. 
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4 Chapter 4. Feasibility study of using emulsion electrospinning for 
the co-delivery of multi-nutrients 
4.1 Introduction 
As discussed in Chapter 1, multiple micronutrient deficiency is more common than single 
nutrient deficiency. Therefore, the development of novel delivery systems and methods that 
are capable of delivering several nutrients simultaneously is needed. This would be similar to 
pharmaceutical products which have multi-drug combinations in a single unit dose, in which 
different drugs can be incorporated into one formulation, but are released at different rates 
[393-395]. If the nutrients that need to be co-delivered in a single supplement product have 
different aqueous solubility levels, then the delivery system must be able to incorporate both 
water-soluble and oil-soluble compounds. Lipid-based formulations have been proven to be 
one of the efficient carrier systems for the incorporation of poorly and highly water-soluble 
drugs and nutrients. Numerous techniques are well documented in the literature for 
manufacturing lipid-based formulations. In this chapter, we explore the use of EE technology 
for producing lipid formulation, which allows the production of a lipid-based core which can 
solubilize oil-soluble compounds and a shell made of water-soluble polymers that can host 
water-soluble compounds. This core-sheath structure can provide good protection for 
sensitive oil-soluble vitamins and can potentially be used for the co-delivery of drugs. The 
materials used in EE are usually hydrophilic polymers in the water phase and amphiphilic 
polymers or any spinnable polymers dissolved in organic solvent as the oil phase. However, 
recently, liquid fish oil has been encapsulated in nanofibres by EE [137, 138]. 
In this chapter, we used PEO and PVP polymers in the water phase, due to their good water-
soluble and electrospinnability, as they could carry water-soluble nutrients such as KIO3 (as 
demonstrated in Chapter 3). Oil-soluble nutrients such as vitamin A, where it has been 
reported that deficiency can be connected with hypothyroidism [396], and vitamin E, which 
has also been reported to have a positive effect on this clinical state [43], can both be 
delivered in the oil core of the EE fibres. This allows a synergistic effect to tackle the iodine 
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deficiency. The solution of EE is an emulsion composed of the water phase and the oil phase 
(dispersed phase). In this chapter, we investigate the use of a range of oils, namely sunflower, 
fish, flaxseed, squalene and olive oils, as the dispersed phase carrier oil and their effects on 
the EE process. These oils were selected as they are widely used in food and pharmaceutical 
formulations as functional ingredients and carriers for poorly water soluble active ingredients. 
TPGS was selected as a source of vitamin E and an emulsifying agent. Span 80 is often used in 
EE and was selected to adjust the emulsifier HLB value in a mixture with TPGS, as it has a low 
HLB value of 4.3 [397]. Tween 20 was selected as it is often used in the preparation of o/w 
emulsions.  
EE can be performed by either single spinneret or coaxial electrospinning (a detailed 
description and comparison can be found in Chapter 1, section 1.5). We investigated both 
methods to assess their feasibility for producing emulsion based core-shell fibres or fibres 
incorporating oil drop phases. 
The main purpose of this chapter is to establish the feasibility of EE as a potential method for 
creating formulations for the co-delivery of multi-nutrients. A range of factors that could 
affect the EE process was studied, as listed below: 
1. Study the impact of oil, polymer, emulsifier types and their concentration on stability 
of emulsion and production of nanofibres (SEM and photographic study)  
2. Assess the impact of the type of electrospinning technique used to produce EE 
nanofibres (SEM) 
3. Assess droplet size and size distribution of emulsions (DLS and LD) 
4.2 Materials and methods 
4.2.1 Materials 
The materials used in this chapter are PEO 600K, PVP 90K, KIO3, TPGS, Tween 20, Span 80, 
sunflower, fish, flaxseed, squalene and olive oils. Their physicochemical properties are 
described in Chapter 2, sections 2.2, 2.2.1, 2.2.2, 2.2.4. 
Chapter 4 
130 
 
4.2.2 Methodology 
4.2.2.1 Emulsion preparation technique 
Emulsions were homogenized using HPDI, the technical characteristics of which are described 
in Chapter 2, section 2.3.2.1. 
4.2.2.2 Conventional emulsion electrospinning 
4.2.2.2.1 Emulsions prepared using Tween 20 and TPGS 
Emulsions were prepared using two types of continuous phases, namely PEO and PEO/PVP 
polymer solutions as a continuous phase, and three types of emulsifier compositions, namely 
Tween 20/TPGS, Tween 20 and TPGS. The oil phase was constituted only of sunflower oil. 
The description of the preparation is as follows: first, the emulsifiers and the polymer solution 
already studied in the previous chapter were dissolved in aqueous media to form a continuous 
phase for an o/w emulsion. Second, the dispersed phase constituted of sunflower oil was 
accurately measured and poured into a 50 ml vial. Then the continuous phase was poured 
into the oil phase and homogenized by means of HPDI at 11,400 rpm for 3 minutes, and 
immediately electrospun. The total concentrations of all excipients are given in Table 4.1. 
Two types of collectors, stationary and rotating (1,000 rpm), were used for EE. The EPPs are 
as follow: 200 mm – 0.2 ml/h – 20–30 kV. 
Table 4.1. Concentration of emulsions. 
Polymer 
solution type 
Emulsifier type Emulsifiers 
concentr.  
Continuous 
phase 
v/v % 
Dispersed 
phase 
v/v % 
Sample 
N 
 
5 and 7 w/v % 
of PEO 600K 
Tween 20 
TPGS 
3 v/v % 
5 w/v % 
62 30 4.1 
Tween 20 5 v/v % 65 30 4.2 
TPGS 3 w/v % 67 30 4.3 
5 w/v % (PEO 
600K/PVP 90K-
70/30 w/w %) 
Tween 20 
TPGS 
3 v/v % 
5 w/v % 
62 30 4.4 
Tween 20 5 v/v % 65 30 4.5 
TPGS 3 w/v % 67 30 4.6 
Chapter 4 
131 
 
4.2.2.2.2 Emulsions prepared using Span 80 and TPGS 
The polymer solution already studied in the previous chapter, i.e. 5 w/v % of PEO 600K 
solution, was prepared in aqueous media. This forms a continuous phase for o/w emulsion, 
which constitutes 75 v/v %. The dispersed phase is constituted of 20 v/v % of oils. Sunflower, 
fish, flaxseed, squalene and olive oils were used. Span 80 and TPGS were used as emulsifiers 
with the concentrations presented in Table 4.2. Span 80 was dissolved in an appropriate oil 
phase while TPGS was dissolved in cold water. Oil phase was added into the TPGS/PEO 
aqueous solution and homogenized by means of HPDI at 11,400 rpm for 3 minutes. The 
emulsions obtained were divided into three parts: one to be stored at fridge temperature, 
the other at room temperature for one week to check the stability of emulsions over time 
and a small quantity of the third part was analysed by DLS and LD immediately, with the 
remainder being electrospun immediately. The EPPs are as follow: 150 mm – 0.1 ml/h – 12–
20 kV. 
The HLB values for blended emulsifiers were calculated as follows: 
The wt. % of first emulsifier in the formulation · HLB value of first emulsifier = X1 
The wt. % of second emulsifier in the formulation · HLB value of second emulsifier = X2 
HLB of blend = X1 + X2 [398] 
Table 4.2. Emulsifier concentrations in the formulation and their calculated HLB values. 
Sample No. Emulsifiers blend Calculated 
HLB value Span 80 v/v TPGS w/v 
4.7 100 % ― 4.3 
4.8 87 % 13 % 5.5 
4.9 68 % 32 % 7.1 
4.10 48 % 52 % 8.9 
4.11 28 % 72 % 10.7 
4.12 6 % 94 % 12.7 
4.13 ― 100 % 13.2 
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4.2.2.3 Coaxial emulsion electrospinning 
4.2.2.3.1 Emulsions prepared using Tween 20/TPGS emulsifiers and PEO/KIO3 polymer 
solution 
For coaxial electrospinning, two types of solution were prepared. One is for the inner phase 
and the other for the outer phase. For the inner phase, o/w emulsion was prepared as 
described in section 4.2.2.2.1 for sample N4.1 in Table 4.1. The outer phase is composed of 
PEO 600K/KIO3 polymer solution with 5 w/v % total solution concentration and 98/2 w/w % 
of PEO/KIO3 concentration prepared in aqueous media. The EPPs for coaxial EE are as follows: 
200 mm – 0.1 ml/h (inner phase) and 0.2 ml/h (outer phase) – 20–30 kV. Two types of 
collectors were used: stationary and rotating (1,000 rpm). 
4.2.3 Characterization techniques 
The morphology of the emulsion electrospun films were visualized by means of SEM. 
Photographic study using a digital camera was carried out to assess the impact of oil, 
emulsifier types, storage conditions and HLB value on the stability of emulsions. DLS and LD 
analysis were used to determine the droplet size and size distribution of the emulsions. 
4.3 Results and discussion 
4.3.1 Feasibility study of emulsion electrospinning 
When we started the experiments, there was not any literature available on producing 
nanofibres by means of EE using liquid edible oils. Therefore, we did not know whether it was 
feasible or not, as the principle of electrospinning, including EE, is that the spinning solution 
must be conductive. However, there was only one report from Angeles et al. [126], and the 
authors electrospun o/w emulsion containing mineral oil and reported that emulsion drops 
deform and break up during electrospinning; thus even drop size in the order of tens of 
microns was electrospun, where the drop phase was incorporated into fibre. Thus, we 
anticipated that if mineral oil containing emulsion can be electrospun, we can also 
encapsulate edible oil into a conductive spinnable polymer solution, which will cover the oil 
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drops with a thin layer and will be capable of carrying oil droplets towards the collector if the 
oil drops are small enough to be light. In order to validate our assumption, a series of 
experiments was carried out, as described above in the methodology. The SEM images of all 
the EE samples carried out as the first step of the feasibility experiments are given in Figure 
4.1. 
 
Figure 4.1. The SEM images of emulsion electrospun films: the top three tetrads, i.e. (1–3) are 
made with 5 w/v % of PEO-600K polymer concentration, and the bottom three tetrads, i.e. 
(4-6) are made with 7 w/v % PEO-600K. Both sets emulsified as follows: with Tween 20 (1) 
and (4): a) conventional electrospinning – standing collector (the image of 4a is absent 
because the oil comes out for that sample and the SEM technique was unable to capture an 
image); b) conventional electrospinning – rotating collector; c) coaxial electrospinning – 
standing collector; d) coaxial electrospinning – rotating collector. (2) and (5) were emulsified 
with TPGS and the type of the electrospinning and the collector were used in the same order 
as listed above. (3) and (6) were emulsified with a mix of Tween 20 and TPGS and the type of 
the electrospinning and the collector were used in the same order as listed above. 
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4.3.1.1 The effect of PEO and PEO/PVP continuous phase composition on fibre 
formation 
The preliminary experiment results show an unstable emulsion formation, as the oil started 
to separate during electrospinning. Even so, the o/w emulsions were electrospun, and we 
were able to obtain a number of samples with a dry fibre mat, which releases oil when 
squeezed. From visual observation, all the firm, dry samples were created with emulsions 
prepared using PEO polymer solution as continuous phase. However, from the SEM images 
of the electrospun films, there were no apparent differences in fibre morphology of the 
samples prepared with 5 and 7 w/w % of PEO concentration (Figure 4.1). Whereas, all 
PEO/PVP polymer solutions used as continuous phase failed to encapsulate oil phase, as the 
oil comes out on the surface of the film and we could not take SEM images. 
The inspection of the electrospun films by the naked eye immediately after preparation did 
not reveal any apparent differences between the films prepared with 5 and 7 w/v % of PEO 
concentration. All the samples were dry and non-greasy. However, after 8 months it was seen 
that the majority of the samples prepared with 7 w/v % of PEO concentration were dry and 
without oil on the surface, almost twice the number of the dry samples that was with 5 w/v 
% concentration. The oil comes out for most of the electrospun films prepared using 5 w/v % 
of PEO concentration. These results suggested that the solution viscosity can affect the 
stability of the end product and the encapsulation of the oil phase. 
The preliminary experiments showed promising results and thus validate the feasibility of 
electrospinning o/w emulsions prepared using vegetable oil without hazardous organic 
solvents. However, many improvements were needed to achieve continuous production and 
core-sheath structured nanofibres. Therefore, the following changes in formulation were 
implemented in the next step. In spite of the fact that the 7 w/v % of PEO concentration had 
better stability, it requires a high DC voltage during electrospinning, more than 30kV to 
overcome the surface tension, which is an unsafe condition as our laboratory equipment is 
not suitable for conducting such experiments. Therefore, it was decided to decrease the oil 
content, i.e. by 20 v/v %, and use a polymer solution with a safe 5 w/v % PEO concentration 
which does not require high DC voltage. The results are described below in section 4.3.2. 
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4.3.1.2 The effect of emulsifier type on fibre formation: Tween 20 and TPGS  
The effect of emulsifiers at this stage was not clear, as the electrospun samples with Tween 
20 by itself, TPGS by itself and a mix of them both were dry and few of them became oily. This 
is due to the instability of o/w emulsions, as the oil in the syringe separated during 
electrospinning and thus the oil content was inconstant. Nevertheless, from the SEM images, 
the morphology of the mats of the samples containing Tween 20 shows sparse and thin fibres, 
whereas the morphology of the samples prepared using TPGS show a dense fibre-like net. The 
samples prepared with a mixture of both emulsifiers were somewhere in between, comprised 
of a fibre-like net and thin film (Figure 4.1). 
The results suggest that an improved methodology needs to be developed to obtain stable 
emulsion to see the emulsifiers’ effect and to produce reproducible core-sheath structured 
nanofibres. This was achieved by changing the emulsifier type, which is described in section 
4.3.2. 
4.3.1.3 The effect of conventional and coaxial emulsion electrospinning on fibre 
formation 
The SEM images show that the coaxial electrospun o/w emulsions show comparatively better 
fibre morphology than conventional electrospun emulsions (Figure 4.1). This might be due to 
the PEO/KIO3 solution from the outer needle that provides an extra layer to entrap the oil 
phase and facilitate fibre formation. However, in the next step in section 4.3.2., 
electrospinning was performed using conventional EE from the beginning to work out the 
best solution concentration and component ratio relative to each other. Later, if it is 
necessary, coaxial electrospinning can be utilized.  
4.3.1.4 The effect of the type of collectors: stationary and rotating drum 
The effect of the type of the collector was also inaccurate due to the process of oiling off of 
emulsions (the phase separation of oil from the emulsion) during electrospinning. Therefore, 
it was hard to interpret the results. In the next step, to minimize this complication, and during 
the feasibility studies carried out in this chapter, only the stationary collector was used. 
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4.3.2 Emulsion electrospinning using emulsions prepared using Span 80 and 
TPGS 
From the feasibility experiments with the emulsions prepared using Tween 20/TPGS, we could 
see that it was possible to electrospin emulsions; however, the stability issue led to the 
necessity to formulate emulsions using different emulsifiers. Emulsion stability, of duration 
longer than the Tween 20/TPGS formulation, was achieved by changing the emulsifier type, 
i.e. by replacing Tween 20 with Span 80 and reducing the amount of oil by 20 v/v %. Span 80 
has a low HLB value that can be used to obtain emulsions with a range of HLB values in a 
mixture with emulsifier that has a high HLB value and thus can select the most stable emulsion 
from the range of formulations. In addition, following our aim to formulate a delivery system 
suitable for the delivery of different poorly and highly water-soluble active ingredients, in 
addition to sunflower oil a number of other widely used oils were employed, such as flaxseed, 
fish, olive and squalene oils.  Span 80 helps to achieve the desired HLB value required for each 
oil type. TPGS was retained as it shows better fibre forming capability than Tween 20. In 
addition, using two emulsifiers always promotes better emulsion stability than when one is 
used alone [142]. The sections below discuss the stability of emulsions, prepared using Span 
80 and TPGS emulsifiers, assessed by photographic study and parameters affecting their 
stability. 
4.3.2.1 Stability test of emulsions analysed by photographic study 
Of the variety of analytical instruments available to characterize the composition, 
microstructure and physicochemical properties of emulsions, photographic study is one of 
the most straightforward, simple, cheap and quick approaches to provide information about 
the overall appearance of emulsions [142] and the experimental determination of 
gravitational separation. The principle of this method is to take photographs of an emulsion 
placed in a transparent test-tube over time using a digital camera. The images can be used as 
a record of the stability of the emulsion and/or can be used for further analysis using image 
analysis software by measuring the change in height of any boundaries formed between 
different layers [399, 400]. 
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Thus, a photographic study was carried out to study the stability of emulsions prepared with 
different emulsifier concentrations and stored at room and fridge temperature for one week 
to correlate emulsion stability with fibre formation. We measured the height of phase 
separated boundaries to estimate the stability of emulsions (Table 4.3) and revealed the 
impact of the emulsifier type and storage conditions, and the effect of the HLB value of 
emulsifiers in the formulation and oil type (Figures 4.2-4.6). 
Table 4.3. The height of boundaries of separated phases (measured using ImageJ software), 
which have occurred in samples N4.7, N4.12 and N4.13. Abbreviations: o-oil, w-water. 
Type of oil The height of boundaries of separated phases (mm) 
Sample N4.7 Sample N4.12 Sample N4.13 
Room T Fridge T Room T Fridge T Room T Fridge T 
Sunflower oil 4±0.23 5±0.53 13±0.21 10±0.27 46±0.43 6±0.39 
Flaxseed oil 3±0.28 3±0.56 7±0.26 8±0.16 28±0.59 7±0.28 
Olive oil 5±0.11 (o) 
3±0.08 (w) 
8±0.28 (o) 
2±0.39 (w) 
6±0.42 2±0.24 28±0.34 0 
Fish oil 3±0.21 3±0.35 5±0.54 3±0.08 22±0.45 4±0.23 
Squalene oil 20±0.46 (o) 0 32±0.33 20±0.44 59±0.24 35±0.5 
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Figure 4.2. Photographic study of emulsions prepared using different oils after one week: a) 
sunflower; b) flaxseed; c) olive; d) fish; e) squalene oils. The left picture is of the emulsions 
stored at room T and the right at fridge T. The numbers on the top of each sample are the 
numbers of the samples, which were prepared with different types of emulsifier 
concentrations (Table 4.2). 
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4.3.2.1.1 The impact of oil type  
Figure 4.2 shows the photography of emulsions prepared with different types of oils stored 
at room and fridge temperatures. Here, we will compare emulsions stored at room 
temperature. As can be seen, the type of oil used to prepare emulsions has an impact on the 
stability of o/w emulsions in only two samples. Thus, if we compare the emulsions of samples 
N4.8, N4.9, N4.10 and N4.11 that have the same emulsifier concentration but are 
differentiated by oil type, then we cannot see any apparent differences. However, sample 
N4.7 shows an apparent impact of oil type on the stability of emulsions. In the case of N4.7, 
squalene and olive oils have oiling off, whereas other samples with the same emulsifier 
concentration but with other types of oil show stability of emulsions. We anticipated that this 
might be due to oil viscosity, which has been reported to have an impact on droplet size 
distribution, and consequently on the stability of emulsions. For example, Wooster et al. [401] 
reported that the droplet size of nanoemulsions was affected by the viscosity of oil. High 
viscosity oil such as peanut oil has a larger D = 120 nm than nanoemulsions prepared with low 
viscosity oils such as hexadecane, with a D = 80 nm. Conversely, Bouchemal et al. [402] 
reported that they obtained the smallest droplet size with oils that have high viscosity (3,000-
4,500 mPa s at 20  ⁰C) and low viscosity (4.5-7.5 mPa s at 20 ⁰C), namely α-tocopherol (171 
nm±2) and hexyl laurate (310 nm±14), respectively. Pal et al. [403] also revealed that with the 
increase of emulsion viscosity, the droplet size decreases. Therefore, in order to understand 
the effect of oil viscosity on emulsion stability, we compare the viscosities of oils (Table 4.4) 
and their stability using a photographic study (Table 4.3, Figure 4.2). However, we did not 
conduct LD analysis for squalene and olive oils, and we cannot say with certainty how the 
viscosity affects the droplet size of these emulsions. Nevertheless, if we consider the work of 
Wooster et al. [401], K. Bouchemal et al. [402] and Pal et al. [403], from the photographic 
study we can assume that squalene and olive oils, which have the lowest and the highest 
viscosities of the oils presented in this study, respectively, may probably have larger droplet 
sizes in sample N4.7, which favours oil droplets coalescence faster compared to emulsions 
with smaller droplet sizes. 
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Table 4.4. The viscosities of oils, taken from [182]. 
Oil type Sunflower Flaxseed Olive Fish Squalene 
Viscosity in cSt 
(at 20° C±2) 
47.4 51.2 84.0 42.0 15.9 
Samples N4.12 and N4.13 show a creaming, aqueous phase was separated at the bottom of 
the tube, irrespective of the oil type used in the formulation; however, there were differences 
in the creaming rate depending on oil type (Figures 4.2, Table 2). Therefore, we speculated 
that oil type has a small effect on the stability of emulsions prepared in this study. Additional 
analysis needs to be carried out to confirm the possible influence of oil type on emulsion 
stability for a given formulation, such as droplet size distribution by means of LD and longer 
storage for at least one month, to reveal the differences in stability in samples N4.8, N4.9, 
N4.10 and N4.11. 
4.3.2.1.2 The impact of emulsifier type 
The effect of emulsifier type is significant with samples N4.12 and N4.13 because creaming 
has occurred in those samples irrespective of oil type, as already discussed in the previous 
subsection. This suggests that in sample N4.13, possibly the TPGS emulsifier alone cannot 
provide stability of emulsions with the given emulsion composition in this study and/or with 
the given concentration. If the concentration of the emulsifier is not sufficient enough, oil 
droplets may not be fully covered by the emulsifier during droplet break up and therefore 
emulsifier depletion will occur in the oil-water phase causing droplet creaming [142]. Sample 
N4.12 shows a slower creaming rate, assessed from the height of the aqueous phase, 
compared to the pure TPGS emulsion (Table 4.2, Figures 4.2). This may be due to the Span 
80, which could have completed to some extent the emulsifier depleted surface and thus 
formed a more stable emulsion. Similarly, in samples prepared using squalene and olive oils, 
oiling off has occurred with the emulsion prepared with Span 80 alone. However, other 
samples with the same amount of emulsifier concentration but with different oils show 
stability of emulsions. Therefore, we anticipated that this issue might be due to oil viscosity, 
as mentioned in section 4.3.2.1.1. 
Generally, emulsions prepared with a combination of emulsifiers possess better stability than 
emulsions prepared with only one type of emulsifier [142]. This is probably why samples N4.8, 
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N4.9, N4.10 and N4.11 demonstrated better stability in all types of oil used to prepare 
emulsions, compared to emulsions prepared with only one type of emulsifier.  
4.3.2.1.3 The impact of the HLB value of emulsifiers in the formulation 
Stable emulsions are formed when the HLB values of emulsifiers or the combination of 
emulsifiers are close to the required HLB value of the oil phase [404]. Therefore, we compared 
the stability of emulsions and the emulsifiers’ HLB values in the formulation (Table 4.2) with 
the required HLB value of the oils.  
Sunflower and olive oil require a similar HLB value of 7±1; however, the stability assessment 
shows some differences in the stability of emulsions. Thus both samples, according to the 
literature [404], should have stable emulsions in samples in which the emulsifiers’ HLB values 
are close to 7, i.e. from 5 to 9. This is supported by the case of the emulsion containing olive 
oil, in which oiling off and creaming has occurred with samples that have low and high HLB 
values, i.e. 4.3 (N4.7) and 12.7–13.2 (N4.11-4.13), respectively. However, in emulsion 
containing sunflower oil, creaming has occurred only for samples that have high HLB values 
as in the samples N4.12 and N4.13, but the sample with a low emulsifiers’ HLB value showed 
good stability and no phase separation. As for flaxseed oil, which has a low HLB value 
requirement of oil (3.23±1), good stability should be demonstrated by samples that have low 
emulsifiers’ HLB value. However, no distinguishing changes in stability were observed. As in 
the case with sunflower and olive oils, it shows poor stability with samples that have a high 
emulsifiers’ HLB value, i.e. N4.12 and N4.13, but others were stable. The required HLB values 
of fish and squalene oil were not found in the literature, and determining these values was 
not within the scope of this study. Nevertheless, we can report that emulsions prepared using 
fish and squalene oils also have creaming with samples N4.12 and N4.13. However, Yuan et 
al. [405] have shown that high HLB value emulsifiers facilitate stability of o/w emulsions 
because of their emulsifier type, i.e. their HLB value affects the particle sizes of the emulsion. 
According to Yuan et al.’s results, emulsion prepared using Tween 20 has the smallest particle 
size (173 nm±2.07) and emulsion prepared using Tween 40 has the largest particle size (184 
nm±4.9). The study explained that emulsifiers with a greater hydrophilicity could stabilize the 
particles in o/w emulsion more efficiently and therefore produce smaller particles. Tween 20 
has a higher HLB value (16.7) than Tween 40 (HLB = 16.5). In this study, the most stable 
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emulsions of all five type of oils used in the emulsion preparation were for samples N4.8, 
N4.9, N4.10, N4.11 that have moderate HLB values ranging from 5.5 to 10.7. These results 
suggest that the emulsifiers or the combination of emulsifiers’ HLB values that are close to 
the required HLB value of the oil phase have little impact on emulsion stability for these 
formulations. This conclusion is based on the example of olive and sunflower oils, which have 
instable and stable emulsions at low emulsifier HLB values respectively. As discussed above 
in section 4.3.2.1.1, other parameters such as oil viscosity may also play a role. 
4.3.2.1.4 The impact of storage conditions 
The storage conditions have an impact on emulsion stability depending on the composition 
formulation. Emulsions prepared using sunflower, flaxseed, olive, fish and squalene oils 
resulted in aqueous phase separation in samples N4.12 and N4.13 after one week of storage 
at room temperature. However, this phase separation was not significant for emulsions 
stored at fridge temperature (Figures 4.2, Table 4.2). In addition, the apparent impact of 
storage conditions was seen for the sample prepared using squalene oil, sample N4.7. The oil 
phase separation was clearly seen for the sample stored at room temperature, while the 
sample stored at fridge temperature had a more stable appearance. Conversely, for 
emulsions prepared using olive oil, the phase separation of oil phase was observed also for 
sample N4.7; however, separation was seen with the samples stored at both room and fridge 
temperatures. Other than that, the stability results for squalene and olive oils were the same 
as for sunflower, flaxseed and fish oils. 
4.3.2.2 Particle size analysis 
4.3.2.2.1 Particle size analysis of emulsions using DLS  
The DLS technique was used in order to determine particle size distribution in the emulsion 
and the physical stability of emulsions, because we expected to have particle sizes below 10 
µm. The physical stability of emulsions was estimated by measuring emulsion droplet size as 
a function of time. Three formulation parameters and two storage conditions were studied 
to see the impact on particle size distribution and the stability of the finished product. These 
parameters were oil and emulsifier type, room and fridge temperature storage for 1 week, 
and the HLB value of emulsifiers. However, the results were not informative, as the particle 
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size distribution of o/w emulsions show random size distribution for all samples, namely from 
0.1 µm to 9 µm (Table 4.5), thus it was difficult to assess the impact of the parameters listed 
above on droplet size distribution. This is due to the DLS technique droplet size measurement 
limitations, namely up to 10 µm, and it was reported that particles larger than 3 μm may 
distort the measurements and therefore, additional corroboration with laser diffraction (LD) 
or a laser scattering technique is recommended [350]. Thus, we conducted particle size 
analysis using the LD technique, in the next section, to check whether there are larger 
droplets.
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Table 4.5. Approximate droplet size distribution of emulsion prepared using different type of oils and emulsifiers measured immediately after 
preparation and after one week, stored at room and fridge temperatures. N=3. 
Oil 
type 
Storage 
conditions 
Particle size distribution (µm)-Span 80 v/v % – TPGS w/v % 
100 87–13 68–32 48–52 28–72 6–94 100 
Su
n
fl
o
w
er
 o
il 
1st day >1<10 
unimodal 
- ≥1<10 
unimodal 
>1<10 
unimodal 
>1<10 
unimodal 
>1<10 
unimodal 
>1<10 
bimodal 
After 7 days-
room T 
≥1<10 
bimodal 
>0.1<10 
bimodal 
>0.1<10 
bimodal 
>0.1<10 
bimodal 
>0.1<10 
bimodal 
>1<10 
unimodal 
>1<10 
unimodal 
After 7 days-
fridge T 
>1<10 
unimodal 
>0.1<10 
bimodal 
≥0.1<10 
bimodal 
>0.1<10 
bimodal 
>1<10 
unimodal 
>0.1≤1<10 
bimodal 
>1<10 
bimodal 
 
Fl
ax
se
ed
 o
il 
1st day >1<10 
unimodal 
>1<10 
unimodal 
>1<10 
unimodal 
>1<10 
unimodal 
≥1<10 
bimodal 
>1<10 
bimodal 
>1<10 
bimodal 
After 7 days-
room T 
>1<10 
unimodal 
>0.1<10 
bimodal 
>0.1<10 
bimodal 
>1<10 
unimodal 
>1<10 
unimodal 
>1<10 
unimodal 
>1<10 
unimodal 
After 7 days-
fridge T 
>1<10 
unimodal 
≥0.1<10 
bimodal 
≥0.1<10 
bimodal 
>1<10 
unimodal 
≥1<10 
unimodal 
>1<10 
unimodal 
>1<10 
unimodal 
 
O
liv
e 
o
il 
1st day >1<10 
bimodal 
>0.1<10 
bimodal 
≥0.1<10 
bimodal 
>0.1<10 
unimodal 
>1<10 
unimodal 
≥0.1<10 
trimodal 
≥0.1<10 
trimodal 
After 7 days-
room T 
>1<10 
unimodal 
>1<10 
unimodal 
>0.1<10 
bimodal 
>1<10 
unimodal 
>0.1<10 
bimodal 
>1<10 
unimodal 
>1<10 
unimodal 
After 7 days-
fridge T 
- ≥0.1<10 
bimodal 
>1<10 
unimodal 
≥0.1<10 
bimodal 
≥0.1<1<10 
trimodal 
≥0.1≤1<10 
trimodal 
- 
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(Continuous) 
Oil 
type 
Storage 
conditions 
Particle size distribution (µm)-Span 80 v/v % – TPGS w/v % 
100 87–13 68–32 48–52 28–72 6–94 100 
Fi
sh
 o
il 
1st day >1<10 
unimodal 
>1<10 
unimodal 
>0.1<1<10 
bimodal 
≥0.1<10 
bimodal 
>1<10 
unimodal 
≥0.1<10 
bimodal 
>0.1<1<10 
unimodal 
After 7 days-
room T 
>1<10 
unimodal 
≥1<10 
unimodal 
≥0.1<10 
bimodal 
≥0.1<10 
bimodal 
>1<10 
unimodal 
>1<10 
unimodal 
>0.1<1<10 
bimodal 
After 7 days-
fridge T 
>1<10 
unimodal 
>1<10 
unimodal 
>1<10 
unimodal 
>1<10 
unimodal 
>1<10 
unimodal 
>1<10 
unimodal 
>1<10 
bimodal 
 
Sq
u
al
en
e 
o
il 
1st day >1<10 
unimodal 
- ≥0.1=1<10 
trimodal 
≤0.1<1<10 
bimodal 
>1<10 
bimodal 
≥1<10 
bimodal 
≥1<10 
bimodal 
After 7 days-
room T 
- - ≥0.1<10 
trimodal 
≥0.1<10 
bimodal 
- >1<10 
unimodal 
>1<10 
unimodal 
After 7 days-
fridge T 
- - - - - - >1<10 
unimodal 
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4.3.2.2.2 Particle size analysis of emulsions prepared using sunflower oil by LD 
LD analysis was conducted only for emulsions prepared using sunflower oil. Figure 4.3 shows 
the results of the volume density distribution of emulsions as bimodal size distribution. As we 
assumed, the result of LD analysis shows that the emulsions have a droplet size larger than 
10 µm (Table 4.6). However, there was no correlation between the droplet size distribution 
and the emulsifiers’ HLB values. The droplet size distribution of all emulsions prepared using 
two types of emulsifiers show random results, i.e. the result was not correlated to the HLB 
value. The emulsions with the lowest HLB value of 4.3 and a high HLB value of 12.7 resulted 
in comparatively small particle size distribution. At the same time, emulsions that have a 
comparatively lower HLB value of 5.5 and the highest HLB value of 13.2 resulted in 
comparatively large droplet size distribution. The emulsions having moderate HLB values (7.1, 
8.9 and 10.7) have comparatively moderate particle size distribution. Whereas the 
photographic study shows that emulsions with low and moderate particle size distribution 
have good stability in comparison with high HLB values. In addition, bimodal size distribution 
is attributed to the dominance of coalescence instability of emulsion droplets [145, 406].  
 
Figure 4.3. Volume density distribution of emulsion particle size prepared with HPDI. X-axis is 
plotted on log scale. q3* – density distribution by volume. 
 
Chapter 4 
147 
 
Table 4.6. Droplet size distribution of emulsion prepared using sunflower oil immediately 
after preparation. Emulsifier ratio and their calculated HLB values. N=3. 
Sample 
No. 
Emulsifier blend D10 (µm) D50 (µm) D90 (µm) Calculated 
HLB values Span 80 
v/v % 
TPGS 
w/v % 
4.7 100 ― 1.17±0 5.42±0 10±0.026 4.3 
4.8 87 13 1.82±0.02 12.24±0.29 42.2±0.6 5.5 
4.9 68 32 1.43±0.018 7.31±0.21 21.47±1.02 7.1 
4.10 48 52 1.25±0 4.59±0.02 13.8±0.19 8.9 
4.11 28 72 1.44±0.005 5.02±0.036 14.23±0.07 10.7 
4.12 6 94 1.28±0 4.75±0.015 12.28±0.09 12.7 
4.13 ― 100 1.85±0.025 13.66±0.425 35.85±2.35 13.2 
4.3.2.3 Morphology of the emulsion electrospun films 
When Span 80 was used, the effects of emulsifiers on fibre formation were distinguishable. 
Thus, from the SEM images (Figures 4.4-4.8), it is evident how the morphology of films 
changed, insensible to the human eye, from the thin film to a more fibrous composite in direct 
proportion to TPGS content. When electrospun films were examined by the naked eye, the 
samples emulsified with 100 v/v % of Span 80 were producing subtle and fine films, whereas 
film electrospun from emulsion prepared using 100 w/v % of TPGS showed a firm, fibre-net 
texture. In addition, from the SEM images, better fibre morphology appeared for samples 
with 94 and 72 w/v % of TPGS, i.e. where there was a higher content of TPGS. This confirms 
the advantage of TPGS in producing nanofibres. As for oil type, fibres from emulsions 
prepared using squalene oil produced separate and uniform fibres (Figure 4.8); however, the 
emulsion’s stability was poorer than in emulsions containing sunflower and fish oils (Figure 
4.2, Table 2). Flaxseed oil containing emulsion failed to produce fibres, as the oil comes out 
on the surface of the film, although these emulsions had shown good stability. Therefore, we 
could obtain SEM images of only two samples (Figure 4.5). The samples with fish, sunflower, 
and olive oils showed dry and firm films, yet the fibre morphology from the SEM images are 
not as nice as the fibres from squalene emulsions. However, olive oil containing emulsions 
show poorer stability than sunflower and fish oils containing emulsions. Samples N4.8, N4.9, 
N4.10 and N4.11 demonstrate better emulsion stability compared to samples N4.7, N4.12 and 
N4.13. However, from the SEM images and from inspection of the electrospun films by the 
naked eye, the better morphology appears in samples N4.11, N4.12, N4.13. The results show 
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that the stability of emulsions is not the key parameter that determines the spinnability of 
emulsions. However, the stability of emulsion is crucial for quality control of a delivery system 
during manufacturing. The type of oil and emulsifier demonstrated an impact on fibre 
formation; however, we cannot indicate what physicochemical properties of oil affect the 
fibre formation as there is no correlation with the viscosity of the oil. Flaxseed oil has 
moderate viscosity, as do sunflower and fish oils; however, it failed to form dry and firm films.   
It would be very interesting to study the parameters that affect fibre formation and design a 
more stable emulsion. However, we discontinued this project because we discussed the 
results and came to the conclusion that emulsion electrospinning is a fascinating method to 
prepare ultrathin fibres capable of delivering both poorly and highly water-soluble active 
ingredients. Nevertheless, emulsion electrospun fibres encapsulate a low amount of oil, and 
are therefore an insufficient method to encapsulate large doses of oil-soluble vitamins and 
poorly water-soluble drugs. Therefore, we decided to focus our attention towards SOS, which 
was described by Patel et al. [147] as a system capable of holding enormously large amounts 
of oil. The results are described in the next chapter. 
 
Figure 4.4. SEM images of o/w emulsion electrospun films with sunflower oil. 
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Figure 4.5. SEM images of o/w emulsion electrospun films with flaxseed oil. 
 
Figure 4.6. SEM images of o/w emulsion electrospun films with olive oil. 
 
Figure 4.7. SEM images of o/w emulsion electrospun films with fish oil. 
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Figure 4.8. SEM images of o/w emulsion electrospun films with squalene oil. 
4.4 Conclusion 
A potential delivery system for poorly and highly water-soluble active ingredients has been 
developed by means of conventional EE. O/W emulsions were successfully electrospun 
without the use of organic solvents. Four different functional components can be 
encapsulated in this formulation: Iodine, Vitamin E, vegetable oils and fish oil. TPGS was 
proven as a good emulsifier for protecting the oil phase from leaking, which could often result 
in the greasiness of the film. In addition, TPGS can be used as a source of vitamin E and an 
enhancer of the bioavailability of many drugs and nutrients [48-50]. Thin films, possibly core-
sheath structured nanofibres or oil drops incorporated in fibres, were opaque and matted, 
free of oil on the surface for up to 8 months and demonstrating a good encapsulation of liquid 
oil. However, the drawback of this delivery system is that it can only encapsulate a very limited 
amount of liquid oil, which is often insufficient for the doses required. Therefore, in the next 
chapter we investigate the development of another delivery system, the structured oil system 
(SOS), which can hold a significantly larger amount of oil. 
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5 Chapter 5. Structured oil as a platform for the delivery of water-
soluble and oil-soluble drugs 
5.1 Introduction 
In conventional nutritional and medical products, soft capsule gels are most often used to 
deliver large doses of oil. However, the stability of the soft gel capsules is often a concern. 
The most effective way to maintain the stability of the capsule shells is to individually pack 
the capsules in blister packs using highly impermeable packaging materials (used for medical 
products). However such packaging is more costly and most of the soft gel capsule nutrient 
supplements are often packed in plastic bottles. Tackiness of the shell due to the absorption 
of moisture is one of the most common issues with such products. In this project, we are 
aiming to develop a new type of formulation to deliver a high dose of oil in a soild form. A 
solid structured oil system, which can hold a large amount of oil, has been designed to use as 
a carrier to deliver water-soluble (solubilized and contained in a polymeric scaffold) and oil-
soluble drugs or nutrients (solubilized in the liquid oil and immobolised by a polymeric 
scaffold). As discussed in detail in Chapter 1, structured oils, also known as oleogels, are 
formed by removing the water from a dense emulsion which is often stablised by a blend of 
polymers/surfactants. In this chapter, we utilized the combination of protein and 
polysaccharide that has been used widely in the food and pharmaceutical industry to form 
the stable emulsions. The emulsions were then dehydrated by using either a thermal or freeze 
drying process. Similar structured oil formulations have been developed by food scientists 
and are primarily used as a shortening agent [147, 285, 286]. These works inspired us to adopt 
such structures and apply them in the pharmaceutical area for drug and nutrient delivery. In 
this chapter we also investigated the impact of the formulation and processing parameters 
on the formation, stability and properties of SOSs, the oil holding capacities of the 
formulations and their drug release behaviour using a model drug. 
Gelatine (G) and xanthan gum (X) were utilized in this study to create the SOS because they 
are GRAS and biodegradable excipients. They have been widely used as emulsifying agents 
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and viscosity modifiers in pharmaceutical and food products. Gelatine, being surface active, 
adsorbs at the oil-water interface and Xanthan gum is non-surface active and forms an 
interfacial complex with gelatine. Sunflower oil was used as the model oil phase. In addition, 
HPMC, MC, Tween 20 and CMC were also used to replace either gelatine or Xanthan to 
explore other mechanisms of the formation of SOSs. Metoprolol succinate, used for treating 
high blood pressure, was used as a model of a highly water-soluble drug, and ketoconazole 
and coumarin were used as the oil-soluble model compounds to evaluate the drug 
encapsulation and dissolution behaviour of SOS formulations. 
5.2 Materials and methods 
5.2.1 Materials 
Gelatine, xanthan gum, HPMC, MC, CMC, Tween 20, sunflower oil, ketoconazole, metoprolol 
succinate and coumarin 6. The physicochemical properties of the materials used are 
described in sections 2.2, 2.2.2, 2.2.3, 2.2.4. 
5.2.2 Methodology 
5.2.2.1 Emulsions prepared using HPDI 
Emulsion prepared using pure G. G in 1.6 w/v % concentration was dissolved in a warm 
aqueous solution and was then mixed with the oil phase with the help of HPDI at ≈11,400 
rpm for 5 minutes. The oil ratio to aqueous phase was 30/70 v/v %. 
Emulsion prepared using pure X. Emulsion containing pure X as an emulsifier was prepared as 
described above for G, except, X was dissolved in cold water. 
Emulsion prepared using G and X. G and X were separately dissolved in water to make G and 
X aqueous solutions. The concentration of G and X in all analysis was 1.6 and 0.6 w/v %, 
respectively, except, when the effect of protein to polysaccharide ratio on SOS formation was 
studied where three concentration variations were employed (Table 5.1). The two solutions 
were mixed in a 50/50 v/v % concentration and were used as the aqueous phase of the 
emulsion formulations. For the emulsions, the aqueous and oil phases were mixed in a 70/30 
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v/v % concentration. When the effect of oil volume fraction was studied, emulsions were 
prepared with an oil phase comprising 20, 30, 40 and 60 v/v % of the system. Sunflower oil, 
which was used as an oil phase, was dispersed in the aqueous polymer solution and mixed 
vigorously using HPDI at ≈ 11,400 rpm for 5 minutes, except when the effect of HPDI 
processing parameters were being studied, when the folowing parameters were used: 11,400 
and 14,000 rpm, 5 and 9 minute durations.  
Table 5.1. Concentration of G and X used in the preparation of emulsions when the effect of 
protein-polysaccharide concentration on SOS formation was studied.   
Gelatine w/v % Xanthan gum w/v % 
1.2 0.6 
2.3 0.9 
0.6 1.2 
Emulsion prepared using different emulsifiers. Emulsions were prepared as described in 
section 5.2.2.1 for the emulsion prepared using G and X. The following emulsifier 
compositions were used: HPMC and X, MC and X, Tween 20 and X, G and CMC. The 
concentration of the compositions was the same as for G and X. When G was replaced with 
another emulsifier, that emulsifier would be used in the same concentration as G, i.e. 1.6 w/v 
%, and when X was replaced with another emulsifier, that emulsifier would be used in the 
same concentration as X, i.e. 0.6 w/v %. 
Freeze-dried G/X mixture without oil. Freeze-dried G/X mixture without oil was prepared to 
compare with G/X SOS containing oil. G and X with a concentration of 1.6 w/v % and 0.6 w/v 
% was prepared in aqueous media and homogenized using HPDI at ≈ 11,400 rpm for 5 
minutes, then immediately freeze dried. 
All experiments were performed in triplicate (n=3). 
5.2.2.2 Emulsions prepared using HPH 
Emulsion was prepared as described in section 5.2.2.1, and the G and X concentrations were 
1.6 and 0.6 w/v %, respectively. After homogenization using HPDI, the primary emulsion 
obtained was subjected to HPH homogenization to obtain a secondary emulsion. The inlet 
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pressure of the HPH homogenizer was oscillating from 6,000 to 12,000 psi and for analysis we 
used samples that pass only once, except, when the effect of cycling duration of HPH on 
emulsion stability was studied, when the duration of cycling was for 3, 5 and 7 minutes. All 
experiments were performed in triplicate (n=3). 
5.2.2.3 Producing structured oil systems 
5.2.2.3.1 Freeze drying 
All emulsions prepared in sections 5.2.2.1 and 5.2.2.2 were subjected to lyophilization by 
means of a freeze dryer. The emulsions were first frozen at -23 °C overnight and then freeze 
dried under vacuum for 24 hours to obtain solid SOS at -20 °C. 
5.2.2.3.2 Oven drying 
Emulsion prepared using G and X with concentrations of 1.6 and 0.6 w/v % was subjected to 
lyophilization by means of an oven. The experiments were conducted at 70–80 °C for 24 hours 
using a Carbolite Natural Convection Laboratory Oven – PN 60, with a temperature range of 
30–300 °C. The experiments were performed in triplicate (n=3). 
5.2.2.4 Oil holding capacity under compression 
The measurements were carried out using the compression test mode of a texture analyser. 
The sample was placed on a flat aluminium stage and compressed by a 30,000 gram load disk 
with d 25mm. The movement speed was 0.5mm/sec. The stiffness of 5 samples was high 
enough for that given load, therefore the samples were then kept at a maximum compressed 
point for 30 seconds to observe the resistance of the specimen to the force. Cellulose filter 
paper was placed on the flat aluminium stage of the texture analyser under the SOS. The 
amount of oil released during compression was assessed quantitatively from the weight 
difference between the oil soaked filter paper and the dry filter paper, by weighing the 
cellulose filter paper before compression of the SOS and after compression of the SOS when 
the filter paper is soaked with the released oil. 
Chapter 5 
155 
 
5.2.3 Characterization techniques 
In this chapter, SOS for the delivery of water-soluble and oil-soluble drugs or nutrients were 
characterized using a range of techniques. An upright fluorescence microscope was mainly 
used to image the o/w emulsions. Brightfield images were substituted in some instances 
where the quality of the fluorescent images was poor and where validation of the o/w 
emulsion nature was not needed. CLSM images were also taken as the CLSM has higher 
resolution and better contrast [407]. Emulsions’ particle size and stability were determined 
by means of an LD technique. The internal structure of the SOS and distribution of oil within 
the SOS were examined under fluorescence stereo microscopes, Cryo-SEM, TEM and XμCT. 
ATR FT-IR was used to identify any protein-polysaccharide interaction in the sample of G/X 
SOS. The thermal degradations of raw materials and placebo G/X, HPMC/X, MC/X, G/CMC 
SOSs prepared using HPDI and stored at room, 40 ⁰C and 75% RH were analysed by TGA. DSC 
estimates the thermal transitions of raw materials, freeze-dried G/X mixture without oil, 
placebo G/X SOS and G/X SOS loaded with APIs (ketoconazole and metoprolol succinate). A 
texture analyser was utilized to assess the mechanical properties of G/X, HPMC/X, MC/X, 
G/CMC SOS and their oil holding capacity under compression. Dissolution testing was 
conducted to study the dissolution profile of water-soluble API from G/X SOS prepared using 
two different homogenizing instruments: HPDI and HPH. 
5.3 Results and discussion 
5.3.1 Emulsion formation development 
A number of studies have shown that protein-polysaccharide complexes have better 
emulsifying properties than when they are used by themselves. Selecting the right protein-
polysaccharide ratio is important to produce a small emulsion droplet size with good stability 
to environmental changes. Normally, proteins tend to form smaller emulsion droplets at 
lower concentration than polysaccharides, and polysaccharides are better at producing 
emulsions with higher stability in a range of environmental conditions such as temperature, 
pH, and ionic strength [142]. However, Sun et al. [408] found that when increasing the protein 
concentration, smaller droplet sizes were produced. Similarly, Patel et al. [147] showed that 
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a variation in xanthan concentration does not change the droplet size of emulsions 
significantly; however, the droplet sizes were reduced when gelatine concentration is 
increased. In addition, emulsions prepared with a higher gelatine concentration show an 
increase in the values of elastic modules, G’ and yield force (hardness) of emulsions, 
suggesting a stronger polymer network formation at the oil-water interface. It was found that 
1.6 and 0.6 w/v % of G and X concentration was the best concentration to produce the 
strongest gel hardness. Therefore, all emulsion characterizations were conducted for samples 
prepared in 1.6 w/v % of G and 0.6 w/v % of X, except when the effect of protein to 
polysaccharide ratio on SOS formation was studied, where three concentration variations 
were employed (Table 1). 
5.3.1.1 The effect of processing parameters: HPDI and HPH 
The preparation processing parameters of emulsions may affect emulsion formation, and the 
nature of emulsions, i.e. o/w emulsion or w/o emulsion and droplet size. The fluorescent 
images of emulsions prepared using G/X as emulsifiers show the formation of o/w emulsions 
(Figure 5.1). The morphology of the obtained o/w emulsions shows discrete oil droplets with 
a heterogeneous size distribution. However, on inspection of fluorescent images using the 
naked eye, the impact of duration and speed of homogenizing of HPDI on emulsion droplet 
size were indiscernible. As shown in Figures 5.1a and 5.1b, the variation in duration of 
dispersing of emulsion resulted in nearly the same size distribution and increase in the speed 
of homogenizing, while keeping the duration constant (Figure 5.1c) does not change the 
droplet size dramatically. However, when droplet size measurements were conducted using 
ImageJ analysis software, the impact of the processing parameters was significant. The results 
show a decrease in the particle size distribution substantially with the increase of the duration 
and the speed of homogenization (Figure 5.2). The largest droplet size of an emulsion 
prepared using HPDI at 11,400 rpm for 5 minutes ranged from 120 μm to 130 μm, whereas 
for emulsion prepared using HPDI at 11,400 rpm for 9 minutes and emulsion prepared using 
HPDI at 14,000 rpm for 5 minutes ranged from 60 μm to 70 μm. In addition, emulsion 
prepared using HPDI at 14,000 rpm for 5 minutes has a higher frequency of small droplets 
below 10 μm compared to an emulsion prepared using HPDI at 11,400 rpm for 9 minutes. 
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These results confirm the well-known fact that a higher energy input or longer 
homogenization time results in a smaller droplet size [142]. 
 
Figure 5.1. Fluorescent images taken with an upright microscope of o/w emulsions prepared 
at two different durations and speeds of homogenizing using HPDI: a) duration is 5 minutes 
and the speed is 11,400 rpm; b) duration is 9 minutes and the speed is 11,400 rpm; c) duration 
is 5 minutes and the speed is 14,000 rpm; d) confocal image of emulsion prepared at 11,400 
rpm for 5 minutes. 
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Figure 5.2. Particle size distribution of emulsion prepared using different processing 
parameters of HPDI measured by ImageJ software. 
The size of droplets that emulsions contain determine the shelf life, appearance, texture, 
release characteristics, flavour profile and bilogocial fate [142]. The processing operation of 
emulsification affects the emulsion droplet size and stability. Emulsion preparation can 
involve two steps of emulsification. The first is primary homogenization, which leads to the 
formation of emulsion from two immiscible phases mixing at high speed, and the second is 
secondary homogenization, which causes the further reduction of emulsion droplet size in an 
existing emulsion. Emulsions prepared with two steps of emulsification benefit from a 
substantial impact in terms of emulsion droplet size and stability. Therefore, an emulsion 
prepared in two steps of emulsification, where HPDI and HPH as a secondary homogenizer 
were used, was compared with an emulsion prepared in one step, where HPDI was used, in 
order to observe the impact on emulsion formation and droplet size, and to see the impact 
of two homogenizing instruments. As can be seen in Figure 5.3, emulsions prepared using 
HPDI have more big droplet sizes and are more homogeneous, while emulsions prepared 
using HPH have a heterogeneous distribution with many small droplets and some big droplets. 
Both samples show the o/w emulsion formation under fluorescence microscope.  
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Figure 5.3. Fluorescent images taken with an upright microscope of o/w emulsions prepared 
with two different homogenizing instruments: a) HPDI and b) HPH (1 pass). 
From the fluorescent images of emulsions prepared using different emulsification processing 
parameters, it can be seen that HPDI, in comparison with emulsions prepared using an HPH 
instrument, results in substantial changes in particle sizes. Therefore, in order to obtain a 
more precise estimation, an LD technique was used to determine the particle size distribution 
of emulsion prepared in one step using HPDI and compared with emulsion prepared in two 
steps where HPDI was used with HPH as a secondary homogenizer (Figure 5.4). The 
cumulative size distribution of emulsion prepared using HPDI and HPH is presented in Table 
5.2. Emulsion prepared using HPH has a much smaller size distribution in comparison with 
emulsion prepared using HPDI. 
 
Figure 5.4. Volume density distribution of emulsion prepared with HPDI and HPH. q3* – 
density distribution by volume. 
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Table 5.2. Emulsion droplet size distribution and the span value of HPDI and HPH prepared 
placebo samples immediately after preparation. N = 3. 
Placebo G/X emulsion D10 (µm) D50 (µm) D90 (µm) Span value 
HPDI 6 ±1.25 27 ±2.54 49 ±6.23 1.6 
HPH 1.02 ±0.02 2.6 ±0.05 10 ±0.47 3.5 
The mean droplet size distribution was expressed as a span of distribution as described in the 
British Standards. A small span value (span index <0.7) indicates a narrow particle size 
distribution, whereas a big span value indicates a broad particle size distributuion [409]. Both 
the emulsions prepared using HPDI and HPH show a broad particle size distribution, with span 
indexes of 1.6 and 3.5, respectively (Table 5.2). However, the width of the size distribution of 
the HPDI prepared emulsion was lower than the HPH prepared emulsion. The broad droplet 
size distribution of the emulsion prepared using HPH was possibly because the analysis was 
designed for the sample which has passed through HPH only once in order to save time. The 
number of homogenization cycles has a great impact on particle size distribution, as usually 
two or three passes gives narrower particle size distribution [409]. 
5.3.1.1.1 Stability of emulsions prepared using HPH 
The stability test of emulsions prepared using HPH was performed using a photographic study. 
Different cycling durations, namely 3, 5 and 7 minutes of 10 ml emulsion, were studied after 
5 days (Figure 5.5). The most stable emulsion was the emulsion prepared with 7 minute 
cycling, as after 5 days there was no sign of any phase separation or oiling off. In contrast, 
emulsions prepared with 5 and 3 minute cycling showed oiling off, and small droplets of oil 
and mould can be seen on the surface. This is one of the most common forms of instability in 
emulsions called gravitational separation. Oil droplets have a lower density than the 
surrounding liquid, so a net gravitational force acts upon them; therefore, low density oils 
have a tendency to move upward [142]. This stability test has a good correlation with the 
density distribution of the emulsions prepared with HPH, which has a bimodal size 
distribution. Normally, gravitational separation causes droplets to have a close contact with 
each other for extended periods, which leads to enhanced coalescence and at the end to 
oiling off [142]. 
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Figure 5.5. Stability test of emulsion prepared using HPH: a) 7 minute cycling; b) 5 minute 
cycling; c) 3 minute cycling after 5 days. 
5.3.1.2 The effect of oil volume fraction 
It is well known that emulsion formation and stability are also influenced by oil to water ratio, 
i.e. by the concentration of droplets in an emulsion [410]. This also determines the cost, 
appearance, texture, flavour, and nutritional attributes [142]. The same influence can extend 
to the formation of SOS too and this is discussed in section 5.3.2.3. Therefore, emulsions were 
prepared with a range of oil volume fractions, i.e. 10, 30, 40, and 60 v/v %, while keeping 
other composition concentrations constant. The obtained emulsions were freeze dried 
immediately and the quality of the obtained SOS were examined using the naked eye. The 
results show that the appearance of the SOS was altered with the sample containing 60 v/v 
% of oil (Figure 5.16, section 5.3.2.3.). Therefore, we did not increase the oil volume fraction 
above 60 v/v % and here we present the characterization of o/w emulsions, prepared with up 
to 60 v/v % of oil phase, using upright fluorescence and brightfield microscopes.  
As can be seen in Figures 5.6a and 5.6g, the emulsion droplet size with the sample containing 
60 v/v % of oil has not changed notably in the microscope images, whereas the droplet density 
in the system increased appreciably compared to the sample containing 10 v/v % of oil 
content. However, the droplet size distribution, measured using ImageJ analysis, revealed 
significant changes (Figures 5.6b, d, f, h). The largest droplet size was from 90–100 μm to 30–
40 μm for samples containing 10 and 60 v/v % of oil, respectively. The largest droplet size of 
samples containing 30 and 40 v/v % of oil were the same, namely 120–130 μm. However, the 
highest frequency of droplet size existing in the formulation shifted from 0–10 μm to 10–20 
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μm and to 20–30 μm as the oil content rises from 10 to 40 v/v % and again dropped down to 
0–10 μm at 60 v/v % oil content. Normally, when the percentage of the dispersed phase is 
increased while other parameters are held at constant, the mean droplet diameter increases 
gradually because of the possible increase in emulsion viscosity and the limitation of surface 
active agents in the oil concentrated emulsion, which favours oil droplet coalescence and 
increases the mean droplet diameter [408, 411-414]. However, Schubert et al. [415] reported 
that there is no difference in particle size distribution when changing the dispersed phase 
volume fraction. In addition, at a sufficiently high dispersed phase volume fraction, emulsions 
are more stable to creaming, because the droplets are so closely packed together that they 
are prevented from moving [142]. Therefore, an emulsion with a 60/40 v/v % oil/water ratio 
does not increase its droplet size because increasing the oil phase volume fraction enhances 
emulsion droplet density, which in turn lowers the creaming rate. The creaming rate affects 
the droplet size; for instance, an oil droplet with a radius of 1 μm and ≈17 mm/day creaming 
rate will not have a long shelf life, while an oil droplet with a radius less than ≈0.15 μm and 
less than ≈0.5 mm/day creaming rate is considered to be stable towards creaming. The 
concentrated emulsion has less creaming rate of droplets than that of the diluted emulsions. 
When emulsion droplets move upwards because of gravity, an equal volume of continuous 
phase moves downwards to compensate; as a result, a net flow of continuous phase 
downward resists the upward movement of the droplets and decreases the creaming rate. In 
addition, in more concentrated emulsions, there are a number of other types of 
hydrodynamic interaction, which also reduce the creaming rate of the droplets. Possibly, 
60/40 v/v % is a critical dispersed phase volume fraction at which the droplets are prevented 
from moving because they are so closely packed. Whereas, emulsion with 40/60 v/v % 
probably does not have a sufficiently high dispersed phase volume fraction to prevent 
droplets from movement, but still has a large number of droplets that move and collide with 
each other, come into close contact for extended periods of time and consequently the rate 
of creaming is increased. The same can apply to emulsion containing 10 % oil volume fraction, 
in which the droplet concentration is low and, therefore, the droplets are free to move, collide 
with each other and coalescence occurs if there is no deep secondary minimum, high-energy 
barrier or strong short-range repulsion. This type of coalescence occurs immediately after two 
or more droplets collide with each other during a collision and it is called coalescence 
immediately after collision [142]. 
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Figure 5.6. Fluorescent and brightfield images taken with an upright microscope of o/w 
emulsions prepared with various oil/aqueous phase ratios: a) 60/40 v/v %; b) 40/60 v/v %; c) 
30/70 v/v %; d) 10/90 v/v %. Particle size distribution of emulsion prepared with various 
oil/aqueous phase ratios: b) 60/40 v/v %; d) 40/60 v/v %; f) 30/70 v/v %; h) 10/90 v/v %. 
5.3.1.3 The effect of API: metoprolol succinate and ketoconazole 
The effect of API on emulsion formation and droplet size was investigated using water-soluble 
MS in an aqueous phase and poorly water-soluble ketoconazole in an oil phase. MS and 
ketoconazole were added in quantities ranging from 1 mg/ml to 3mg/ml. As can be seen in 
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Figure 5.7, there was no difference at all. MS has no impact on emulsion formation and 
droplet size. Also there were no crystals seen on the surface of the droplets suggesting good 
solubility of API in the formulation. However, emulsions containing ketoconazole showed 
undissolved crystals, suggesting poor solubility of ketoconazole in sunflower oil (Figure 5.8), 
although ketoconazole’s partitioning coefficient, logP, is 3.73 and it showed good solubility in 
corn and cottonseed oils, at about 40 mg/ml [416]. 
 
Figure 5.7. Brightfield images taken with an upright microscope of o/w emulsions prepared 
with various metoprolol succinate concentrations: a) 1 mg/ml; b) 2 mg/ml; c) 3 mg/ml. 
 
Figure 5.8. Brightfield images taken with an upright microscope of o/w emulsions prepared 
with various ketoconazole concentrations: a) 1 mg/ml; b) 2 mg/ml; c) 3 mg/ml. 
The volume density distibution of emulsion with added water-soluble API (metoprolol 
succinate) shows minor changes for primary emulsion and no change for secondary emulsion 
(Table 5.23). The results are consistent with Yang et al. [417]. They studied the effect of 
bovine serum albumin (BSA) loading on the the size of microspheres, prepared from water-
in-oil-in water (w/o/w) double emulsion, and found that API loading has no significant effect 
on the properties of microspheres. The stability test of placebo and drug loaded emulsions 
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shows an increase of particle size distribution after 7 days and bimodal size distribution 
(Figure 5.9-5.10). This may be attributed to the dominance of coalescence instability of 
emulsion droplets [142, 406]. 
The addition of MS slightly decreases the span distribution for both techniques used to 
prepare emulsions, being 1.5 and 3.4 for HPDI and HPH prepared emulsions, respectively 
(Table 5.3). This indicates slightly narrower particle size distribution. The same was true for 
samples stored for 7 days at ambient conditions. The span value calculated for placebo 
emulsions stored for 7 days were 1.7 for emulsion prepared using HPDI and 6.2 for emulsion 
prepared using HPH, whereas the span value of emulsions containing metoprolol succinate 
were 1.4 and 5.9 respectively. However, the span values of both placebo emulsion and API 
containing emulsion prepared using HPDI and HPH measured after 7 days were increased in 
comparison with freshly prepared emulsions, indicating coalescence instability when two or 
more droplets merge together and form a single large droplet [409, 418]. Moreover, the 
larger droplets tend to merge more rapidly than the smaller droplets causing more 
polydispersed particle size distribution [142]. The exception was for emulsion containing 
metoprolol succinate prepared using HPDI. The span value for this emulsion decreased from 
1.5 to 1.4. This might be because the larger droplets move upward more rapidly then small 
droplets; however, during this movement they may collide with smaller droplets and 
aggregate. These aggregates will cream at a faster rate than the isolated droplets, thus small 
droplets disappear and the polydispersity becomes narrower [142]. 
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Figure 5.9. Volume density distribution of emulsion particle size prepared with HPDI: 1) 
placebo emulsion measured immediately after preparation; 2) placebo emulsion measured 
after 7 days; 3) MS loaded emulsion measured immediately after preparation; 4) MS loaded 
emulsion measured after 7 days. X-axis is plotted on log scale. q3* – density distribution by 
volume.  
 
Figure 5.10. Volume density distribution of emulsion particle size prepared with HPH: 1) 
placebo emulsion measured immediately after preparation; 2) placebo emulsion measured 
after 7 days; 3) MS loaded emulsion measured immediately after preparation; 4) MS loaded 
emulsion measured after 7 days. q3* – density distribution by volume. 
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Table 5.3. Emulsion droplet size distribution and the span value of HPDI and HPH samples 
with and without drug loadings immediately after preparation and after one week. N = 3. 
G/X emulsion – HPDI D10 (µm) D50 (µm) D90 (µm) Span value 
Placebo after preparation 6 ±1.25 27 ±2.54 49 ±6.23 1.6 
MS loaded after preparation 7 ±1.64 32 ±2.6 54 ±3.76 1.5 
Placebo after one week 5 ±1.49 28 ±3.29 53 ±9.01 1.7 
MS loaded after one week 10 ±3.04 35 ±2.64 58 ±2.94 1.4 
G/X emulsion – HPH D10 (µm) D50 (µm) D90 (µm) Span value 
Placebo after preparation 1.02 ±0.02 2.6 ±0.05 10 ±0.47 3.5 
MS loaded after preparation 1.04 ±0.03 2.66 ±0.06 10 ±049 3.4 
Placebo after one week 0.94 ±0.02 2.1 ±0.05 14 ±1.56 6.2 
MS loaded after one week 1.2 ±0.04 5.1 ±0.68 31 ±5.58 5.9 
5.3.1.4 The effect of emulsifiers type: G/X, HPMC/X, MC/X, Tween 20/X, G/CMC 
In addition, the ability to form and stabilize emulsions depends on the molecular and 
physicochemical characteristics of the emulsifier [142, 405]. Therefore, to see the effect of 
different emulsifiers on emulsion formation, four different compositions were evaluated, 
namely HPMC/X, MC/X, Tween 20/X and G/CMC. All processing parameters, emulsifier 
concentrations and oil to water ratios were held at a constant. Figure 5.11 shows fluorescent 
images of emulsions consisting of different emulsifiers. The fluorescent images show the o/w 
nature of the emulsions and there were no substantial changes in droplet size and 
morphology of obtained emulsions. The exception was with emulsions prepared using MC/X 
and G/CMC as emulsifiers, where the formation of flocs is seen clearly (Figures 5.11c and 
5.11e). Whereas, emulsions prepared using G/X, HPMC/X and Tween 20/X show partial 
flocculation, as it looks as though there are some flocs but, at the same time, there are 
individual droplets too. The stability analysis of emulsions by means of LD provides 
supplementary information about the nature of instability, which is discussed below. 
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Figure 5.11. Fluorescent images taken with an upright microscope of o/w emulsions prepared 
with different emulsifiers while keeping all other parameters constant: a) G/X; b) HPMC/X; c) 
MC/X; d) Tween 20/X; e) G/CMC. 
The density distribution of emulsion particle size prepared with HPDI with different 
emulsifiers immediately after preparation is presented in Figure 5.12. As can be seen on the 
graph, composition G/X and HPMC/X showed more homogeneous density distributions 
compared to the other three compositions. Compositions MC/X, Tween 20/X and G/CMC 
showed heterogeneous density distribution, having very small and very big particle sizes. The 
cumulative size distribution of primary emulsion is presented in Table 5.4. The stability test 
of placebo emulsions shows a slight increase of particle size distribution on the third day for 
emulsion prepared using a G/X composition and a decrease for the four other formulations 
(Figure 5.13). This may be attributable to the dominance of coalescence [142, 406] and 
flocculation instabilities of emulsion droplets, respectively. Before measuring the emulsions 
by droplet size analyser, samples were highly diluted in an aqueous phase and stirred. If there 
is an increase in droplet size after measurement it means a coalescence instability has 
occurred. However, if there is a decrease in droplet size after measurement it means that 
flocs were disrupted during stirring, and consequently the droplet size is decreased [142]. 
These results confirm the nature of instability seen with the fluorescence microscope. 
In addition, the span values were calculated for those emulsions and are given in Table 5.4. 
The highest span value was for emulsion prepared using G/CMC emulsifiers, namely 14.9, 
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then for Tween 20/X and MC/X compositions having 7.5 and 6 span values, respectively. G/X 
and HPMC/X give relatively narrower particle size distribution, namely 1.6 and 1.4, 
respectively. However, the span value was decreased significantly after three days for the 
measurement of the emulsion prepared using Tween 20/X emulsifiers, namely 1.2. Then it 
was followed by emulsion prepared using MC/X emulsifiers, where the span value was 3 and 
an insignificant decrease was for G/CMC, 14. These are due to flocculation instability, where 
mixing the diluted samples causes disruption of the flocs and hence decreases the particle 
sizes. The span value of HPMC/X was increased after three days, namely 1.8, which indicates 
a dominance of coalescence instability [409, 418]. G/X did not change the span value after 
three days indicating the stability of the emulsion for three days. 
 
Figure 5.12. Volume density distribution of emulsion particle size prepared with different 
emulsifiers immediately after preparation: 1) G/X; 2) HMPC/X; 3) MC/X; 4) Tween 20/X; 5) 
G/CMC. X-axis is plotted on log scale. q3* – density distribution by volume. 
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Figure 5.13. Volume density distribution of emulsion particle size prepared with different 
emulsifiers on third day: 1) G/X; 2) HPMC/X; 3) MC/X; 4) Tw. 20/X; 5) G/CMC. X-axis is plotted 
on log scale. q3* – density distribution by volume. 
Table 5.4. Emulsion droplet size distribution and the span value of emulsions prepared with 
different emulsifiers immediately after preparation and on third day. ± – standard deviation. 
1st day D10 (µm) D50 (µm) D90 (µm) Span value 
G/X 6 ±1.25 27 ±2.54 49 ±6.23 1.6 
HPMC/X 7 ±0.43 16 ±1.37 30 ±4.84 1.4 
MC/X 10  ±2.15 33 ±10.64 208 ±132.85 6 
Tween 20/X 8 ±0.54 17 ±1.87 132 ±172.78 7.5 
G/CMC 7 ±2.17 20 ±3.4 305 ±243.65 14.9 
3rd day D10 (µm) D50 (µm) D90 (µm) Span value 
G/X 7.26 ±1.09 31 ±2.98 56 ±2.83 1.6 
HPMC/X 6 ± 0.67 14 ±1.1 31 ±5.52 1.8 
MC/X 11 ±1.1 40 ±4.38 129 ±5 3 
Tween 20/X 10 ±0.85 20 ±2.45 34 ±4.35 1.2 
G/CMC 8 ±0.16 20 ±2.5 292 ±82 14 
5.3.2 Producing structured oil systems 
5.3.2.1 Impact of protein and polysaccharide ratio 
Emulsions prepared with different G and X concentrations show good stability against 
freezing and an acceptable quality of SOS were obtained for all formulations, irrespective of 
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the protein and polysaccharide ratio. As can be seen in Figure 5.14, all samples have a similar 
morphology, i.e. a white, matted, dry, cottony, thick, densely packed sponge-like structure. 
This indicates that the G and X ratio was not the key factor influencing the formation of SOS. 
Thereby, the formulation with 1.6 % w/v of G and 0.6 % w/v of X were selected for further 
characterization based on the overall stability of the emulsion and the quality of the SOS.  
 
Figure 5.14. SOS prepared with different G and X concentrations using a freeze drier: a) G 
with 1.2 w/v % and X with 0.6 w/v %; b) G with 0.6 w/v % and X with 1.2 w/v %; c) G with 2.3 
w/v % and X with 0.9 w/v %. 
5.3.2.2 Impact of dehydration method 
The method of drying was also checked, and the oven-dried samples were easy to crack and 
fracture, as they have a frangible structure. Neveretheless, oil was encapsulated successfully, 
indicating good stability against thermal processing too. 
 
Figure 5.15. SOS prepared with different dehydration methods: a) freeze-dried G with 1.6 w/v 
% and X with 0.6 w/v %; b) oven-dried G with 1.6 w/v % and X with 0.6 w/v %. 
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5.3.2.3 Impact of oil volume fraction 
The impact of oil content in the emulsion on the formation and morphology of SOS was 
studied. For this, emulsions were prepared with an oil phase comprising 10, 30, 40, and 60 
v/v % of the system. As can be seen in Figure 5.16, there was no difference on SOS 
morphology with samples prepared with 10, 30 and 40 v/v. However, the morphology of SOS 
was changed when the oil content reached 60 v/v %. The matted appearance altered with a 
glassy like morphology appearing; however, it was still holding a large amount of oil. 
Nevertheless, the recommended maximum oil loading is 40 v/v %. 
 
Figure 5.16. Study the impact of oil volume fraction on formation and morphology of SOS: a) 
10 v/v %; b) 40/60 v/v % (with fluorescent dye); c) 30 v/v %; d) 60 v/v %. 
5.3.2.4 Impact of processing parameters: HPDI and HPH 
The morpholology was changed too when emulsion was prepared using HPDI and HPH, as 
seen in Figure 5.17. The samples prepared with HPDI were rougher than the sample prepared 
with HPH. SOS prepared with HPH had a smoother surface, drier and airier texture and was 
whiter in colour, which could be attributed to the fact that the SOS prepared using HPH had 
a much smaller droplet size in the emulsion then the ones prepared using HPDI. 
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Figure 5.17. Placebo G/X SOS prepared with a) HPDI and b) HPH. 
5.3.2.5 Impact of protein and polysaccharide: G and X 
We studied the effect of G and X on the formation of SOS separately. Figure 5.18 shows the 
appearance of SOS prepared with pure G and pure X. Interestingly, both G and X can form SOS 
independently. However, the textural properties are different. SOS prepared using X alone 
showed soft, cottony, marshmallow-like morphology while SOS prepared using G alone has a 
rigid, glassy and dry property as examined by naked eye. In addition, the literature suggested 
that X does not adsorb at oil interface [419]; however, in this study, X shows that it can hold 
liquid oil by forming a firm layer around the oil phase, i.e. encapsulating the oil phase, without 
leaking the oil and protecting against stress conditions, as examined by naked eye. 
 
Figure 5.18. SOS prepared with pure: a) X; b) G. 
5.3.2.6 Impact of emulsifiers 
As the ability to form and stabilize emulsions depends on the molecular and physicochemical 
characteristics of the emulsifier [142, 405] we anticipated that the type of emulsifier can also 
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affect the formation of SOS. In addition, it would help to understand the underpinning 
principles of its oil holding capacity and nature. Therefore, in order to understand the nature 
and key parameters affecting the formation of SOS and for comparison purposes, four 
different compositions were evaluated, namely HPMC/X, MC/X, Tween 20/X and G/CMC. All 
processing parameters, emulsifier concentrations and oil to aqueous phase ratios were held 
at a constant. In addition, following our aim to develop delivery system for any water-soluble 
and oil-soluble drugs or nutrients, we would like to offer a range of materials that can be 
utilized for variety purposes. 
The study shows that the type of emulsifier used in the emulsion formulation has great impact 
on the morphology of SOS. Depending on the emulsifier type, different SOSs were produced 
(Figure 5.19). Although all samples were prepared using HPDI, the G/CMC sample gave the 
best SOS in terms of appearance, as if it was prepared using HPH. As with the sample prepared 
using HPH, HPDI prepared G/CMC was smooth, and was the driest and most white, although 
the droplet size was much bigger than the sample prepared using HPH. This suggested that 
the droplet size of emulsions is not the key parameter to obtain SOS. HPMC/X and MC/X were 
soft, cottony and have a marshmallow-like appearance. The Tween 20/X sample failed to form 
SOS, although the emulsion was stable and the droplet size was approximately the same as 
the sample prepared using G/X as an emulsifier, suggesting that the formation of a stable 
emulsion and droplet size are not important factors affecting the formation of SOS. Moreover, 
Tween 20 is also as surface active as HPMC, MC and G, and potentially it should interact with 
the non-surface active X by forming a stable layer against stress conditions such as freezing. 
However, it failed to form SOS, suggesting that probably there is no strong interaction 
between Tween 20 and X or the polysaccharide-surfactant concentration was not optimal. It 
may also have failed because, generally, polysaccharide-surfactant interactions (electrostatic 
and hydrophobic) strongly depend on polysaccharide and surfactant characteristics such as 
the backbone, pendant groups, hydrophobic moieties, chain stiffness, and on their relative 
concentrations [420-422]. In addition, there could be a lack of surfactant at the interface or 
polysaccharide may retard the diffusion of the surfactant to the interface which may in turn 
affect the continuous phase viscosity and hence the mechanical properties and stability. 
Although there is abundant literature about surfactant and polysaccharide interaction [420-
424], there are only two papers where a combination of Tween 20 and Xanthan were used as 
Chapter 5 
175 
 
an emulsion stabilizer [425] and encapsulation layer in the hybrid entrapment–encapsulation 
system [426]. However, these papers did not study whether there is an interaction between 
Tween 20 and X or not.  
 
Figure 5.19. Study the impact of emulsifier type in emulsion on formation and morphology of 
SOS: a) G/X; b) HPMC/X; c) MC/X; d) Tw. 20/X; e) G/CMC. 
5.3.3 Characterization of structured oil systems 
5.3.3.1 Structured oil system under a fluorescence stereomicroscope 
Macroscopically, SOSs look dry and matted and, therefore, in order to see the dispersion of 
oil in SOS a fluorescent image was taken using a stereo microscope. As can be seen in Figures 
5.20-5.21, a piece of SOS, loaded with fluorescent marker coumarin-6 in an oil phase, was 
examined under a fluorescence microscope and clearly defined the presence of oil. In 
addition, the fluorescence microscope confirms the hollow structure of SOS, and the cavities 
are shown as a dark-green colour. 
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Figure 5.20. Surface and cross-section of a small piece of SOS (SOS was immersed in liquid 
nitrogen before examination). 
 
Figure 5.21. Higher magnification of cross-section of SOS. 
5.3.3.2 X-ray micro computed tomography (XμCT) 
XμCT imaging is a non-destructive technique that allows the visualization of the inner 
structure of an object. It relies on the different absorption of X-rays for different materials, 
i.e. when the beam passes through matter, the intensity of the X-rays decreases according to 
the density, thickness and attenuation coefficient of the different materials [427, 428]. The 
density difference of the different samples enables the presentation of the object in different 
colours that are linked to the density of the material. In food and pharmaceutical research, it 
has been used widely for the inspection of the presence of various material sub-components 
and their local distribution [329]. 
The density of the analysed materials is in the following order: X > water > oil > G, namely 1.5 
g/cm3 (20 °C) > 1 g/cm3  [429] > 0.9188 g/cm3 [430] > 0.68 g/cm³ (20 °C), respectively. In Figure 
5.22, G/X SOS is depicted in green, yellow and purple colours in the 2D reconstructed images. 
The scale band on the left side of Figure 5.22 shows the density of the materials linked to 
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each colour. The low density materials start from the beginning of the scale as a black colour 
and move to the higher density materials at the other end as a white colour. The green, yellow 
and purple colours appear in a decremental order of density in the scale band. However, in 
this system the order of densities does not determine the way in which the system is formed. 
Densities would be important if the system was not mixed and the layers were formed due to 
gravity for example in a water and oil system without mixing the layers separate with the 
lower density material on top. Whereas, when water and oil are mixed together to form o/w 
or w/o emulsions, the density is not the determining factor in this case but the interfacial 
properties are. In the figure the oil is depicted in the green colour and it is surrounded by G/X, 
shown in the yellow colour. The purple coloured network is the back part of this structure and 
the black area represents air spaces. This suggests that the oil is entrapped in a polymer 
network.  
Figure 5.23 illustrates XμCT images of freeze-dried G/X solution without oil. As was expected, 
in comparison with SOS, it does not have oil in its content, i.e. there are not many greenish 
and yellowish colours. It has only a purple network and thin area of yellowish colour. From 
TGA analysis, it is known that the G/X placebo mixture contains water; therefore, we 
concluded that this yellowish colour indicates the presence of water and the purple colour 
represents G/X polymers. In addition, the structure of the freeze-dried G/X solution without 
oil has mild air pocket size with a well-defined mosaic grid of irregular shape; in contrast, the 
size of the air pockets of SOS has a population of small air pockets divided by large and mild 
size gaps. The small size of the air pockets of SOS is due to formation of emulsions, i.e. oil 
droplets that makes the structure of SOS denser and compact. 
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Figure 5.22. XμCT images of G/X SOS prepared using HPDI. 
 
Figure 5.23. XμCT images of G/X placebo mixture. 
5.3.3.3 Cryo-SEM 
Cryo-SEM is widely used to characterize the microstructure of liquid containing specimens 
through rapid freezing, which allows the immobilization of the original microstructure of the 
liquid containing specimen [322]. In our case, Cryo-SEM images allow direct visualization of 
the shape of the oil droplets and polymer layer surrounding the droplets. Therefore, in order 
to obtain more detailed information of the structural integrity of the oil droplets entrapped 
by the polymer network, selected formulations were analysed using Cryo-SEM. These 
formulations were a G/X SOS prepared using HPDI and a freeze-dried G/X mixture without oil 
Chapter 5 
179 
 
for comparison purposes. The G/X SOS sample was attached to the sample holder and 
immediately plunged into liquid nitrogen slush at approximately -210°C to cryo-preserve the 
material.  This was transferred onto the cryo-stage, where the sample was fractured at -100°C 
and subjected to sputter coating with platinum for 90 seconds at 10mA.  After sputter coating, 
the sample was moved onto the cryo-stage in the main chamber of the microscope, held at 
approximately -130°C and was imaged at 3kV. Digital TIFF files were stored.  
Figures 5.24 and 5.25 represent Cryo-SEM images of G/X SOS prepared using HPDI and a 
freeze-dried G/X mixture without oil, respectively. As can be seen in Figures 5.24a and 5.24a’, 
G/X SOS shows a porous structure with sizes in the range of 10-200 μm. Figures 5.24a’’ and 
5.24a’’’ illustrate the higher magnification of the fractured area, where a shell-like layer of 
G/X polymers covering the oil are seen clearly. In contrast, Cryo-SEM images of the freeze-
dried G/X mixture without oil shows hollow, flat, irregular form shells with widths of about 4-
5 μm (Figure 5.25). These results also confirmed that the oil droplets were covered by a thin, 
shell-like layer of polymer and the width of the polymer layer may vary depending on the 
formulation components. 
 
Figure 5.24. Cryo-SEM images of (a) G/X SOS prepared using HPDI. (a’) (a’’) and (a’’’) images 
are higher magnifications of (a). 
Chapter 5 
180 
 
 
Figure 5.25. Cryo-SEM images of (a) G/X placebo mixture prepared using HPDI. (b’) image is a 
higher magnification of (b). 
5.3.3.4 TEM 
TEM has much higher magnification abilities and a greater resolution then light microscope. 
Therefore, TEM analysis was conducted to observe the nano-structure of SOS prepared using 
HPDI and HPH. In order to obtain TEM images, SOS was subjected to a series of treatments 
and at the end it was put into BEEM capsules with fresh resin and polymerised overnight at 
60 °C. This procedure was undertaken because the TEM instrument, as opposed to Cryo-SEM, 
cannot just freeze the sample, a process which enables the sample to be cut into stable pieces 
and images to be taken. SOS is a semi-solid component and the integrity of the sample can be 
destroyed if it is cut into pieces, which is necessary when you analyse with the TEM technique. 
Therefore, pre-treatment of the sample was conducted to preserve the integrity of the 
structure. The treatment procedure is described in detail in section 2.4.1.2.3. However, it is 
worth mentioning that the pre-treatment during the sample preparation of TEM may cause 
some level of swelling of the structured oil. Therefore, the dimensions of the polymer 
domains observed in the TEM may not fully correspond and be larger than the ones observed 
in the Cryo-SEM images.  
Figure 5.26 illustrates TEM images of G/X SOS prepared using HPDI where at lower 
magnification it shows large oil areas with separated borders and at higher magnification it is 
clearly seen that the oil droplets are surrounded by thick polymer layers. In comparison, the 
TEM images of G/X SOS prepared using HPH showed big and small oil droplets in a polymer 
matrix (Figure 5.27). There were not clear borders, but well-defined oil droplets were seen 
clearly. These results are consistent with the fluorescence microscope results, where the 
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emulsion prepared using HPH has heterogeneous droplet size distribution compared to the 
emulsion prepared using HPDI. Thus, the SOS prepared using HPH has heterogeneous oil 
droplets and SOS prepared using HPDI has homogeneous large droplets after processing too.  
 
Figure 5.26. TEM images of G/X SOS prepared using HPDI. 
 
Figure 5.27. TEM images of G/X SOS prepared using HPH. 
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5.3.3.5 ATR-FT IR 
Organic compounds can be determined qualitatively by infrared spectroscopy because each 
molecular group, influenced by the surrounding functional groups, have a characteristic 
vibrational mode, which causes the appearance of bands at a specific frequency in the 
infrared spectrum. It is possible to perform quantitative analyses too because, according to 
Beer-Lambert law, the intensity of the bands is dependent on the product of the extinction 
coefficient and the concentration [431]. In this study, infrared spectroscopy was used to see 
if there are any interactions between protein and polysaccharide, the sequence or nature of 
adsorptions of protein and polysaccharide on the surface of the oil interface and the presence 
of oil. The FT-IR analysis was carried out for pure G powder, X powder, pure sunflower oil, 
freeze-dried G/X mixture without oil, and G/X SOS prepared using HPDI or HPH (Figure 5.28). 
The infrared spectrum of xanthan gum and sunflower oil and their frequencies, functional 
groups and mode of vibrations are given in Appendix 2. Here we have presented the IR 
assignments of G only in Table 5.5. 
The FT-IR spectrum of pure G powder shows vibration bands at 3274 cm−1 NH, OH stretching; 
2939 cm−1 CH2
 
asymmetrical stretching; 1628 cm−1 C=O, NH stretching (Amid I); 1522 cm−1 NH 
bending (Amide II), C–N, C–C stretching; 1445 cm−1 CH2 bending; 1332 cm−1 CH2 wagging; 1235 
cm−1 C–N stretching, NH bending (Amid III) and a shoulder at approximately 1400 cm−1 COO- 
stretching. Those bands were shifted to a higher frequency for the freeze-dried G/X mixture 
without oil, namely to 3290, 2932 (exception), 1633, 1546, 1451, 1337 and 1238 cm−1 
respectively. The shifting of absorption peaks to a higher frequency suggests that there is 
some interaction between G and X. If there is an electrostatic interaction, changes in the 
Amide I and Amide II regions are expected [432]. In addition, G and X are believed to interact 
with each other via hydrogen bonding with the involvement of NH and OH groups [433]. Also, 
the shoulder band, at approximately 1400 cm−1 emerged in G powder, appeared as an 
intensive band at 1400 cm−1 for the freeze-dried G/X mixture without oil, which is 
concentration dependant. G/X SOS prepared using HPDI and HPH also shows some interesting 
changes in absorption peaks. Compared to the freeze-dried G/X mixture without oil, the 
frequencies of absorption peaks of SOS were shifted again to a higher frequency (Table 5.5). 
What is more,  the SOS prepared using HPH have higher frequencies than the SOS prepared 
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using HPDI, namely the Amide A,  Amide I, Amide II and CH2 bending shifted from 3303 to 
3330, 1636 to 1652, from 1547 to 1552 and from 1455 to 1457 cm−1 respectively. However, 
the intensities of all HPH absorption peaks were lower than that of SOS prepared using HPDI. 
The decrease in the intensities can be explained, as SOS prepared using HPH has a small oil 
droplet size compare to SOS prepared using HPDI. This may facilitate the fine distribution of 
a protein-polysaccharide layer on the surface of the oil droplets of SOS prepared using HPH, 
in comparison with the bulky oil droplets of SOS prepared using HPDI. Consequently, SOS 
prepared using HPH has a lower concentration of protein-polysaccharide layer per square 
centimetre. In addition, the intensity of oil absorption peaks were higher for the HPH sample 
than for the HPDI sample, also confirming that a large quantity of small oil droplets resulted 
in a fine distribution of protein-polysaccharide layer.  
As can be seen from Figure 5.28, the pure X powder IR spectrum showed one strong band at 
1018 cm−1 OH bending and two medium bands at 3266 cm−1 axial deformation of the OH group 
[434] and 1601 cm−1 –C=O of pyruvate [435]. The IR spectrum of the freeze-dried G/X mixture 
without oil demonstrated shifting to a higher frequency too, as it was for G, namely from 1018 
cm−1 to 1031 cm−1 (Appendix 2). SOS prepared using HPDI showed shifting and splitting of 
1018 cm−1 into three strong bands, namely 1083, 1060, 1031 cm−1. Shifting the absorption 
peak of the G/X placebo mixture and the splitting into three bands of SOS prepared using HPDI 
suggest that there is some interaction between G and X. However, all other absorption peaks 
and the absorption peaks of SOS prepared using HPH were overlapped by G and sunflower oil 
bands, due to the low concentration of X in the formulation. Therefore, it is hard to interpret 
any apparent peak shifts. 
The FT-IR results confirmed the presence of oil in dry SOS as the main IR peaks of sunflower 
oil 3008, 2922, 2853, 1743, 1465, 1377, 1237, 1160, 1120, 1098, 1031, 913, 722 cm−1 exist in 
both SOS prepared using HPDI and HPH (Figure 5.28) (Appendix 2). Only 1120, 1098 and 722 
cm−1 IR peaks in the HPDI sample were overlapped by X bands. 
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Figure 5.28. ATR FT-IR spectra of pure X and G powder, pure sunflower oil, freeze-dried G/X 
mixture without oil, G/X SOS prepared using HPDI and HPH.  
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Table 5.5. Frequencies (cm-1) of bands of G mid-infrared spectra, together with the tentatively assigned functional group, the mode of vibration, 
and the approximate intensity. Abbrevation sh denotes shoulder, st – strong, m – medium, vw – very weak, SF – sunflower oil, X – xanthan gum. 
Gelatine type B – IR peak assignments 
Frequency (cm-1)  
raw material 
Frequency (cm-1) 
HPDI G/X mixture 
without oil 
Frequency (cm-1) 
HPDI G/X SOS  
Frequency (cm-1) 
HPH G/X SOS  
Assignment & mode of vibration  
[342, 436] 
Region 
3274 3290 3303 3330 NH, OH stretching                  Amide A   
2939 2932 overlapped SF overlapped SF Asym. CH2
 
–stretching,  
N–H stretching 
Amide B 
1628 1633 1636 1652 C=O stretching, N–H bending Amide I 
1522 1546 1547 1552 NH bending, C–N stretching,  
C–C stretching  
Amide II 
1445 1451 1455 1457 CH2 bending  
 
sh 1400 s 1399 m 1399 sh COO – stretching  
 
1332 1337 1338 - CH2 wagging 
 
1235 1238 1238 1238 C–N stretching, NH bending  Amide III 
1081 - 1083 overlapped X - Skeletal C–O stretching  
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5.3.3.6 DSC 
DSC analysis was conducted for pure metoprolol succinate powder, pure ketoconazole 
powder, pure G powder, pure X powder, freeze-dried G/X mixture without oil, G/X placebo 
SOS prepared using HPDI, G/X SOS containing 2 mg/ml water-soluble metoprolol, G/X SOS 
containing 1 mg/ml poorly water-soluble ketoconazole (Figure 5.29). Scans were performed 
from 0 to 250 °C at a controlled constant heating rate of 10 °C/min. We performed DSC 
analysis for X to detect Tg according to the method described in the literature [266]; however, 
we could not detect Tg. Therefore, we did not present DSC results for pure X powder. 
The DSC thermographs of metoprolol succinate show two endothermic peaks: the first refers 
to the melting temperature of pure metoprolol succinate at 137.69 °C [225] and the second 
refers to the decomposition temperature starting from 161 °C. Enagbare [437] conducted TGA 
analysis and found that the decomposition of metoprolol succinate starts from 139 °C to 300 
°C [438, 439]. As can be seen in Figure 5.29, the melting temperature of pure ketoconazole is 
at 149.16 °C. The result is consistent with the literature [212]. The DSC thermogram of pure 
G powder shows two endothermic peaks at about 92 °C (broad) and 225 °C (small). This broad 
peak can be attributed to water evaporation [440] which interfered with the ability to see the 
melting temparature of G. Li et al. [259] found that the melting temperature for pure G fibres 
was 93.8° C. The melting temperature at 225 °C can possibly be attributed to decomposition 
of G, because TGA analysis of G showed that it starts to decompose at 212 °C.  The freeze-
dried G/X mixture without oil also shows two melting transitions at 103 °C and 234.98 °C 
corresponding to water evaporation and possibly decomposition of G (which started at 218 
°C ), respectively. The DSC results of the G/X placebo SOS, the G/X SOS containing metoprolol 
succinate and the G/X SOS containing ketoconazole, all showed one small melting peak at 
about 125 °C, 125 °C and 129 °C, respectively. TGA analysis showed that SOS does not contain 
water, therefore, we were able to see one small transition peak at 125 °C and we assumed 
that this might be the melting temperature of G, which was shifted to a higher temperature. 
This may mean that there is some interaction between G and X which resulted in the 
formation of a G/X complex and the changing of the physical properties of gelatine [267]. G 
and X have electrostatic and/or hydrophobic interaction, so possibly these interactions take 
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place [441]. Neither metoprolol nor ketoconazole exhibit melting transition during DSC 
analysis, indicating non-crystalline form or low concentration of APIs [92]. 
 
Figure 5.29. DSC thermographs of starting materials and freeze-dried G/X mixture without oil, 
placebo G/X SOS and G/X SOS loaded with APIs. 
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5.3.3.7 TGA 
TGA experiments were performed for all the freeze-dried SOS and raw materials in order to 
estimate moisture content and thermal degradation of the fresh samples and after storage. 
Figure 5.30 shows the TGA results of raw materials G and X, the freeze-dried G/X mixture 
without oil, and the SOS of G/X immediately after preparation, after 24 h and after 72 h 
(stored at ambient conditions). As can be seen on the graph, weight loss is observed for raw 
materials and the G/X freeze-dried mixture without oil, up until 100 °C for the freeze-dried 
G/X mixture without oil and up until 155 °C for G and X powder, which corresponds to water 
desorption in the samples. The thermal degradation, as can be seen, started at 212 °C and 
completed at 342 °C for X and at 400 °C for G and the freeze-dried G/X mixture without oil in 
a single step process. These results are in good agreement with the literature for X [442] and 
G [443]. However, water loss was not observed for the SOS of G/X measured immediately 
after preparation, after 24 h, after 72 h and after 1 month (stored at ambient conditions) 
(Figure 5.30), suggesting no moisture uptake by the samples. The decomposition for these 
samples started, as for the raw materials, at 212 °C and it was also a single step process. The 
absence of water was observed for G/CMC, HPMC/X, MC/X SOS stored at ambient 
temperature, at 40 °C and 75% RH (Figures 5.30), also indicating no significant moisture 
uptake, which favours better stability of the finished product. The thermal degradation 
started at 200 °C for samples stored at ambient temperature and at 75% RH, whereas for 
samples stored at 40 °C it started at 150 °C in a single step process, except for G/X SOS-HPDI 
which has a two step degradation process, the first at 128 °C and the second at 245 °C. 
Although in the literature, pure HPMC decomposes in two step processes, the first refers to 
evaporation of unbound water at 65.5 °C and the second decomposition refers to cellulose 
ether degradation, dehydration and demethoxyhlation at 300 °C (the weight loss is ∼75%) 
with the maximal rate at 355–356 °C [444, 445]. From the literature, CMC decomposes in two-
step processes, first due to water removal at 38–172 °C and with the second thermal event 
starting at 172 °C and finishing at 327 °C, which may correspond to the degradation of the 
side chain and loss of CO2 [291]. In another source, CMC decomposes in a three step process. 
In the first step, from 25–100 °C (the weight loss is ∼10%)  which is due to loss of moisture 
and then from 100–300°C (the weight loss is ∼39%) the CMC starts to decompose due to loss 
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of CO2 from the polysaccharide, and the third decomposition of the polysaccharide backbone 
in the CMC occurs in the range of 300–800 °C (the weight loss is ∼22%) [292]. 
 
Figure 5.30. TGA thermogram of raw materials and processed samples immediately after 
preparation and after storage: a) at ambient temperature for 24 h and 72 h; b) G/X, HPMC/X, 
MC/X and G/CMC SOSs prepared using HPDI and HPH after storage at room (ambient) 
temperature (RT) for 1 month; c) G/X, HPMC/X, MC/X and G/CMC SOS prepared using HPDI 
and HPH after storage at 75% RH for 1 month; d) G/X, HPMC/X, MC/X and G/CMC SOS 
prepared using HPDI and HPH after storage at 40 °C for 1 month. 
5.3.3.8 Mechanical properties and oil holding capacity under compression 
The measurements were carried out using a compression test mode to examine the 
resistance of the specimen to force. As can be seen in Figure 5.31, G/CMC showed the highest 
rigidity than those SOS prepared with X mixture; namely it could resist the force for 30 
seconds of a load of 20,000 grams. G/X prepared using HPDI and HPH showed medium 
stiffness, while HPMC/X and MC/X have the softest structural properties; they could resist the 
force for 30 seconds of 1,800 and 1,500-1,400 grams loads respectively. Blank paper was used 
for comparison purposes to show the behaviour of line for rigid material. The results showed 
that the SOSs prepared using G has higher rigidity than those prepared without it. The degree 
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of complexation is possibly different for those compositions, which affects the mechanical 
properties of these samples [446]. This should be checked with ATR FT IR. The amount of oil 
released during compression was assessed quantitatively by weighing the cellulose filter 
paper before and after soaking with oil and it was placed on a flat aluminium cylinder under 
the SOS. Table 5.6 represents the summary in grams. The amount of oil released correlates 
well with the stiffness of the samples; the softest MC/X sample released the highest amount 
of oil, namely 1.73 grams, whereas the rigid G/CMC released 0.5 grams.   
 
Figure 5.31. Mechanical strength of 5 different SOS under compression. 
Table 5.6. Amount of oil released during compression. 
Type of SOS Amount of oil released in grams 
G/X – HPDI 0.5698 ± 0.02 
G/X – HPH  0.5533 ± 0.1 
HPMC/X 0.7433 ± 0.03 
MC/X 1.7309 ± 0.34 
G/CMC 0.5077 ± 0.23 
5.3.3.9 Water uptake ability 
The drug release kinetics from SOS depends on the rate of water uptake and drug 
dissolution/diffusion rate, which in turn can also be affected by the preparation method [447]. 
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Therefore, a water uptake study was performed for SOS prepared using HPDI and HPH as 
described in the literature [448]. The equilibrium water uptake ability of SOS was measured 
as follows: a pre-weighed dry sample was immersed in distilled water and at different time 
intervals was taken out to measure the weight of the wet sample. The water uptake ability 
was calculated according to the following equation: 
Water uptake ability = (Ww – Wd)/Wd 
where Ww represents the weight of the wet sample and Wd represents the weight of the dry 
sample. 
Figures 5.32 and 5.33 illustrate the water uptake of G/X SOS prepared using HPDI and HPH, 
respectively. As can be seen in the images, the prepration method has a great impact on water 
uptake ability and disintegration in the aqueous phase. SOS prepared using HPDI showed a 
slow water uptake and disintegration in water. There was a burst uptake within 5 minutes, 
the weight was increased to almost twice of its weight, then it slowed down and almost no 
changes were observed after 45 minutes. During water uptake, swelling of the SOS was 
observed. If the initial length and width of the SOS pieces were 1.2 cm and 0.5 cm respectively, 
at the end, after 60 minutes, they were 1.6 cm and 0.7 cm. SOS prepared using HPH showed 
a burst of water uptake and disintegration within 5 minutes. The same swelling behaviour 
was observed for SOS prepared using HPH. The initial length and width were 1.1 cm and 0.4 
cm respectivly, after 5 minutes they were 1.2 cm and 0.6 cm. Table 5.7 represents the water 
uptake ability which was determined from the weight difference between the wet state and 
dry state of SOS. 
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Figure 5.32. Water uptake of G/X SOS prepared using HPDI. 
 
Figure 5.33. Water uptake of G/X SOS prepared using HPH. 
Table 5.7. Water uptake ability of placebo G/X SOS prepared using HPDI and HPH. 
Sample Amount of water in mg 
5 min 10 min 20 min 30 min 45 min 60 min 
SOS HPDI 0.9146 1.4350 2.5459 3.3275 4.201 4.35 
SOS HPH 1.2809 and then 
disintegrated  
 
5.3.3.10 Dissolution testing 
In vitro drug release of SOS was conducted for G/X SOS prepared using HPDI and HPH. 
Metoprolol succinate was selected as a model of highly water soluble drug.  
Figure 5.34 shows the dissolution testing results obtained for G/X SOS prepared using HPDI 
and HPH in acidic media. It can be seen that the release rate of metoprolol succinate was 
different for formulations prepared using HPDH and HPH. G/X SOS prepared using HPH 
showed faster drug dissolution compared to the G/X SOS prepared using HPDI. In the SOS 
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formulation prepared using HPH, over 60% of the drug releases in the first 3 minutes, whereas 
in the SOS formulation prepared using HPDI, the same amount of drug was released over 20 
minutes and then sustained release was observed. These results showed that the preparation 
process has a great impact on the dissolution profile of API, indicating the dissolution 
enhancement effect of formulations prepared using HPH. This can be explained as the SOS 
prepared using HPH has greater air pockets in the bulk, so the water penetration is faster. In 
addition, a high pressure homogenized sample has smaller emulsion droplet size distribution, 
which has resulted in a higher surface to volume ratio thus faster polymer swelling and 
dissolution. SOS prepared using HPDI shows sustained drug release, which is consistent with 
the water uptake ability test. The release of the drug from both dosage forms was incomplete 
in this experiment because the selected time of 60 min and 90 min was not enough to 
completely dissolve the given amount of dosage form (this is due to miscalculation, which 
was based on water uptake study that lead to assumed that that time was enough to dissolve 
the dosage form. Unfortunately, we did not have time to repeat this experiment with lower 
dosage weight)  
 
Figure 5.34. In vitro drug release of SOS prepared using HPDI and HPH. 
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5.4 Conclusion 
A novel drug delivery system called SOS has been designed to use as a carrier to deliver water-
soluble and oil-soluble drugs or nutrients. This structured oil system was prepared using an 
organic solvent-free method and a relatively inexpensive freeze drying technique which is 
preferential for heat sensitive agents. Electrostatic and/or hydrophobic interaction between 
protein and polysaccharide was utilized to produce emulsions stable against stress conditions. 
The materials used in preparation are inexpensive food and pharmaceutical grades. 
In this chapter, the preparation and characterization of freeze-dried SOS prepared using HPDI 
and HPH was discussed. Two different model drugs, metoprolol succinate and ketoconazole, 
and five different compositions, namely G/X, HPMC/X, MC/X, Tween 20/X and G/CMC were 
used to prepare freeze-dried SOSs. First emulsion characterizations were performed using 
upright brightfield and fluorescence microscopes, a confocal microscope and an LD particle 
size analyser to investigate the impact of emulsion stability and particle size on the formation 
of SOS. Second, the morphology and inner structure of SOS was studied using a stereo 
fluoresence microscope, TEM, XμCT and Cryo-SEM to confirm the entrapping of sunflower oil 
in the polymer network. DSC and ATR FT-IR analysis confirms electrostatic and/or 
hydrophobic interaction between G/X polymers. TGA analysis showed good stability of the 
prepared SOS against moisture. A texture analyser revealed the most resistant SOS against 
force, which was the SOS prepared using G/CMC polymers, and also determined oil holding 
capacity. Dissolution testing was conducted for only water-soluble API prepared using HPDI 
and HPH. The results revealed two different dissolution profiles depending on the preparation 
tool, namely burst and sustained release of metoprolol succinate for SOS prepared using HPH 
and HPDI, respectively. The dissolution testing results were consistent with the water uptake 
ability of SOS prepared using HPDI and HPH. 
The oil holding capacity of SOSs directly depends on the ability of emulsifiers to resist stress 
conditions. The Tween 20/X system failed to form a structured oil system, confirming that the 
formation of stable emulsions and particle sizes are not key parameters ensuring the 
formation of SOS. The morphology of SOS can be affected by the preparation method as well 
as polymer type. G/X SOS prepared using HPH and G/CMC SOS prepared using HPDI showed 
the best morphology and appearance of the samples tested. 
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6 Chapter 6. Concluding remarks and future prospects 
6.1 Reflection on the key findings 
In Chapter 3, the preparation and characterization of an orodispersible film of iodine delivery 
was discussed. KIO3 loaded nanofibres show excellent stability for at least four years and 
efficient release of iodine upon wetting. This novel formulation design by means of 
electrospinning allows easy administration of iodine for preventing childhood iodine 
deficiency. In addition, this orodispersible film potentially can be used as medication for 
radiation protection. It can be of benefit in this respect since the concept of taking KI and KIO3 
containing tablets during radiation is to quickly provide the body with a stable source of iodine 
in order to prevent accumulation of radioactive iodine, and the ultrarapid dissolution of 
orodispersible film in the oral cavity can ensure a rapid delivery of iodine into the body. In 
addition, the orodispersible film does not require water intake compared to conventional 
tablets, which is important in an emergency situation, when looking for water can be a bit 
stressful because of panic. Moreover, the stability of KIO3 in extreme conditions and the long 
shelf life of the finished product allows for it to be stocked in quantities in places far away 
from towns and cities. Besides, this study has demonstrated: 1) that electrospinning 
technology has a great potential for use in the formulation of dosage forms for children; 2) 
that not all salts facilitate better fibre formation and can improve fibre morphology; 3) the 
importance of the characterization of electrospun nanofibres loaded with active ingredient 
using TEM along with SEM, showing that TEM is a simple and straight forward instrument to 
reveal and visualize the distribution of the crystalline active ingredient within nanofibres or 
confirm the absence of a crystalline form; 4) a novel and easy method for producing and 
harvesting nanocrystals of inorganic salts; 5) a contribution to the research area of polymeric-
based solid dispersion for inorganic material delivery; 6) the importance of handling the 
electrospun nanofibres during sample examination. Even mild to moderate stretching of the 
fibres can lead to the change of molecular conformation of polymer and hence its 
physicochemical properties. Thus, we revealed the change in molecular conformation of PEO 
in the stretched state, previously not reported, examined using PXRD.  
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Chapter 4 is an extension of the work presented in Chapter 3, wherein EE was explored to 
produce lipid-based biphasic drug release delivery system for a water-soluble and oil-soluble 
drugs or nutrient. The key challenges of this project were (1) utilizing non-conducting edible 
oil, an uncommon approach in EE, as an oil phase in o/w emulsion that was designed for 
further electrospinning, (2) selecting only food grade substances and (3) organic solvent free 
formulation and processing. The results obtained from this study show the feasibility of EE for 
certain types of formulations, namely for formulations prepared using TPGS as the emulsifier, 
which prove to be effective in facilitating fibre formation based on the SEM images and ensure 
better encapsulation of liquid oil within an electrospun fibrous-like film as examined by the 
naked eye. These results open a wide area to explore different materials for the development 
of lipid-based solid dispersion using EE wherein liquid edible oils and fish oil can be 
encapsulated. However, the maximum oil volume fraction in the disperse phase of o/w 
emulsion that was achieved during the given period of time was 20 v/v %. That oil volume 
fraction was not sufficient for the purpose of the study and therefore this study was 
discontinued. However, these results were presented in this thesis because this delivey 
systems has a great potential to be evaluated for other nutrients and APIs that require small 
doses. This study, in addition, provides primary information about the formulation and 
processing parameters affecting fibre formation in EE. However, in order to establish the 
applicability of these formulations as delivery system for water-soluble and oil-soluble drugs 
or nutrients, additional investigations and improvements are needed, such as in relation to 
the stability of emulsions and end product, reproducibility, carrier-drug interactions, and drug 
dissolution tests of two types of drug or nutrient. 
Despite the numerous lipid-based formulations that are available today, the majority of oral 
dosage forms that can carry large amounts of oil is limited by the soft or sealed hard gelatine 
capsules in use [449], which are limiting the possibilities to improve the dosage forms for 
children. SOS studied in Chapter 5 contributed to the research area of large oil containing 
delivery systems. It presents a thorough investigation of a novel G/X structured oil system, 
capable of holding a large amount of oil, to be applied in the pharmaceutical area as a carrier 
of water-soluble and oil-soluble nutrients or drugs. The results, which are mainly  based  on 
the example of G/X SOS, show that emulsifier type (G/X, HPMC/X, MC/X, Tween 20/X, 
G/CMC), oil volume fraction (20–60 v/v %) and processing parameters (HPDI and HPDI/HPH) 
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affect the formation and properties of emulsions and hence SOSs. The oil holding capacity of 
SOSs directly depends on the ability of emulsifiers to resist stress conditions. The freeze-dried 
SOS comes out as white, matted, dry, and cottony with a sponge-like structure and looks 
heavy/ponderous/bulky/cumbrous if HPDI was used in the emulsion preparation and 
lightweight/gentle/delicate/fine if HPDI/HPH were used in the emulsion preparation or if 
G/CMC emulsifiers were used. The shape of SOS can take any form depending on the jar that 
was used during freeze drying. This property is advantageous as it allows direct production of 
a round disk dosage similar to tablets in continuous manufacturing as a future prospect. 
However, it needs thorough investigation to fully assess the applicability of this system as a 
carrier, particularly, in the first place, with a dissolution test for the oil-soluble active 
ingredient. 
6.2 Future outlook 
Building on the foundations established by this project, two ranges of supplement 
formulations that can be used and scaled up for nutrient delivery should be further refined 
and developed. To achieve this, first, the permeation of nutrients or drugs through the oral 
mucosa should be studied to ensure the efficacy of delivery of the nutrient or drug from both 
orodispersible films and SOS, as well as the palatability and safety of the dosage forms. 
Secondly, whereas the freeze-drying technique has established a routine procedure for large-
scale production, the industrial scale up of the emerging electrospinning technique is still in 
its developing stages and, as discussed in Chapter 1, the main challenges associated with mass 
production of electrospun nanofibres could nullify the processing parameters used to 
produce nanofibres in the lab. Therefore, for the orodispersible films electrospun in the lab, 
it is important to re-check the processing parameters for large-scale production and validate 
the reproducibility of the final product. 
One of the challenges in this research was estimating the amount of released oil from SOS. 
We had a fine accumulation of oil on the top of the dissolution media, which raised the 
question of sampling the released oil. There are no standard pharmacopoeial methods for 
testing lipid-based formulations. However, we came across the work of Onoue et al. [450], 
who  carried out dissolution testing using a conventional dissolution test apparatus. They 
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were withdrawing the aliquot from the dissolution media, then centrifuging it at 15,000 rpm 
for 5 minutes, then supernatants were diluted with a 10-fold volume of methanol and they 
then measured the concentration. Thus, we used the same principle but with some changes. 
Sudan III was used as the oil-soluble substance, of which the concentration in oil can be 
correlated with the amount of oil released at a certain period of time. The test was carried 
out in a handmade set up because we used organic solvents, such as hexane, toluene and 1-
octanol, which are harmful to dissolution vessels, and we did not sample, we took the whole 
medium, diluted it with solvent and then centrifuged the supernatant (Figure 6.1). However, 
centrifugation did not help to separate the oil phase from the dissolution media; conversely, 
it resulted in many air bubbles and re-emulsification. Then we decided to shake the sample 
gently by hand to ensure that the solvent extracts the oil (we do not have a shaking incubator 
in the lab) and leave it for 15 minutes to allow time for oil to accumulate on the top of the 
media. Thus, we were able to withdraw only a small amount of oil, which was then diluted 
with standard solution and analysed using UV-Vis spectroscopy at 259 – 265 nm. However, 
the release of dye was undulant. We anticipated that this might be due to human factors, 
because the dissolution media was shaken by hand, which cannot ensure the fixed speed of 
shaking. The second reason is that the solvents that we used were affecting the UV maximum, 
which was shifting every time. Therefore, the development of a proper methodology for 
testing the released oil from the dosage form is important both for conventional oral tablets 
and for oral disintegrating tablets. 
 
Figure 6.1. Testing the release oil from the dosage form using oil-soluble dye Sudan III.  
Chapter 6 
199 
 
When emulsifier type was studied, HPMC/X, MC/X and G/CMC show capability to serve as a 
structuring system for oil phase. Characterizing these systems, as it was done for G/X SOS, 
may provide new insights into protein-polysaccharide and polysaccharide-polysaccharide 
interactions, into their dissolution profile and mechanism, and understanding the oil holding 
ability of SOS. In addition, HPMC/X, MC/X and especially G/CMC show interesting morphology 
that is different from G/X SOS. It would be very interesting to conduct two-step emulsification 
to prepare emulsions for producing those SOS to see the impact of the HPH instrument on 
their properties. This would give a range of delivery systems capable of carrying oil phase and 
open up a wide range of possible combinations. Particularly, G/CMC SOS prepared by HPDI 
shows a fine and light morphology as with the G/X SOS prepared using HPDI and HPH in a 
two-step emulsification method. This means that if G/CMC SOS were prepared in a two-step 
emulsification method, the morphology of the end product most probably will be even finer 
and lighter, which in turn can increase the disintegrating and the dissolution rate, hence can 
also be used as a fast disintegrating tablet.  
Another characteristic of protein and polysaccharide that is worthy of study is to determine 
how G/X, HPMC/X, MC/X and G/CMC were distributed on the oil-water interface. This 
information is useful for predicting the stability of emulsion droplets to flocculation or 
coalescence. A range of techniques, including AFM, scattering techniques and spectroscopy 
techniques, are used to analyse changes in interfacial thickness and structural organization 
that can give information about the distribution of protein and polysaccharide on the oil-
water interface [142]. In addition, ATR-FTIR and PXRD analysis for HPMC/X, MC/X and G/CMC 
SOS formulations would give information on the type of interactions and of the crystalline 
and amorphous state of the materials after processing, respectively, which in turn may 
explain the mechanical properties of SOS discussed in Chapter 5, section 5.3.3.8. 
Furthermore, this study opens two new research areas worthy of investigation. These aspects 
were not investigated here because it was not within the scope of this study.   
 Investigate the properties of KIO3 and NaCl nanocrystals in order to explore and find 
application areas where they can be of benefit. Determine the key processing 
parameters affecting the production of nanocrystals of inorganic salts and apply to 
other inorganic crystals to establish a routine production. Besides, in obtaining 
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nanocrystals of inorganic salts, we anticipated that different polymorphs can also be 
obtained during electrospinning processing. Generally, electrospinning and 
electrospraying technologies have been employed for the production of nano-range 
materials such as nanofibres and polymer nanoparticles; however, it was not reported 
to be used for the production of nanocrystals. We anticipate that this method can be 
used not only for the production of inorganic nanocrystals but also can be applied to 
any other chemical substances that can be dissolved or melted. In contrast with other 
methods of obtaining nanocrystals, electrospinning/electrospraying technology offers 
a simple three-step process: solution preparation, electrospinning or electrospraying, 
and collecting the nanocrystals. In the case of electrospinning, it is necessary to use 
special solvents that can dissolve fibres but will not dissolve the nanocrystals and to 
perform the procedure on a flat surface that immediately can wash down or adsorb 
the solvent, so the nanocrystals will not get in contact with each other; the dry 
nanocrystals can then be collected on the surface area and it is possible to sieve them. 
In the case of electrospraying, collect the crystals and simply sieve them through a 
nano-range orifice.  
 Investigate the molecular conformation of PEO in its stretched state using other 
analytical tools, such as ATR-FT IR to validate the conformational changes and 
scanning tunnelling microscopy that can help to obtain visual evidence of 
conformational changes, as well as the tensile strength in order to determine the 
maximum applied force to rapture the film. In addition, the change in molecular 
conformation of PEO upon stretching the electrospun sample led us to make an 
assumption that other polymers that change their molecular conformation upon 
stretching may also exhibit new conformation upon stretching an electrospun sample. 
Thus, we found a number of polymers that change their conformation upon stretching 
and performed a literature search to find out whether these polymers are 
electrospinnable. We found that among them polypropylene, poly(vinylidene 
fluoride), polybutene and nylon 6 are electrospinnable. We anticipated that these 
polymers may also exhibit different conformation changes if stretched after 
electrospinning, because electrospinning gives a certain flexibility to electrospun 
polymers thus they may possess higher tensile strength and hence higher stretching 
is obtained, which resulted in stronger changes in the polymer conformation. 
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Investigation of the conformation of these polymers after stretching them following 
electrospinning will give scientists and manufacturers information on how to handle 
such samples, contribute to the area of polymer research and may open new arenas 
for application. 
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7 Appendices 
7.1 Appendix 1. The effect of Tween 20 surfactant on fibre morphology 
This experiment was carried out to see the effect of surfactant and oil on fibre formation 
when attempting to electrospin emulsion. Emulsion electrospinning failed to effectuate 
(Chapter 4). However, the results show significant improvement of fibre morphology from 
beaded fibres to smooth and uniform fibres with only a small amount of surfactant, namely 1 
w/w % (Figure A1.1). 
 
Figure A1.1. SEM images of a) pure PEO 300K with 7 w/v % solution concentration; b) PEO 
300K mixed with 1 w/w % of Tween 80 with 7 w/v % solution concentration. The EPPs: 150 
mm – 0.5 ml/h – 12 kV. 
7.2 Appendix 2. ATR-FT IR analysis of G/X SOS 
ATR FT-IR analysis was carried out for pure gelatine and xanthan gum powders, pure 
sunflower oil, a mixture of G/X solution without oil and subsequently freeze dried, G/X SOS 
prepared using HPDI and HPH (Chapter 5). The infrared spectrum of each of the samples is 
given in Figures A2.1 – A2.6. The frequency, functional groups and mode of vibration of 
xanthan gum powder and pure sunflower oil are given in Tables A2.1 – A2.2.  
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Figure A2.1. ATR-FTIR spectra of pure sunflower oil. 
 
Figure A2.2. ATR-FTIR spectra of pure xanthan gum powder. 
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Figure A2.3. ATR-FTIR spectra of pure gelatine powder. 
 
Figure A2.4. ATR-FTIR spectra of G/X mixture without oil and freeze dried. 
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Figure A2.5. ATR-FTIR spectra of G/X SOS prepared using HPDI. 
 
Figure A2.6. ATR-FTIR spectra of G/X SOS prepared using HPH.  
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Table A2.1. Frequencies (in cm-1) of bands of sunflower oil mid-infrared spectra, their 
functional groups, the mode of vibration, and the approximate intensity. Adapted from [451]. 
Abbreviations: vst denotes very strong, st – strong, m – medium, vw – very weak. 
Sunflower oil - IR peak assignments 
Frequency (cm-1) Functional group Mode of vibration Intensity 
3008 =C–H (cis)  stretching m 
2922 –C–H (CH
2
) stretching (asym) vst 
2853 –C–H (CH
2
) stretching (sym) vst 
1743 –C=O (ester) stretching vst 
1465 –C–H (CH
2
, CH
3
) bending (scissoring) m 
1377 –C–H (CH
3
) bending (sym)  m 
1237 –C–O, –CH
2
– stretching, bending m 
1160 –C–O, –CH
2
– stretching, bending st 
1120 –C–O stretching m 
1097 –C–O Stretching m 
1031 –C–O Stretching vw 
913 –HC=CH– (cis) bending out of plane vw 
721 –(CH2)n – ,–HC=CH– (cis) rocking, bending out  m 
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Table A2.2. Frequencies (in cm-1) of bands of X powder mid-infrared spectra, together with the tentatively assigned functional group, the mode 
of vibration, and the approximate intensity. Abbreviation: st denotes strong, m – medium, vw – very weak, G – gelatine. 
Xanthan gum - IR peak assignments 
Frequency (cm-1) 
row material and intensities 
Frequency (cm-1) 
HPDI G/X placebo mixture 
Frequency (cm-1) 
HPDI G/X SOS 
Frequency (cm-1) 
HPH G/X SOS 
Assignment & mode of vibration 
[435, 452-454] 
3266 m overlapped G overlapped G overlapped G –OH stretching  
2891 vw overlapped G  overlapped G  overlapped G  –CH2 stretching  
1719 vw overlapped G  overlapped G  overlapped G  –C=O stretching  
1601 m overlapped G  overlapped G  overlapped G  –C=O of pyruvate  
1400 vw overlapped G  overlapped G  overlapped G  CH bending  
1367 vw overlapped G  overlapped G  overlapped G  –C–H  
1243 vw overlapped G  overlapped G  overlapped G  –C–O–C– 
1193 vw overlapped G  overlapped G  overlapped G  –C–O–C–O–C– acetal 
- - 1083 - axial deformation of C–O 
- - 1060 - CO stretching of alcohol 
1018 st 1031 1031 - OH bending 
890 vw overlapped G  overlapped G  overlapped G  – C1–H of β-pyranose 
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7.3 Appendix 3. PXRD analysis of xanthan gum 
We conducted PXRD analysis to confirm the crystalline or amorphous form of xanthan gum 
used in this study because different sources stated different properties. Kumar et al. [453] 
and Yahoum et al. [455] reported that xanthan gum has an amorphous structure, whereas 
Izawa et al. [456] reported that xanthan gum has a higher-ordered structure in the gel and Su 
et al. [435] reported that xanthan gum has a higher degree of crystallinity. Guo et al. [433] 
reported that xanthan gum decreases crystallinity with the increase of the aldehyde content. 
Lad et al. [457] found that the intensity of the diffraction peak of xanthan gum gradually 
decreases with the increase of water content in the sample. From our PXRD results (Figure 
A3.1), the xanthan gum that we used in our experiments is amorphous. However, at the same 
time, two broad humps may indicate a low degree of ordering. A broad peak at 2θ=20.21 and 
a sharp peak at 2θ=32.27 corresponds, probably, to double-helix conformation of xanthan 
gum [456] and the presence of sodium sulphate crystals [457], respectively. 
 
Figure A3.1. PXRD diffraction patterns of xanthan gum powder. 
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7.4 Appendix 4. The new crystal modification of electrospun poly 
(ethylene oxide) under stretching 
Introduction 
Polyethylene oxide is a semi-crystalline polymer that has two diffraction peaks at 2θ = 19° and 
23° on powder X-ray diffraction (PXRD); and two well-known conformations, 7/2 helical 
conformation in the normal state [458] and planar zigzag conformation, stable only under 
tension [459]. It also has various helical conformations in crystalline complexes with urea 
[460], HgCl2 [461, 462], NaI, NaSCN and KSCN [463, 464]. Takahashi et al. [459] showed the 
existence of a planar zigzag conformation for pure PEO. This conformation is stable only when 
stretched and is not characteristic in the absence of an applied stretching. On an X-ray 
diffraction, planar zigzag conformation is shown as a halo at 2θ≈21° and 2θ≈24°–25°. 
In this study, the new crystalline conformation of PEO in a stretched state is revealed, which 
is a finding that has not been previously reported. In the proposed discovery, PEO also 
underwent tension but the structural changes are different from the conformations known 
to date. The PEO nanofibers, obtained by electrospinning and stretched on a metal disk, 
showed the diffraction peaks at 2θ = 19°, 23° (typical for semi-crystalline PEO) and 2θ=43.75° 
(not typical for PEO) in an x-ray diffraction analysis. X-ray diffraction analysis was carried out 
using the powder X-ray diffraction, which showed an intense diffraction peak at 2θ = 43.75°, 
previously not reported. 
Initially, the effect of KIO3 on the structural confirmation of PEO was investigated. The results 
show that KIO3 has no impact on structural conformation or the degree of crystallinity of PEO. 
Then, PXRD analysis was conducted for KIO3 to explore whether there are changes in the KIO3 
crystal structure after electrospinning. KIO3 is an inorganic compound, which at atmospheric 
pressure undergoes five phase transitions with temperature change and all phases are 
ferroelectric, except phase I (Figure A4.1). It has a triclinic structure (P1) with very 
pronounced pseudorhombohedral symmetry at room temperature (phase III). 
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Figure A4.1. Five phase transitions of KIO3 under atmospheric pressure with temperature 
change. The data was adopted from references. 
The PXRD patterns of pure KIO3 were compared with the simulated PXRD patterns of KIO3 
from the atomic positional parameters of KIO3 using The Cambridge Crystallographic Data 
Centre (CCDC) Mercury 3.7 software. The atomic positional parameters of KIO3, which were 
determined by neutron powder-profile-structure refinement with wavelength 1.9090 Å, were 
taken from the work of Lucas [170, 171] and Belokoneva [465]. The PXRD patterns of pure 
PEO were reconstructed from the crystallographic information file, which was downloaded 
from the CCDC official website, using CCDC Mercury 3.7 software. The obtained simulated 
PXRD pattern was then compared with the PXRD patterns of PEO used in this experiment.  
Materials and methods 
Materials and characterization techniques 
PEO (Mw. = 6 × 105 g/mol) and KIO3. Samples were characterized using SEM and PXRD. 
Experimental part 
PEO nanofibre preparation. PEO was dissolved in Milli Q water and electrospun subsequently. 
The concentration of the electrospun solution was 5 w/v %. The EPPs: 150 mm – 0.1 mL/h – 
16-17kV. 
PEO loaded KIO3 nanofibre preparation. PEO and KIO3 were dissolved in Milli Q water in 
different w/w % in order to produce solid fibres containing 0.4% – 43% w/w KIO3. The solid 
content concentration of the electrospun solutions were 5% and 7% w/v. The EPPs: 150 mm 
– 0.1 ml/h – 12 to 25 kV. 
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Placing samples in sample holder:  
1) To obtain its own, correct diffraction of poly (ethylene oxide) on an X-ray diffractogram. 
The nanofibre is removed from the aluminium foil carefully, without stretching the 
nanofibre mat, then folded into several layers with tweezers on a special metal sample 
holder (disk) with zero background and incorporated onto a spinner stage; 
2) To obtain a non-characteristic for poly (ethylene) oxide diffraction peak on an X-ray 
diffractogram when applying a tension force. The nanofibre is removed from the 
aluminium foil carefully, without stretching the nanofibre mat, then stretched over the 
metal disc used for X-ray analysis into a single layer. 
Results and Discussions 
Figure A4.2 shows SEM images of electrospun nanofibres of PEO. As described in Chapter 3, 
PEO nanofibres have a uniform diameter range between 50 nm and 1.2 μm. 
 
Figure A4.2. SEM images of electrospun PEO nanofibres (the right side is increased 
magnification). 
Figure A4.3 shows the PXRD diffraction pattern of electrospun nanofibres of PEO. Under 
mechanical stretching, the conformations of PEO chains in the fibres show significant 
difference. As seen in Figure A4.3b, upon applying mechanical stretching to the PEO fibre 
mats, as indicated with a red arrow, an intensive peak at 2θ = 43.75° is clearly seen. After 
releasing the fibre mat from stretching, the relaxed fibre mat shows the absence of this peak 
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(Figure A4.3a). Although this peak has not been reported in the literature, we anticipated that 
this peak can be associated with the changes of structural conformation of the PEO chain. 
 
Figure A4.3. PXRD diffraction patterns of the electrospun nanofibres: a) folded; b) stretched. 
At the beginning, we conducted PXRD analysis for PEO loaded with 0.4 w/w % of KIO3 but with 
different polymer concentrations, namely 5 w/v % and 7 w/v %. As can be seen in Figure A4.4, 
the results show intensive peaks at 2θ = 43.75° and less intensive peaks at 2θ = 19°, 23° for 
the sample with 5 w/v % solution concentration. In contrast, a less intensive peak at 2θ = 
43.75°, 23° and a very intensive peak at 2θ = 19° were shown for the sample with 7 w/v % 
solution concentration. We anticipated that potassium iodate might affect the 
conformational changes in PEO because the concentration of KIO3 in the sample with 5 w/v 
% solution concentration is higher than in the sample with 7 w/v % solution concentration. 
Therefore, we conducted PXRD analysis for electrospun nanofibres loaded with KIO3 in which 
the concentration was increased gradually from 0 to 43 w/w %.  
 
 
Appendices 
213 
 
 
Figure A4.4. PXRD diffraction patterns of the stretched PEO electrospun nanofibres loaded 
with 0.4 w/w % KIO3: a) the solution concentration is 5 w/v %; b) the solution concentration 
is 7 w/v %. 
Figures A4.5 represents PXRD diffraction patterns of the stretched electrospun nanofibres 
loaded with KIO3 with the concentration ranging from 0 to 43 w/w % and the solution 
concentration is 5 w/v % for all samples. However, as can be seen from the obtained results, 
there is no correlation between KIO3 content and the intensity of diffraction peaks. The 
intensity of diffraction peaks was not related to KIO3 content. High content of KIO3 did not 
result in strong or weak intensities, or vice versa. The intensities were random. In addition, it 
was not clear what caused the origin of the intensive peak at 2θ = 43.75°, because the PEO 
powder does not exhibit it (Figure A4.7) and it does not exist in the literature. We anticipated 
that this might be due to electrospinning. Kim et al. [323] reported that PEO was transformed 
from 7/2 helical conformation in the normal state to planar zigzag conformation due to high 
extensional flow caused by electrospinning. However, in our case the ATR-FT IR analysis did 
not reveal such changes. In addition, Takahashi et al. [459] reported that planar zigzag 
conformation resulted in a  halo at 2θ≈21° and 2θ≈24°-25° in PXRD analysis. Then we 
anticipated that we might be destroying the PEO conformation by stretching the nanofibres 
onto the PXRD sample holder. Therefore, we conducted PXRD analysis for pure PEO 
electrospun nanofibres without KIO3 for the stretched sample and folded sample: the results 
are shown in Figure A4.3, and we found that the intensive peak at 2θ = 43.75° is present in 
the stretched sample and absent in the folded sample. Additionally, we conducted PXRD 
analysis for PEO nanofibres loaded with 0.4 and 43 w/w % of KIO3 and with one sample 
stretched onto the PXRD sample holder and another with the same formulations but 
accurately folded and placed in the PXRD sample holder. As can be seen in Figures A4.6c, d, 
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all diffraction patterns associated with PEO and KIO3 exist. However, in Figures A4.6b, d there 
is one intensive peak at 2θ = 43.75° which is seen for the stretched sample and is not seen in 
Figures A4.6a, c for the folded sample. Therefore, we concluded that the origin of the 
diffraction peak at 2θ = 43.75° is associated with conformational changes during stretching, 
not because of electrospinning or KIO3 presence. The degree of conformational changes is 
related to the force of applying stretching. The higher the force of applied stretching, the 
higher the degree of conformational changes. PXRD analysis for all samples studied in Chapter 
3 are given in Figure A4.7.  
The reason we stretched the nanofibre onto the PXRD sample holder was because we wanted 
to have a plateau surface to get better results. However, it was a mistake; nanofibres should 
be folded and placed on a sample holder without stretching. Caution should be taken when 
peeling off the nanofibres from the Al foil to place in a sample holder to measure with PXRD, 
as weak stretching during peeling off may also cause conformational changes. Thus we 
anticipated that the other polymers that were presented in Takahashi et al. [459] work as 
polymers that undergo crystal transition due to stretching and may also exhibit new structural 
conformation changes if electrospun and tension force is applied. Additional experimental 
work needs to be conducted. 
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Figure A4.5. PXRD diffraction patterns of the stretched PEO electrospun nanofibres loaded 
with: a) 0 w/w % KIO3; b) 0.4 w/w % KIO3; c) 0.8 w/w % KIO3; d) 1.3 w/w % KIO3; e) 2 w/w % 
KIO3; f) 4 w/w % KIO3; g)21 w/w % KIO3; h) 43 w/w % KIO3. The solution concentration is 5 w/v 
%. 
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Figure A4.6. PXRD diffraction patterns of PEO electrospun nanofibres loaded with: a) 0.4 w/w 
% KIO3 – folded; b) 0.4 w/w % KIO3 – stretched; c) 13 w/w % KIO3 – folded; d) 13 w/w % KIO3 
– stretched. The solution concentration is 5 w/v %. 
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Figure A4.7. PXRD diffraction patterns of the folded PEO electrospun nanofibres loaded with: 
a) 0.4 w/w % KIO3; b) 1.3 w/w % KIO3; c) 2 w/w % KIO3; d) 3 w/w % KIO3; e) 4 w/w % KIO3; f) 
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13 w/w % KIO3; g) 21 w/w % KIO3; i) 43 w/w % KIO3; j) 64 w/w % KIO3. The solution 
concentration was 5 w/v %. The red arrows indicate the diffraction peaks of KIO3. 
PEO has two PXRD diffraction patterns in CCDC: one has P1 space group and the other P21/a 
space group (Figures A4.7b, c). Both were reported by Takahashi et al. [459, 466]. The PEO 
used in this study belongs to P21/a space group as its PXRD pattern is similar to the PXRD 
pattern of PEO 600K (Figure A4.7a). 
 
Figure A4.7. PXRD diffraction patterns of pure PEO 600K powder: a) PEO 600K used in this 
study; b) PEO with P1 space group reported by Takahashi et al. [459]; c) PEO with P21/a space 
group reported by Takahashi et al. [466]. 
Various space groups have been reported for potassium iodate. The crystal systems, space 
groups and cell constant of KIO3 were summarized by Crane in his work up until 1972 [467]. 
Lucas, in his work from 1984 and 1985, reported that phase III, IV and V belong to P1 (triclinic, 
Z = 4) space group [171]. In 1987, Byrom and Lucas suggested that the transition from phase 
III to phase I (from triclinic (pseudo-rhombohedral) to rhombohedral (pseudo-cubic)) is the 
only structural transtion that occurs in the temperature range of 10K to 523K [468]. Kasatani 
et al. [469] reported that the space group of KIO3 is as follows: the phase I belongs to R3m 
(rhombohedral, Z = 2), the phase II belongs to Cm (monoclinic, Z = 8), phase III belongs to P1 
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(triclinic, Z = 4). Belokoneva et al. [465] reported that KIO3 belongs to R3 space group (trigonal 
crystal system) at 293K. Naray-Szabo and Kalman [470] reported that several modifications of 
KIO3 can exist together at room temperature. Therefore, we reconstructed PXRD patterns of 
three phases (Figure A4.8) and found that the KIO3 used in this study has the same PXRD 
pattern as the PXRD pattern of the trigonal crystal system at 293K reported by Belokoneva 
[465] and the triclinic crystal system at 100K reported by Lucas [171]. The KIO3 used in this 
study belongs to R3 space group (trigonal crystal system) because the PXRD analysis of KIO3 
used in this study was obtained at room temperature and it cannot undergo any phase 
transitions (Figure A4.8). KIO3 with an R3 space group has diffraction peaks at 2θ = 19.8°, 28°, 
35°, 40°, 45°, 50°, 58°. Phase IV KIO3 has diffraction peaks at 2θ = 19.9°, 28°, 35°, 40°, 45°, 50°, 
59°. Phase III KIO3 has diffraction peaks at 2θ = 13.9°, 19.8°, 24°, 28°, 31.78°, 35°, 37.78°, 40°, 
43°, 45°, 50°, 58°. Phase V KIO3 has diffraction peaks at 2θ = 14°, 19.9°, 25°, 28°, 32°, 35°, 38°, 
40°, 45°, 50°, 59°. 
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Figure A4.8. PXRD diffraction patterns of pure KIO3: a) used in this study; b) simulated PXRD 
diffraction patterns of pure KIO3 from atomic positional parameters of KIO3 taken from 
Belokoneva et al. [465]; c) simulated PXRD diffraction patterns of pure KIO3 from atomic 
positional parameters of KIO3 taken from Lucas [171]; d) simulated PXRD diffraction patterns 
of pure KIO3 from atomic positional parameters of KIO3 taken from Lucas [170]; e) simulated 
PXRD diffraction patterns of pure KIO3 from atomic positional parameters of KIO3 taken from 
Lucas [171]. 
We conducted PXRD analysis for a physical mixture of PEO and KIO3, 50/50 w/w % in order to 
see the difference in PXRD patterns of the physical mixture and the electrospun processed 
sample and to observe if there are any changes. As can be seen in Figure A4.9, there is no 
difference in the PXRD patterns of PEO and KIO3, except for the intensity, which is higher for 
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the electrospun sample. All characteristic peaks of PEO and KIO3 exist in both the physical 
mixture and electrospun sample. 
 
Figure A4.9. PXRD diffraction patterns of physical mixture of PEO 600K powder and KIO3 
powder, 50/50 w/w % compared with PEO loaded KIO3 nanofibres. 
Conclusion 
The PXRD analysis of stretched PEO electrospun nanofibres show a sharp peak at 2θ=43.75°, 
not typical for PEO. We anticipated that this is attributed to a new crystalline conformation 
of PEO in a stretched state, which is different from that reported by Takahashi et al. [459, 
466]. In order to confirm the nature of confirmation, ATR FT-IR and scanning tunnelling 
microscopy should be further conducted. 
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